Zlatan的个人主页 - 老虎社区

Zlatan

Zlatan

暂无个人介绍

IP属地：未知

479关注

31粉丝

0主题

0勋章

2021-12-29

Ok

S&P 500 Ends Lower after Four-Day Rally to Record High

2021-12-28

9kkk

Netflix Stock: This Analyst Predicts 20% Returns

2021-12-27

Buy

Santa Claus Rally watch: What to know this week

2021-12-25

Ok

3 Best Buffett Stocks to Buy for the Long Haul

2021-12-24

No

U.S. authorizes Merck pill as second at-home COVID-19 treatment

2021-12-23

Merry Xmas

2021-12-23

Oo

U.S. authorizes Pfizer oral COVID-19 treatment, first for at-home use

2021-12-22

Ok

Wall Street closes up strongly with boost from Nike, Micron, following Omicron slide

2021-12-21

Oo

Wall Street skids on Omicron worry, obstacle to Biden social-spending package

2021-12-21

Ok

Wall Street skids on Omicron worry, obstacle to Biden social-spending package

2021-12-20

Ok

Biden electric vehicle push hits setback in U.S Senate

2021-12-19

Ok

Got $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows

2021-12-18

Ok

Wall Street ends down after mostly negative week

2021-12-17

Ok

Nasdaq ends sharply lower as investors dump growth stocks

2021-12-16

Ok

Sources: Rivian to build $5B electric truck plant in Georgia

2021-12-15

Ok

Wall Street ends down, investors eye inflation and Omicron

2021-12-14

Ok

Wall Street ends down; investors eye Omicron and Fed meeting

2021-12-13

Ok

These 6 overvalued stocks are making the S&P 500 look more pricey than it really is

2021-12-12

Ok

抱歉，原内容已删除

2021-12-11

Ok

GM eyes $3 billion in investment in Michigan EV plants - source

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3586734124712023,"uuid":"3586734124712023","gmtCreate":1623645770276,"gmtModify":1625642318704,"name":"Zlatan","pinyin":"zlatan","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":31,"headSize":479,"tweetSize":380,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.32%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.10.30","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"60.77%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":696511365,"gmtCreate":1640733906682,"gmtModify":1640733907030,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/696511365","repostId":"1186633322","repostType":4,"repost":{"id":"1186633322","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640732718,"share":"https://www.laohu8.com/m/news/1186633322?lang=&edition=full","pubTime":"2021-12-29 07:05","market":"us","language":"en","title":"S&P 500 Ends Lower after Four-Day Rally to Record High","url":"https://stock-news.laohu8.com/highlight/detail?id=1186633322","media":"Reuters","summary":"Dec 28  - The S&P 500closed slightly lower after hitting a record intraday high on Tuesday, as a four-day rally lost steam in thin trading and investors weighed Omicron-driven travel disruptions and store closures.The Centers for Disease Control and Prevention  on Monday shortened the recommended isolation time for Americans with asymptomatic cases of COVID-19 to five days from the previous guidance of 10 days.The update follows approvals for new pills and more vaccines to fight COVID-19. It hel","content":"<p>Dec 28 (Reuters) - The S&amp;P 500(.SPX)closed slightly lower after hitting a record intraday high on Tuesday, as a four-day rally lost steam in thin trading and investors weighed Omicron-driven travel disruptions and store closures.</p>\n<p>The Centers for Disease Control and Prevention (CDC) on Monday shortened the recommended isolation time for Americans with asymptomatic cases of COVID-19 to five days from the previous guidance of 10 days.</p>\n<p>The update follows approvals for new pills and more vaccines to fight COVID-19. It helped investors shrug off concerns over thousands of flight cancellations and <a href=\"https://laohu8.com/S/AAPL\">Apple</a> Inc(AAPL.O)shutting its <a href=\"https://laohu8.com/S/NWY\">New York</a> stores due to surging cases, and put U.S. stocks on pace for monthly gains.</p>\n<p>\"This is a holiday-shortened week. So daily movements will likely be exaggerated because of a low relative volume,\" said Sam Stovall, chief investment strategist at CFRA Research in <a href=\"https://laohu8.com/S/NYRT\">New York</a>.</p>\n<p>Seven&nbsp;of the 11 major S&amp;P 500 sector indexes rose on Tuesday. Technology(.SPLRCT)and <a href=\"https://laohu8.com/S/JCS\">Communications</a> Services(.SPLRCL)led declines.</p>\n<p>The Dow Jones Industrial Average(.DJI)rose 95.83 points, or 0.26%, to 36,398.21; the S&amp;P 500(.SPX)lost 4.84 points, or 0.10%, to 4,786.35 and the <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a> Composite(.IXIC)dropped 89.54 points, or 0.56%, to 15,781.72.</p>\n<p>In company news, <a href=\"https://laohu8.com/S/BA\">Boeing</a> Co(BA.N)rose 1.46% as Indonesia lifted a ban on its 737 MAX, three years after the crash of <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the aircraft and loss of all 189 people on board.</p>\n<p>Markets are in the seasonal Santa Claus rally, with CFRA Research data showing the S&amp;P 500 has on average risen 1.3% in the last five trading days of the year, and first two days of the new year since 1969.</p>\n<p>\"<a href=\"https://laohu8.com/S/ISBC\">Investors</a> are digesting the gains from the last three days, ... but there are concerns such as how will the Omicron variant affect the market? Would that end up undoing the Santa Claus rally? What about the Fed raising interest rates, could that cause challenges for the year ahead?\" Stovall said.</p>\n<p>The Federal Reserve signaled earlier this month three quarter-percentage-point interest rate hikes by the end of 2022 as the economy nears full employment and the U.S. central bank copes with an inflation surge. L1N2SZ1G5</p>\n<p>Volume on U.S. exchanges was 7.55 billion shares, compared with the 11.56 billion average for the full session over the last 20 trading days.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.04-to-1 ratio; on Nasdaq, a 1.88-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 81 new 52-week highs and no new lows; the Nasdaq Composite recorded 105 new highs and 264 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500 Ends Lower after Four-Day Rally to Record High</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500 Ends Lower after Four-Day Rally to Record High\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-29 07:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 28 (Reuters) - The S&amp;P 500(.SPX)closed slightly lower after hitting a record intraday high on Tuesday, as a four-day rally lost steam in thin trading and investors weighed Omicron-driven travel disruptions and store closures.</p>\n<p>The Centers for Disease Control and Prevention (CDC) on Monday shortened the recommended isolation time for Americans with asymptomatic cases of COVID-19 to five days from the previous guidance of 10 days.</p>\n<p>The update follows approvals for new pills and more vaccines to fight COVID-19. It helped investors shrug off concerns over thousands of flight cancellations and <a href=\"https://laohu8.com/S/AAPL\">Apple</a> Inc(AAPL.O)shutting its <a href=\"https://laohu8.com/S/NWY\">New York</a> stores due to surging cases, and put U.S. stocks on pace for monthly gains.</p>\n<p>\"This is a holiday-shortened week. So daily movements will likely be exaggerated because of a low relative volume,\" said Sam Stovall, chief investment strategist at CFRA Research in <a href=\"https://laohu8.com/S/NYRT\">New York</a>.</p>\n<p>Seven&nbsp;of the 11 major S&amp;P 500 sector indexes rose on Tuesday. Technology(.SPLRCT)and <a href=\"https://laohu8.com/S/JCS\">Communications</a> Services(.SPLRCL)led declines.</p>\n<p>The Dow Jones Industrial Average(.DJI)rose 95.83 points, or 0.26%, to 36,398.21; the S&amp;P 500(.SPX)lost 4.84 points, or 0.10%, to 4,786.35 and the <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a> Composite(.IXIC)dropped 89.54 points, or 0.56%, to 15,781.72.</p>\n<p>In company news, <a href=\"https://laohu8.com/S/BA\">Boeing</a> Co(BA.N)rose 1.46% as Indonesia lifted a ban on its 737 MAX, three years after the crash of <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the aircraft and loss of all 189 people on board.</p>\n<p>Markets are in the seasonal Santa Claus rally, with CFRA Research data showing the S&amp;P 500 has on average risen 1.3% in the last five trading days of the year, and first two days of the new year since 1969.</p>\n<p>\"<a href=\"https://laohu8.com/S/ISBC\">Investors</a> are digesting the gains from the last three days, ... but there are concerns such as how will the Omicron variant affect the market? Would that end up undoing the Santa Claus rally? What about the Fed raising interest rates, could that cause challenges for the year ahead?\" Stovall said.</p>\n<p>The Federal Reserve signaled earlier this month three quarter-percentage-point interest rate hikes by the end of 2022 as the economy nears full employment and the U.S. central bank copes with an inflation surge. L1N2SZ1G5</p>\n<p>Volume on U.S. exchanges was 7.55 billion shares, compared with the 11.56 billion average for the full session over the last 20 trading days.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.04-to-1 ratio; on Nasdaq, a 1.88-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 81 new 52-week highs and no new lows; the Nasdaq Composite recorded 105 new highs and 264 new lows.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF",".SPX":"S&P 500 Index","SPY":"标普500ETF","SSO":"两倍做多标普500ETF","BK4559":"巴菲特持仓","UPRO":"三倍做多标普500ETF","SPXU":"三倍做空标普500ETF","BK4534":"瑞士信贷持仓","BK4550":"红杉资本持仓","IVV":"标普500指数ETF","OEF":"标普100指数ETF-iShares","BK4504":"桥水持仓","SH":"标普500反向ETF","SDS":"两倍做空标普500ETF","OEX":"标普100"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1186633322","content_text":"Dec 28 (Reuters) - The S&P 500(.SPX)closed slightly lower after hitting a record intraday high on Tuesday, as a four-day rally lost steam in thin trading and investors weighed Omicron-driven travel disruptions and store closures.\nThe Centers for Disease Control and Prevention (CDC) on Monday shortened the recommended isolation time for Americans with asymptomatic cases of COVID-19 to five days from the previous guidance of 10 days.\nThe update follows approvals for new pills and more vaccines to fight COVID-19. It helped investors shrug off concerns over thousands of flight cancellations and Apple Inc(AAPL.O)shutting its New York stores due to surging cases, and put U.S. stocks on pace for monthly gains.\n\"This is a holiday-shortened week. So daily movements will likely be exaggerated because of a low relative volume,\" said Sam Stovall, chief investment strategist at CFRA Research in New York.\nSeven of the 11 major S&P 500 sector indexes rose on Tuesday. Technology(.SPLRCT)and Communications Services(.SPLRCL)led declines.\nThe Dow Jones Industrial Average(.DJI)rose 95.83 points, or 0.26%, to 36,398.21; the S&P 500(.SPX)lost 4.84 points, or 0.10%, to 4,786.35 and the Nasdaq Composite(.IXIC)dropped 89.54 points, or 0.56%, to 15,781.72.\nIn company news, Boeing Co(BA.N)rose 1.46% as Indonesia lifted a ban on its 737 MAX, three years after the crash of one of the aircraft and loss of all 189 people on board.\nMarkets are in the seasonal Santa Claus rally, with CFRA Research data showing the S&P 500 has on average risen 1.3% in the last five trading days of the year, and first two days of the new year since 1969.\n\"Investors are digesting the gains from the last three days, ... but there are concerns such as how will the Omicron variant affect the market? Would that end up undoing the Santa Claus rally? What about the Fed raising interest rates, could that cause challenges for the year ahead?\" Stovall said.\nThe Federal Reserve signaled earlier this month three quarter-percentage-point interest rate hikes by the end of 2022 as the economy nears full employment and the U.S. central bank copes with an inflation surge. L1N2SZ1G5\nVolume on U.S. exchanges was 7.55 billion shares, compared with the 11.56 billion average for the full session over the last 20 trading days.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.04-to-1 ratio; on Nasdaq, a 1.88-to-1 ratio favored decliners.\nThe S&P 500 posted 81 new 52-week highs and no new lows; the Nasdaq Composite recorded 105 new highs and 264 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":676,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696139057,"gmtCreate":1640647762503,"gmtModify":1640647762823,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"9kkk","listText":"9kkk","text":"9kkk","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696139057","repostId":"1144860100","repostType":4,"repost":{"id":"1144860100","pubTimestamp":1640619133,"share":"https://www.laohu8.com/m/news/1144860100?lang=&edition=full","pubTime":"2021-12-27 23:32","market":"us","language":"en","title":"Netflix Stock: This Analyst Predicts 20% Returns","url":"https://stock-news.laohu8.com/highlight/detail?id=1144860100","media":"TheStreet","summary":"Even after NFLX's performance so far in 2021, Wall Street analysts see long-term gain potential in t","content":"<p>Even after NFLX's performance so far in 2021, Wall Street analysts see long-term gain potential in this streaming stock.</p>\n<p>Netflix&nbsp;stock has retreated from its late October high around $690 per share to below $610.</p>\n<p>Some investors are worried that the streaming giant's stock will continue to drop. But others are wondering whether Netflix shares will reach new highs in the coming months, making right now a good opportunity to buy.</p>\n<p>Wall Street analysts are starting to feel bullish about Netflix. They're setting increasingly higher price targets for its stock.</p>\n<p>So let's take a closer look at NFLX and assess its long-term investment potential.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6e4620ec9673ba0cb8ccca4acd4ade01\" tg-width=\"1240\" tg-height=\"864\" width=\"100%\" height=\"auto\"><span>Figure 1: Netflix headquarters in Los Gatos, CA.</span></p>\n<p><b>Evercore Forecasts a 20% Return for NFLX</b></p>\n<p>Evercore ISI analyst Mark Mahaney has set his NFLX target at $710, keeping his buy recommendation. This price target opens up an opportunity to achieve an almost 20% return on Netflix shares, compared with today's trading price ($605).</p>\n<p>If Netflix stock does reach $710, it will be the company's all-time high.</p>\n<p>Mahaney is among TipRanks.com's top 100 analysts. He covers the technology sector and has a success rate of over 60% on his recommendations. Additionally, Mahaney has an average return of 43% within TipRanks.</p>\n<p><b>TipRanks Price Targets for NFLX</b></p>\n<p>According to TipRanks, based on 31 analysts who cover NFLX, the average target share price is $678. This already suggests a great upside potential of around 12% from the current price. On average, the stock is rated a moderate buy.</p>\n<p>The highest reported price target is $800, which points to potential gains of over 30% ahead. Such a high valuation probably takes into account Netflix remaining the market leader of the streaming sector in coming years. To do that, it will have to stay ahead of its biggest competitors, Disney&nbsp;and Amazon.</p>\n<p>The lowest NFLX price target on TipRanks is $342, which would represent a loss of more than 40%.</p>\n<p>Of all 31 ratings on NFLX, 24 analysts label the stock a buy, four indicate you should hold, and three recommend selling.</p>\n<p><b>Our Take</b></p>\n<p>Even after Netflix's big stock rally last fall, we still see room for appreciation. Year to date, NFLX has appreciated by more than 15%. But it is already far from its top. And that leaves room for a possible buying opportunity.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bd970e1a30a0271380825554f364907d\" tg-width=\"811\" tg-height=\"428\" width=\"100%\" height=\"auto\"><span>Figure 2: AMZN, DIS, NFLX and SPY performance.</span></p>\n<p>Even so, it's up to the investor to decide whether the company isn't overpriced and whether the Netflix's metrics are evolving as expected by the market. After all, currently, NFLX is trading at multiples much higher than the rest of the streaming industry.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Netflix Stock: This Analyst Predicts 20% Returns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNetflix Stock: This Analyst Predicts 20% Returns\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-27 23:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/streaming/nflx/netflix-stock-this-analyst-predicts-20-returns><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Even after NFLX's performance so far in 2021, Wall Street analysts see long-term gain potential in this streaming stock.\nNetflix stock has retreated from its late October high around $690 per share to...</p>\n\n<a href=\"https://www.thestreet.com/streaming/nflx/netflix-stock-this-analyst-predicts-20-returns\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NFLX":"奈飞"},"source_url":"https://www.thestreet.com/streaming/nflx/netflix-stock-this-analyst-predicts-20-returns","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144860100","content_text":"Even after NFLX's performance so far in 2021, Wall Street analysts see long-term gain potential in this streaming stock.\nNetflix stock has retreated from its late October high around $690 per share to below $610.\nSome investors are worried that the streaming giant's stock will continue to drop. But others are wondering whether Netflix shares will reach new highs in the coming months, making right now a good opportunity to buy.\nWall Street analysts are starting to feel bullish about Netflix. They're setting increasingly higher price targets for its stock.\nSo let's take a closer look at NFLX and assess its long-term investment potential.\nFigure 1: Netflix headquarters in Los Gatos, CA.\nEvercore Forecasts a 20% Return for NFLX\nEvercore ISI analyst Mark Mahaney has set his NFLX target at $710, keeping his buy recommendation. This price target opens up an opportunity to achieve an almost 20% return on Netflix shares, compared with today's trading price ($605).\nIf Netflix stock does reach $710, it will be the company's all-time high.\nMahaney is among TipRanks.com's top 100 analysts. He covers the technology sector and has a success rate of over 60% on his recommendations. Additionally, Mahaney has an average return of 43% within TipRanks.\nTipRanks Price Targets for NFLX\nAccording to TipRanks, based on 31 analysts who cover NFLX, the average target share price is $678. This already suggests a great upside potential of around 12% from the current price. On average, the stock is rated a moderate buy.\nThe highest reported price target is $800, which points to potential gains of over 30% ahead. Such a high valuation probably takes into account Netflix remaining the market leader of the streaming sector in coming years. To do that, it will have to stay ahead of its biggest competitors, Disney and Amazon.\nThe lowest NFLX price target on TipRanks is $342, which would represent a loss of more than 40%.\nOf all 31 ratings on NFLX, 24 analysts label the stock a buy, four indicate you should hold, and three recommend selling.\nOur Take\nEven after Netflix's big stock rally last fall, we still see room for appreciation. Year to date, NFLX has appreciated by more than 15%. But it is already far from its top. And that leaves room for a possible buying opportunity.\nFigure 2: AMZN, DIS, NFLX and SPY performance.\nEven so, it's up to the investor to decide whether the company isn't overpriced and whether the Netflix's metrics are evolving as expected by the market. After all, currently, NFLX is trading at multiples much higher than the rest of the streaming industry.","news_type":1},"isVote":1,"tweetType":1,"viewCount":602,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696063033,"gmtCreate":1640576372079,"gmtModify":1640576372435,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Buy","listText":"Buy","text":"Buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696063033","repostId":"2194177239","repostType":4,"repost":{"id":"2194177239","pubTimestamp":1640559609,"share":"https://www.laohu8.com/m/news/2194177239?lang=&edition=full","pubTime":"2021-12-27 07:00","market":"us","language":"en","title":"Santa Claus Rally watch: What to know this week","url":"https://stock-news.laohu8.com/highlight/detail?id=2194177239","media":"Yahoo Finance","summary":"As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for the coming days.The S&P 500  is entering the period known for ushering in the so-called Santa Claus Rally, or seasonally strong timeframe for stocks at the end of each year.According to data from LPL Financial, the Santa Claus Rally period encapsulates the seven days most likely to be higher in any ","content":"<p>As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for the coming days.</p>\n<p>The S&amp;P 500 (^GSPC) is entering the period known for ushering in the so-called Santa Claus Rally, or seasonally strong timeframe for stocks at the end of each year.</p>\n<p>The term, coined by Stock Trader's Almanac in the 1970s, encompasses the final five trading days of the year and first two sessions of the new year. This year, that Santa Claus Rally window is set to start on Monday, Dec. 27 — or the latest a Santa Claus rally has started in 11 years, due to the timing of the holidays this year.</p>\n<p>According to data from LPL Financial, the Santa Claus Rally period encapsulates the seven days most likely to be higher in any given year. Since 1950, the Santa Claus Rally period has produced a positive return for the S&amp;P 500 78.9% of the time, with an average return of 1.33%.</p>\n<p>“Why are these seven days so strong?” wrote Ryan Detrick, LPL Financial chief market strategist, in a note. “Whether optimism over a coming new year, holiday spending, traders on vacation, institutions squaring up their books — or the holiday spirit — the bottom line is that bulls tend to believe in Santa.”</p>\n<p>And if history is any indication, the absence of a Santa Claus Rally has also typically served as a harbinger of lower near-term returns.</p>\n<p>\"Going back to the mid-1990s, there have been only six times Santa failed to show in December. January was lower five of those six times, and the full year had a solid gain only once (in 2016, but a mini-bear market early in the year),\" Detrick added.</p>\n<p>“Considering the bear markets of 2000 and 2008 both took place after <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the rare instances that Santa failed to show makes believers out of us,\" he said. A bear market typically refers to when stocks drop at least 20% from recent record highs. \"Should this seasonally strong period miss the mark, it could be a warning sign.\"</p>\n<p>And this year, investors do have considerable additional concerns to mull heading into the new year. Though stocks closed out Thursday's session at fresh record highs before the long holiday weekend, December still marked a volatile month to start, with renewed concerns over the Omicron variant and the potential for tighter monetary policy from the Federal Reserve weighing on risk assets. Plus, prospects for more near-term fiscal support via the Biden administration's Build Back Better bill have dwindled, and inflation concerns spiked further. Last week, the Bureau of Economic Analysis reported core personal consumption expenditures (PCE) — the Fed's preferred inflation gauge — rose at a 4.7% year-over-year clip, or the fastest since 1983.</p>\n<p>\"If the U.S. was not battling the Omicron variant, U.S. stocks would be dancing higher as the Santa Claus Rally would have kept the climb going into uncharted territory,\" Edward Moya, chief market strategist at OANDA, wrote in a note last week. \"It is too early to say for sure if we will get a Santa Claus Rally, but given all the short-term risks of Fed tightening, Chinese weakness, fiscal support uncertainty and COVID, Wall Street is not complaining.\"</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1279eeacff5d764e6ff5b3e8f7a24f49\" tg-width=\"4000\" tg-height=\"2667\" referrerpolicy=\"no-referrer\"><span>A man in a Santa Claus costume gestures on the floor at the closing bell of the Dow Industrial Average at the New York Stock Exchange on December 5, 2019 in New York. (Photo by Bryan R. Smith / AFP) (Photo by BRYAN R. SMITH/AFP via Getty Images)BRYAN R. SMITH via Getty Images</span></p>\n<h2>Economic calendar</h2>\n<ul>\n <li><p><b>Monday: </b>Dallas Federal Reserve Manufacturing Activity Index, Dec. (13.0 expected, 11.8 in November)</p></li>\n <li><p><b>Tuesday: </b>FHFA House Price Index, month-over-month, October (0.9% in September); S&amp;P <a href=\"https://laohu8.com/S/CLGX\">CoreLogic</a> Case-Shiller 20 City Composite Index, month-over-month, October (0.9% expected, 0.96% in September); S&amp;P CoreLogic Case-Shiller 20 City Composite Index, year-over-year, October (18.6%. expected, 19.05% in September); S&amp;P CoreLogic Case-Shiller Home Price Index, year-over-year, November (19.51% in October); Richmond Fed Manufacturing Index, December (11 expected,11 in November)</p></li>\n <li><p><b>Wednesday: </b>Wholesale Inventories, month-over-month, November preliminary (1.7% expected, 2.3% in October); Advance Goods Trade Balance, November (-$89.0 billion expected, -$82.9 billion in October); Retail Inventories, month-over-month, November (0.5% expected, 0.1% in October); Pending Home Sales, month-over-month, November (0.5% expected, 7.5% in October)</p></li>\n <li><p><b>Thursday: </b>Initial jobless claims, week ended Dec. 25. (205,000 during prior week); Continuing claims, week ended Dec. 18 (1.859 million during prior week); MNI Chicago PMI, December (62.2 expected, 61.8 in November)</p></li>\n <li><p><b>Friday: </b><i>No notable reports scheduled for release</i></p></li>\n</ul>\n<h2>Earnings calendar</h2>\n<ul>\n <li><p><b>Monday: </b><i>No notable reports scheduled for release</i></p></li>\n <li><p><b>Tuesday: </b><i>No notable reports scheduled for release</i></p></li>\n <li><p><b>Wednesday: </b>FuelCell Energy Inc. (FCEL) before market open</p></li>\n <li><p><b>Thursday: </b><i>No notable reports scheduled for release</i></p></li>\n <li><p><b>Friday: </b><i>No notable reports scheduled for release</i></p></li>\n</ul>","source":"yahoofinance_au","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Santa Claus Rally watch: What to know this week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSanta Claus Rally watch: What to know this week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-27 07:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for ...</p>\n\n<a href=\"https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4096":"电气部件与设备","BK4541":"氢能源","FCEL":"燃料电池能源","SPY.AU":"SPDR® S&P 500® ETF Trust"},"source_url":"https://finance.yahoo.com/news/santa-claus-rally-watch-what-to-know-this-week-142909627.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194177239","content_text":"As traders return from the holiday-shortened week, the price action heading into the new year will be closely monitored — especially given the relatively light economic data and earnings calendar for the coming days.\nThe S&P 500 (^GSPC) is entering the period known for ushering in the so-called Santa Claus Rally, or seasonally strong timeframe for stocks at the end of each year.\nThe term, coined by Stock Trader's Almanac in the 1970s, encompasses the final five trading days of the year and first two sessions of the new year. This year, that Santa Claus Rally window is set to start on Monday, Dec. 27 — or the latest a Santa Claus rally has started in 11 years, due to the timing of the holidays this year.\nAccording to data from LPL Financial, the Santa Claus Rally period encapsulates the seven days most likely to be higher in any given year. Since 1950, the Santa Claus Rally period has produced a positive return for the S&P 500 78.9% of the time, with an average return of 1.33%.\n“Why are these seven days so strong?” wrote Ryan Detrick, LPL Financial chief market strategist, in a note. “Whether optimism over a coming new year, holiday spending, traders on vacation, institutions squaring up their books — or the holiday spirit — the bottom line is that bulls tend to believe in Santa.”\nAnd if history is any indication, the absence of a Santa Claus Rally has also typically served as a harbinger of lower near-term returns.\n\"Going back to the mid-1990s, there have been only six times Santa failed to show in December. January was lower five of those six times, and the full year had a solid gain only once (in 2016, but a mini-bear market early in the year),\" Detrick added.\n“Considering the bear markets of 2000 and 2008 both took place after one of the rare instances that Santa failed to show makes believers out of us,\" he said. A bear market typically refers to when stocks drop at least 20% from recent record highs. \"Should this seasonally strong period miss the mark, it could be a warning sign.\"\nAnd this year, investors do have considerable additional concerns to mull heading into the new year. Though stocks closed out Thursday's session at fresh record highs before the long holiday weekend, December still marked a volatile month to start, with renewed concerns over the Omicron variant and the potential for tighter monetary policy from the Federal Reserve weighing on risk assets. Plus, prospects for more near-term fiscal support via the Biden administration's Build Back Better bill have dwindled, and inflation concerns spiked further. Last week, the Bureau of Economic Analysis reported core personal consumption expenditures (PCE) — the Fed's preferred inflation gauge — rose at a 4.7% year-over-year clip, or the fastest since 1983.\n\"If the U.S. was not battling the Omicron variant, U.S. stocks would be dancing higher as the Santa Claus Rally would have kept the climb going into uncharted territory,\" Edward Moya, chief market strategist at OANDA, wrote in a note last week. \"It is too early to say for sure if we will get a Santa Claus Rally, but given all the short-term risks of Fed tightening, Chinese weakness, fiscal support uncertainty and COVID, Wall Street is not complaining.\"\nA man in a Santa Claus costume gestures on the floor at the closing bell of the Dow Industrial Average at the New York Stock Exchange on December 5, 2019 in New York. (Photo by Bryan R. Smith / AFP) (Photo by BRYAN R. SMITH/AFP via Getty Images)BRYAN R. SMITH via Getty Images\nEconomic calendar\n\nMonday: Dallas Federal Reserve Manufacturing Activity Index, Dec. (13.0 expected, 11.8 in November)\nTuesday: FHFA House Price Index, month-over-month, October (0.9% in September); S&P CoreLogic Case-Shiller 20 City Composite Index, month-over-month, October (0.9% expected, 0.96% in September); S&P CoreLogic Case-Shiller 20 City Composite Index, year-over-year, October (18.6%. expected, 19.05% in September); S&P CoreLogic Case-Shiller Home Price Index, year-over-year, November (19.51% in October); Richmond Fed Manufacturing Index, December (11 expected,11 in November)\nWednesday: Wholesale Inventories, month-over-month, November preliminary (1.7% expected, 2.3% in October); Advance Goods Trade Balance, November (-$89.0 billion expected, -$82.9 billion in October); Retail Inventories, month-over-month, November (0.5% expected, 0.1% in October); Pending Home Sales, month-over-month, November (0.5% expected, 7.5% in October)\nThursday: Initial jobless claims, week ended Dec. 25. (205,000 during prior week); Continuing claims, week ended Dec. 18 (1.859 million during prior week); MNI Chicago PMI, December (62.2 expected, 61.8 in November)\nFriday: No notable reports scheduled for release\n\nEarnings calendar\n\nMonday: No notable reports scheduled for release\nTuesday: No notable reports scheduled for release\nWednesday: FuelCell Energy Inc. (FCEL) before market open\nThursday: No notable reports scheduled for release\nFriday: No notable reports scheduled for release","news_type":1},"isVote":1,"tweetType":1,"viewCount":526,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698216293,"gmtCreate":1640404122349,"gmtModify":1640404122705,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698216293","repostId":"2193917872","repostType":4,"repost":{"id":"2193917872","pubTimestamp":1640398248,"share":"https://www.laohu8.com/m/news/2193917872?lang=&edition=full","pubTime":"2021-12-25 10:10","market":"us","language":"en","title":"3 Best Buffett Stocks to Buy for the Long Haul","url":"https://stock-news.laohu8.com/highlight/detail?id=2193917872","media":"Motley Fool","summary":"Each of these three big pharma stocks are featured in Berkshire Hathaway's massive portfolio.","content":"<p>Since Warren Buffett took full control of <b>Berkshire Hathaway</b> in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of writing.</p>\n<p>The Oracle of Omaha's reputation of buying the highest quality businesses means that many individual investors could also benefit from adding these stocks to their portfolios. Here are three healthcare stocks that Buffett owns, which you may also want to consider buying and holding for the long run.</p>\n<h2>1. Johnson &amp; Johnson</h2>\n<p>The first pharma stock within Berkshire's portfolio to contemplate purchasing is <b>Johnson &amp; Johnson</b> (NYSE:JNJ). While the stock is one of Buffett's smallest holdings, valued at just under $55 million, this doesn't take away from its 59 consecutive years of dividend increases that make the stock a Dividend King.</p>\n<p>J&amp;J will be spinning off its slower-growing and less profitable consumer health segment in the next 18 to 24 months, which should allow the company to focus on its faster-growing, more profitable pharmaceutical segment.</p>\n<p>J&amp;J has a strong existing drug portfolio, which should be able to make up for the upcoming 2025 to 2026 patent expirations for its top-selling drug known, Stelara. Year to date, the immunology drug made up just 9.9% of J&amp;J's $69 billion in net sales.</p>\n<p>These drugs include the immunology blockbuster Tremfya, which received its first of three U.S. Food and Drug Administration (FDA) approvals to date in July 2017. Another drug that was recently approved by the FDA was the oncology blockbuster called Darzalex, which received its first of nine FDA approvals to date in November 2015. These two drugs have grown their year-to-date revenue at high-40% clips year over year and should remain under patent most of this decade.</p>\n<p>J&amp;J's enviable existing drug portfolio and its nearly four dozen indications in late-stage clinical trials explain why analysts anticipate that the stock will deliver 8% annual non-GAAP (adjusted) earnings per share (EPS) growth over the next five years.</p>\n<p>Income investors can scoop up J&amp;J's 2.5% dividend yield at a forward P/E ratio of just 16.2 times, which makes the steady healthcare stock a great buy for the long term.</p>\n<h2>2. Bristol Myers Squibb</h2>\n<p>Another Buffett stock that could be a great fit in your portfolio is <b>Bristol Myers Squibb</b> (NYSE:BMY). Berkshire's Bristol Myers Squibb stake totals nearly $1.4 billion, making it one of the largest healthcare holdings in Berkshire's portfolio.</p>\n<p>Bristol Myers Squibb's oncology blockbusters Revlimid and Opdivo and the anticoagulant blockbuster co-owned with <b>Pfizer</b> (NYSE:PFE) named Eliquis each face patent expirations later this decade. While looming patent expirations on three drugs that account for approximately two-thirds of your company's total revenue sounds frightening, this is nothing new; it's just the nature of Bristol Myers Squibb's industry.</p>\n<p>What matters most is that a company is proactive in developing and acquiring its next generation of blockbuster drugs to absorb key patent expirations. With more than 50 compounds in over 40 different disease areas currently in development at Bristol Myers Squibb, this is exactly what the company has been doing for years now.</p>\n<p>As a result, analysts are projecting that Bristol Myers Squibb will be able to generate 6% annual earnings growth through the next five years.</p>\n<p>Yield-hungry investors can buy Bristol Myers Squibb's market-crushing 3.5% yield at a ridiculously cheap forward P/E ratio of 7.9, which is what makes the stock a buy for those looking to hedge against inflation.</p>\n<h2>3. AbbVie</h2>\n<p>Finally, a Buffett stock that'd also be a good fit for income investors is <b>AbbVie</b> (NYSE:ABBV). Berkshire currently holds about $1.9 billion worth of AbbVie stock.</p>\n<p>It's well known at this point that the biopharmaceutical's top-selling drug in the world, Humira, will be facing intense biosimilar competition in the U.S. beginning in 2023. Even though the immunology drug's U.S. sales made up 31% of AbbVie's $41.24 billion total year-to-date sales, the company's pipeline should be able to stabilize and grow its net revenue beyond 2023.</p>\n<p>AbbVie has 54 compounds in various stages of clinical trials, which is why analysts are forecasting that the stock will grow its adjusted EPS 4.5% annually in the next five years.</p>\n<p>AbbVie's massive 4.4% dividend yield can be picked up at a forward P/E ratio of only 9.3.&nbsp;This is an attractive valuation for a stock with the ability to fight off inflation with healthy dividend hikes.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Best Buffett Stocks to Buy for the Long Haul</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Best Buffett Stocks to Buy for the Long Haul\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-25 10:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Since Warren Buffett took full control of Berkshire Hathaway in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ABBV":"艾伯维公司","BMY":"施贵宝","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193917872","content_text":"Since Warren Buffett took full control of Berkshire Hathaway in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of writing.\nThe Oracle of Omaha's reputation of buying the highest quality businesses means that many individual investors could also benefit from adding these stocks to their portfolios. Here are three healthcare stocks that Buffett owns, which you may also want to consider buying and holding for the long run.\n1. Johnson & Johnson\nThe first pharma stock within Berkshire's portfolio to contemplate purchasing is Johnson & Johnson (NYSE:JNJ). While the stock is one of Buffett's smallest holdings, valued at just under $55 million, this doesn't take away from its 59 consecutive years of dividend increases that make the stock a Dividend King.\nJ&J will be spinning off its slower-growing and less profitable consumer health segment in the next 18 to 24 months, which should allow the company to focus on its faster-growing, more profitable pharmaceutical segment.\nJ&J has a strong existing drug portfolio, which should be able to make up for the upcoming 2025 to 2026 patent expirations for its top-selling drug known, Stelara. Year to date, the immunology drug made up just 9.9% of J&J's $69 billion in net sales.\nThese drugs include the immunology blockbuster Tremfya, which received its first of three U.S. Food and Drug Administration (FDA) approvals to date in July 2017. Another drug that was recently approved by the FDA was the oncology blockbuster called Darzalex, which received its first of nine FDA approvals to date in November 2015. These two drugs have grown their year-to-date revenue at high-40% clips year over year and should remain under patent most of this decade.\nJ&J's enviable existing drug portfolio and its nearly four dozen indications in late-stage clinical trials explain why analysts anticipate that the stock will deliver 8% annual non-GAAP (adjusted) earnings per share (EPS) growth over the next five years.\nIncome investors can scoop up J&J's 2.5% dividend yield at a forward P/E ratio of just 16.2 times, which makes the steady healthcare stock a great buy for the long term.\n2. Bristol Myers Squibb\nAnother Buffett stock that could be a great fit in your portfolio is Bristol Myers Squibb (NYSE:BMY). Berkshire's Bristol Myers Squibb stake totals nearly $1.4 billion, making it one of the largest healthcare holdings in Berkshire's portfolio.\nBristol Myers Squibb's oncology blockbusters Revlimid and Opdivo and the anticoagulant blockbuster co-owned with Pfizer (NYSE:PFE) named Eliquis each face patent expirations later this decade. While looming patent expirations on three drugs that account for approximately two-thirds of your company's total revenue sounds frightening, this is nothing new; it's just the nature of Bristol Myers Squibb's industry.\nWhat matters most is that a company is proactive in developing and acquiring its next generation of blockbuster drugs to absorb key patent expirations. With more than 50 compounds in over 40 different disease areas currently in development at Bristol Myers Squibb, this is exactly what the company has been doing for years now.\nAs a result, analysts are projecting that Bristol Myers Squibb will be able to generate 6% annual earnings growth through the next five years.\nYield-hungry investors can buy Bristol Myers Squibb's market-crushing 3.5% yield at a ridiculously cheap forward P/E ratio of 7.9, which is what makes the stock a buy for those looking to hedge against inflation.\n3. AbbVie\nFinally, a Buffett stock that'd also be a good fit for income investors is AbbVie (NYSE:ABBV). Berkshire currently holds about $1.9 billion worth of AbbVie stock.\nIt's well known at this point that the biopharmaceutical's top-selling drug in the world, Humira, will be facing intense biosimilar competition in the U.S. beginning in 2023. Even though the immunology drug's U.S. sales made up 31% of AbbVie's $41.24 billion total year-to-date sales, the company's pipeline should be able to stabilize and grow its net revenue beyond 2023.\nAbbVie has 54 compounds in various stages of clinical trials, which is why analysts are forecasting that the stock will grow its adjusted EPS 4.5% annually in the next five years.\nAbbVie's massive 4.4% dividend yield can be picked up at a forward P/E ratio of only 9.3. This is an attractive valuation for a stock with the ability to fight off inflation with healthy dividend hikes.","news_type":1},"isVote":1,"tweetType":1,"viewCount":712,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698395449,"gmtCreate":1640301773093,"gmtModify":1640301774476,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"No","listText":"No","text":"No","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698395449","repostId":"1154370846","repostType":4,"repost":{"id":"1154370846","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640299823,"share":"https://www.laohu8.com/m/news/1154370846?lang=&edition=full","pubTime":"2021-12-24 06:50","market":"us","language":"en","title":"U.S. authorizes Merck pill as second at-home COVID-19 treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1154370846","media":"Reuters","summary":"Dec 23 (Reuters) - The U.S. on Thursday authorized Merck & Co's(MRK.N)antiviral pill for COVID-19 fo","content":"<p>Dec 23 (Reuters) - The U.S. on Thursday authorized Merck &amp; Co's(MRK.N)antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving a broader go-ahead to a&nbsp;similar but more effective treatment&nbsp;from Pfizer Inc.</p>\n<p>The U.S. Food and Drug Administration said Merck's drug could be used when other authorized treatments are not accessible or clinically appropriate.</p>\n<p>The drug,molnupiravir, was developed with Ridgeback Biotherapeutics and shown to reduce hospitalizations and deaths by around 30% in a clinical trial of high-risk individuals early in the course of the illness.</p>\n<p>The authorization allows use of the drug for mild-to-moderate COVID-19 and along with the&nbsp;Pfizer pill, could be an important tool against the fast-spreading Omicron variant, which is now dominant in the United States.</p>\n<p>Pfizer's drug,Paxlovid, was authorized on Wednesday for people aged 12 and older and has shown to be nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to trial data.</p>\n<p>The FDA says some patients should avoid Pfizer's two-drug regimen because it includes an older antiviral called ritonavir that is known to have interactions with some other prescription medicines. It is also not recommended for people with severe kidney issues.</p>\n<p>Merck plans to ship hundreds of thousands of treatment courses in coming days and 1 million over the next few weeks. Pfizer plans to ship about 250,000 courses in the next month.</p>\n<p>Availability of other treatments is the first consideration for doctors thinking of prescribing Merck's treatment, according to Patrizia Cavazzoni, the director of FDA's Center for Drug Evaluation and Research.</p>\n<p>The FDA has authorized intravenous treatments, mostly for hospital use, called monoclonal antibodies but availability is limited and efficacy against the Omicron variant is lower.</p>\n<p>FDA official John Farley said during a press briefing that GlaxoSmithKline's&nbsp;and Vir Biotech's&nbsp;antibody drug - which has been shown to work against Omicron - is expected to be in short supply this winter.</p>\n<p>Merck said that its treatment had advantages over the Pfizer pill.</p>\n<p>\"It doesn't require any second drug to boost its efficacy, and you can give it in a variety of special patient populations, including people who have significant issues with liver function or kidney function,\" Nick Kartsonis, Merck's senior vice president of clinical research for vaccines and infectious diseases, told Reuters.</p>\n<p>\"This approval comes at the right time since more COVID-19 treatments are needed to supplement the vaccination effort, especially in light of variants of concern,\" said Cantor Fitzgerald analyst Louise Chen.</p>\n<p>Nearly 62% of people in the United States are fully vaccinated, leaving many Americans unprotected against a wave of Omicron infections. Two doses of the highly successful vaccine from Pfizer Inc and BioNTech SE are only somewhat protective against infection with the Omicron variant while a third dose improves the immune response.</p>\n<p>Merck's and Pfizer's antiviral both work by preventing the virus from replicating. Merck's pill does so by introducing errors into the genetic code of the virus.</p>\n<p>Some of the FDA's experts have said that could lead to more troublesome variants.</p>\n<p>There have also been some safety concerns around the drug because it may affect bone cartilage and growth.</p>\n<p>Due to that reason, Merck's drug is not authorized for use in patients younger than 18, the FDA said. The pill is not recommended for use during pregnancy, the agency added.</p>\n<p>The agency advised that men of reproductive potential use a reliable method of birth control during treatment with molnupiravir, and for at least three months after the final dose.</p>\n<p>The drug is meant to be taken twice a day - four pills each time - for five days, making a full treatment course 40 pills. The treatment was priced at about $700 per course in a deal with the U.S. government for up to 5 million courses.</p>\n<p>The U.S. government has ordered 10 million courses of the Pfizer drug at a price of $530 per course compares to the deal with Merck for as many as 5 million courses of molnupiravir at a price of $700 per course.</p>\n<p>Merck has said molnupiravir, which helps prevent the virus from replicating, should be effective against any variant, including the new Omicron variant.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. authorizes Merck pill as second at-home COVID-19 treatment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. authorizes Merck pill as second at-home COVID-19 treatment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-24 06:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 23 (Reuters) - The U.S. on Thursday authorized Merck &amp; Co's(MRK.N)antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving a broader go-ahead to a&nbsp;similar but more effective treatment&nbsp;from Pfizer Inc.</p>\n<p>The U.S. Food and Drug Administration said Merck's drug could be used when other authorized treatments are not accessible or clinically appropriate.</p>\n<p>The drug,molnupiravir, was developed with Ridgeback Biotherapeutics and shown to reduce hospitalizations and deaths by around 30% in a clinical trial of high-risk individuals early in the course of the illness.</p>\n<p>The authorization allows use of the drug for mild-to-moderate COVID-19 and along with the&nbsp;Pfizer pill, could be an important tool against the fast-spreading Omicron variant, which is now dominant in the United States.</p>\n<p>Pfizer's drug,Paxlovid, was authorized on Wednesday for people aged 12 and older and has shown to be nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to trial data.</p>\n<p>The FDA says some patients should avoid Pfizer's two-drug regimen because it includes an older antiviral called ritonavir that is known to have interactions with some other prescription medicines. It is also not recommended for people with severe kidney issues.</p>\n<p>Merck plans to ship hundreds of thousands of treatment courses in coming days and 1 million over the next few weeks. Pfizer plans to ship about 250,000 courses in the next month.</p>\n<p>Availability of other treatments is the first consideration for doctors thinking of prescribing Merck's treatment, according to Patrizia Cavazzoni, the director of FDA's Center for Drug Evaluation and Research.</p>\n<p>The FDA has authorized intravenous treatments, mostly for hospital use, called monoclonal antibodies but availability is limited and efficacy against the Omicron variant is lower.</p>\n<p>FDA official John Farley said during a press briefing that GlaxoSmithKline's&nbsp;and Vir Biotech's&nbsp;antibody drug - which has been shown to work against Omicron - is expected to be in short supply this winter.</p>\n<p>Merck said that its treatment had advantages over the Pfizer pill.</p>\n<p>\"It doesn't require any second drug to boost its efficacy, and you can give it in a variety of special patient populations, including people who have significant issues with liver function or kidney function,\" Nick Kartsonis, Merck's senior vice president of clinical research for vaccines and infectious diseases, told Reuters.</p>\n<p>\"This approval comes at the right time since more COVID-19 treatments are needed to supplement the vaccination effort, especially in light of variants of concern,\" said Cantor Fitzgerald analyst Louise Chen.</p>\n<p>Nearly 62% of people in the United States are fully vaccinated, leaving many Americans unprotected against a wave of Omicron infections. Two doses of the highly successful vaccine from Pfizer Inc and BioNTech SE are only somewhat protective against infection with the Omicron variant while a third dose improves the immune response.</p>\n<p>Merck's and Pfizer's antiviral both work by preventing the virus from replicating. Merck's pill does so by introducing errors into the genetic code of the virus.</p>\n<p>Some of the FDA's experts have said that could lead to more troublesome variants.</p>\n<p>There have also been some safety concerns around the drug because it may affect bone cartilage and growth.</p>\n<p>Due to that reason, Merck's drug is not authorized for use in patients younger than 18, the FDA said. The pill is not recommended for use during pregnancy, the agency added.</p>\n<p>The agency advised that men of reproductive potential use a reliable method of birth control during treatment with molnupiravir, and for at least three months after the final dose.</p>\n<p>The drug is meant to be taken twice a day - four pills each time - for five days, making a full treatment course 40 pills. The treatment was priced at about $700 per course in a deal with the U.S. government for up to 5 million courses.</p>\n<p>The U.S. government has ordered 10 million courses of the Pfizer drug at a price of $530 per course compares to the deal with Merck for as many as 5 million courses of molnupiravir at a price of $700 per course.</p>\n<p>Merck has said molnupiravir, which helps prevent the virus from replicating, should be effective against any variant, including the new Omicron variant.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154370846","content_text":"Dec 23 (Reuters) - The U.S. on Thursday authorized Merck & Co's(MRK.N)antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving a broader go-ahead to a similar but more effective treatment from Pfizer Inc.\nThe U.S. Food and Drug Administration said Merck's drug could be used when other authorized treatments are not accessible or clinically appropriate.\nThe drug,molnupiravir, was developed with Ridgeback Biotherapeutics and shown to reduce hospitalizations and deaths by around 30% in a clinical trial of high-risk individuals early in the course of the illness.\nThe authorization allows use of the drug for mild-to-moderate COVID-19 and along with the Pfizer pill, could be an important tool against the fast-spreading Omicron variant, which is now dominant in the United States.\nPfizer's drug,Paxlovid, was authorized on Wednesday for people aged 12 and older and has shown to be nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to trial data.\nThe FDA says some patients should avoid Pfizer's two-drug regimen because it includes an older antiviral called ritonavir that is known to have interactions with some other prescription medicines. It is also not recommended for people with severe kidney issues.\nMerck plans to ship hundreds of thousands of treatment courses in coming days and 1 million over the next few weeks. Pfizer plans to ship about 250,000 courses in the next month.\nAvailability of other treatments is the first consideration for doctors thinking of prescribing Merck's treatment, according to Patrizia Cavazzoni, the director of FDA's Center for Drug Evaluation and Research.\nThe FDA has authorized intravenous treatments, mostly for hospital use, called monoclonal antibodies but availability is limited and efficacy against the Omicron variant is lower.\nFDA official John Farley said during a press briefing that GlaxoSmithKline's and Vir Biotech's antibody drug - which has been shown to work against Omicron - is expected to be in short supply this winter.\nMerck said that its treatment had advantages over the Pfizer pill.\n\"It doesn't require any second drug to boost its efficacy, and you can give it in a variety of special patient populations, including people who have significant issues with liver function or kidney function,\" Nick Kartsonis, Merck's senior vice president of clinical research for vaccines and infectious diseases, told Reuters.\n\"This approval comes at the right time since more COVID-19 treatments are needed to supplement the vaccination effort, especially in light of variants of concern,\" said Cantor Fitzgerald analyst Louise Chen.\nNearly 62% of people in the United States are fully vaccinated, leaving many Americans unprotected against a wave of Omicron infections. Two doses of the highly successful vaccine from Pfizer Inc and BioNTech SE are only somewhat protective against infection with the Omicron variant while a third dose improves the immune response.\nMerck's and Pfizer's antiviral both work by preventing the virus from replicating. Merck's pill does so by introducing errors into the genetic code of the virus.\nSome of the FDA's experts have said that could lead to more troublesome variants.\nThere have also been some safety concerns around the drug because it may affect bone cartilage and growth.\nDue to that reason, Merck's drug is not authorized for use in patients younger than 18, the FDA said. The pill is not recommended for use during pregnancy, the agency added.\nThe agency advised that men of reproductive potential use a reliable method of birth control during treatment with molnupiravir, and for at least three months after the final dose.\nThe drug is meant to be taken twice a day - four pills each time - for five days, making a full treatment course 40 pills. The treatment was priced at about $700 per course in a deal with the U.S. government for up to 5 million courses.\nThe U.S. government has ordered 10 million courses of the Pfizer drug at a price of $530 per course compares to the deal with Merck for as many as 5 million courses of molnupiravir at a price of $700 per course.\nMerck has said molnupiravir, which helps prevent the virus from replicating, should be effective against any variant, including the new Omicron variant.","news_type":1},"isVote":1,"tweetType":1,"viewCount":547,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691464116,"gmtCreate":1640229210948,"gmtModify":1640229211249,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Merry Xmas","listText":"Merry Xmas","text":"Merry Xmas","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691464116","isVote":1,"tweetType":1,"viewCount":458,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691241411,"gmtCreate":1640215649064,"gmtModify":1640215649390,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Oo","listText":"Oo","text":"Oo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691241411","repostId":"1131862374","repostType":4,"repost":{"id":"1131862374","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640213195,"share":"https://www.laohu8.com/m/news/1131862374?lang=&edition=full","pubTime":"2021-12-23 06:46","market":"us","language":"en","title":"U.S. authorizes Pfizer oral COVID-19 treatment, first for at-home use","url":"https://stock-news.laohu8.com/highlight/detail?id=1131862374","media":"Reuters","summary":"Dec 22 (Reuters) - The United States on Wednesday authorized Pfizer Inc's antiviral COVID-19 pill fo","content":"<p>Dec 22 (Reuters) - The United States on Wednesday authorized Pfizer Inc's&nbsp;antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first oral treatment and which can be taken at home, providing a potentially important tool in the fight against the fast-spreading&nbsp;Omicron variant.</p>\n<p>Pfizer's antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company's clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.</p>\n<p>Pfizer raised its 2022 production projections to 120 million courses of treatment from 80 million and said it was ready to start immediate delivery in the United States. The treatment's two-drug regimen includes a new medicine and a second older antiviral called ritonavir.</p>\n<p>\"Paxlovid's approval is a major milestone that marks another step towards making COVID-19 a much more manageable infection,\" said Amesh Adalja, a senior scholar at the Johns Hopkins Institute for Health Security.</p>\n<p>\"There are two key issues, however, that remain: It will be scarce in the coming weeks and its optimal use requires prompt diagnosis, which can be difficult with the continual testing problems that plague us,\" Adalja added.</p>\n<p>Pfizer has said it has 180,000 treatment courses ready to ship this year. The U.S. government's contract for 10 million courses of the drug is priced at $530 per course.</p>\n<p>The Food and Drug Administration's decision to issue emergency authorization for the treatment comes as the U.S. combats a surge in COVID-19 cases driven by the Omicron variant, with President Joe Biden announcing&nbsp;plans for more federal&nbsp;vaccination and testing sites.</p>\n<p>The pills can fill a treatment gap opened by the Omicron variant, said William Schaffner, a leading infectious disease expert from the Vanderbilt University School of Medicine. The most widely used monoclonal antibody treatments for COVID-19 have proven to be less effective at fighting the variant and there is limited supply of the one remaining treatment that works, he said.</p>\n<p>Monoclonal antibodies are typically given intravenously in hospitals, are not widely available and are more than twice the cost of the Pfizer pill.</p>\n<p>The Omicron variant, first identified in southern Africa and Hong Kong in November, has spread across the world and now constitutes over 70% of new coronavirus cases in the United States, according to data from the U.S. Centers for Disease Control and Prevention. Prior infection and vaccines have been shown in studies to only partly prevent infection from the variant, though a booster shot does increase protection.</p>\n<p>The FDA said it authorized Paxlovid for emergency use for the treatment of mild-to-moderate disease in adults and children 12 years and older, who are at high risk for progression to severe COVID-19.</p>\n<p>The drug is available by prescription only and should be initiated as soon as possible after diagnosis of COVID-19 and within five days of symptom onset, the FDA&nbsp;said. The pills are meant to be taken every 12 hours for five days beginning shortly after the onset of symptoms.</p>\n<p>While the clinical trials did not include patients under the age of 18, Pfizer said, the authorized adult dosing regimen is expected to result in comparable blood concentration levels of the drug in pediatric patients 12 and older weighing at least 40 kg (88.2 lbs).</p>\n<p>The second drug, ritonavir, is known to have interactions with some other prescription medicines. Pfizer has said that should be manageable and suggested most patients would be able to lower the dose of their other medications while being treated for COVID-19.</p>\n<p>Pfizer said it plans to file a new drug application with the FDA in 2022 for potential full regulatory approval. The European Union's drug regulator last week said that EU countries can use Paxlovid early after diagnosis of an infector, although the its full review of the drug has not been completed.</p>\n<p>Pfizer has agreed to allow generic manufacturers to supply versions of the treatment to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool (MPP). The generic versions are expected later next year.</p>\n<p>A rival pill from Merck &amp; Co&nbsp;is under review by the FDA. The drug, molnupiravir, developed with Ridgeback Biotherapeutics, cut hospitalization and death risk by 30% in a trial.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. authorizes Pfizer oral COVID-19 treatment, first for at-home use</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. authorizes Pfizer oral COVID-19 treatment, first for at-home use\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-23 06:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 22 (Reuters) - The United States on Wednesday authorized Pfizer Inc's&nbsp;antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first oral treatment and which can be taken at home, providing a potentially important tool in the fight against the fast-spreading&nbsp;Omicron variant.</p>\n<p>Pfizer's antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company's clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.</p>\n<p>Pfizer raised its 2022 production projections to 120 million courses of treatment from 80 million and said it was ready to start immediate delivery in the United States. The treatment's two-drug regimen includes a new medicine and a second older antiviral called ritonavir.</p>\n<p>\"Paxlovid's approval is a major milestone that marks another step towards making COVID-19 a much more manageable infection,\" said Amesh Adalja, a senior scholar at the Johns Hopkins Institute for Health Security.</p>\n<p>\"There are two key issues, however, that remain: It will be scarce in the coming weeks and its optimal use requires prompt diagnosis, which can be difficult with the continual testing problems that plague us,\" Adalja added.</p>\n<p>Pfizer has said it has 180,000 treatment courses ready to ship this year. The U.S. government's contract for 10 million courses of the drug is priced at $530 per course.</p>\n<p>The Food and Drug Administration's decision to issue emergency authorization for the treatment comes as the U.S. combats a surge in COVID-19 cases driven by the Omicron variant, with President Joe Biden announcing&nbsp;plans for more federal&nbsp;vaccination and testing sites.</p>\n<p>The pills can fill a treatment gap opened by the Omicron variant, said William Schaffner, a leading infectious disease expert from the Vanderbilt University School of Medicine. The most widely used monoclonal antibody treatments for COVID-19 have proven to be less effective at fighting the variant and there is limited supply of the one remaining treatment that works, he said.</p>\n<p>Monoclonal antibodies are typically given intravenously in hospitals, are not widely available and are more than twice the cost of the Pfizer pill.</p>\n<p>The Omicron variant, first identified in southern Africa and Hong Kong in November, has spread across the world and now constitutes over 70% of new coronavirus cases in the United States, according to data from the U.S. Centers for Disease Control and Prevention. Prior infection and vaccines have been shown in studies to only partly prevent infection from the variant, though a booster shot does increase protection.</p>\n<p>The FDA said it authorized Paxlovid for emergency use for the treatment of mild-to-moderate disease in adults and children 12 years and older, who are at high risk for progression to severe COVID-19.</p>\n<p>The drug is available by prescription only and should be initiated as soon as possible after diagnosis of COVID-19 and within five days of symptom onset, the FDA&nbsp;said. The pills are meant to be taken every 12 hours for five days beginning shortly after the onset of symptoms.</p>\n<p>While the clinical trials did not include patients under the age of 18, Pfizer said, the authorized adult dosing regimen is expected to result in comparable blood concentration levels of the drug in pediatric patients 12 and older weighing at least 40 kg (88.2 lbs).</p>\n<p>The second drug, ritonavir, is known to have interactions with some other prescription medicines. Pfizer has said that should be manageable and suggested most patients would be able to lower the dose of their other medications while being treated for COVID-19.</p>\n<p>Pfizer said it plans to file a new drug application with the FDA in 2022 for potential full regulatory approval. The European Union's drug regulator last week said that EU countries can use Paxlovid early after diagnosis of an infector, although the its full review of the drug has not been completed.</p>\n<p>Pfizer has agreed to allow generic manufacturers to supply versions of the treatment to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool (MPP). The generic versions are expected later next year.</p>\n<p>A rival pill from Merck &amp; Co&nbsp;is under review by the FDA. The drug, molnupiravir, developed with Ridgeback Biotherapeutics, cut hospitalization and death risk by 30% in a trial.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1131862374","content_text":"Dec 22 (Reuters) - The United States on Wednesday authorized Pfizer Inc's antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first oral treatment and which can be taken at home, providing a potentially important tool in the fight against the fast-spreading Omicron variant.\nPfizer's antiviral regimen, Paxlovid, was nearly 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness, according to data from the company's clinical trial. Recent lab data suggests the drug retains its effectiveness against Omicron, Pfizer said.\nPfizer raised its 2022 production projections to 120 million courses of treatment from 80 million and said it was ready to start immediate delivery in the United States. The treatment's two-drug regimen includes a new medicine and a second older antiviral called ritonavir.\n\"Paxlovid's approval is a major milestone that marks another step towards making COVID-19 a much more manageable infection,\" said Amesh Adalja, a senior scholar at the Johns Hopkins Institute for Health Security.\n\"There are two key issues, however, that remain: It will be scarce in the coming weeks and its optimal use requires prompt diagnosis, which can be difficult with the continual testing problems that plague us,\" Adalja added.\nPfizer has said it has 180,000 treatment courses ready to ship this year. The U.S. government's contract for 10 million courses of the drug is priced at $530 per course.\nThe Food and Drug Administration's decision to issue emergency authorization for the treatment comes as the U.S. combats a surge in COVID-19 cases driven by the Omicron variant, with President Joe Biden announcing plans for more federal vaccination and testing sites.\nThe pills can fill a treatment gap opened by the Omicron variant, said William Schaffner, a leading infectious disease expert from the Vanderbilt University School of Medicine. The most widely used monoclonal antibody treatments for COVID-19 have proven to be less effective at fighting the variant and there is limited supply of the one remaining treatment that works, he said.\nMonoclonal antibodies are typically given intravenously in hospitals, are not widely available and are more than twice the cost of the Pfizer pill.\nThe Omicron variant, first identified in southern Africa and Hong Kong in November, has spread across the world and now constitutes over 70% of new coronavirus cases in the United States, according to data from the U.S. Centers for Disease Control and Prevention. Prior infection and vaccines have been shown in studies to only partly prevent infection from the variant, though a booster shot does increase protection.\nThe FDA said it authorized Paxlovid for emergency use for the treatment of mild-to-moderate disease in adults and children 12 years and older, who are at high risk for progression to severe COVID-19.\nThe drug is available by prescription only and should be initiated as soon as possible after diagnosis of COVID-19 and within five days of symptom onset, the FDA said. The pills are meant to be taken every 12 hours for five days beginning shortly after the onset of symptoms.\nWhile the clinical trials did not include patients under the age of 18, Pfizer said, the authorized adult dosing regimen is expected to result in comparable blood concentration levels of the drug in pediatric patients 12 and older weighing at least 40 kg (88.2 lbs).\nThe second drug, ritonavir, is known to have interactions with some other prescription medicines. Pfizer has said that should be manageable and suggested most patients would be able to lower the dose of their other medications while being treated for COVID-19.\nPfizer said it plans to file a new drug application with the FDA in 2022 for potential full regulatory approval. The European Union's drug regulator last week said that EU countries can use Paxlovid early after diagnosis of an infector, although the its full review of the drug has not been completed.\nPfizer has agreed to allow generic manufacturers to supply versions of the treatment to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool (MPP). The generic versions are expected later next year.\nA rival pill from Merck & Co is under review by the FDA. The drug, molnupiravir, developed with Ridgeback Biotherapeutics, cut hospitalization and death risk by 30% in a trial.","news_type":1},"isVote":1,"tweetType":1,"viewCount":529,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691925226,"gmtCreate":1640129185796,"gmtModify":1640129186128,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691925226","repostId":"2193663561","repostType":4,"repost":{"id":"2193663561","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640125936,"share":"https://www.laohu8.com/m/news/2193663561?lang=&edition=full","pubTime":"2021-12-22 06:32","market":"us","language":"en","title":"Wall Street closes up strongly with boost from Nike, Micron, following Omicron slide","url":"https://stock-news.laohu8.com/highlight/detail?id=2193663561","media":"Reuters","summary":"Dec 21  - Wall Street's main indexes ended sharply higher on Tuesday, with strength in travel and tech shares as well as in Nike and Micron Technology following their earnings, as stocks rebounded from a coronavirus-fueled rout the session before.The rapidly spreading Omicron variant of the coronavirus has rattled stock markets around the world, triggering volatility in the final month of 2021, which has otherwise been a strong year for equities.Gains in massive technology and tech-related stock","content":"<ul>\n <li>Energy, tech top-gaining S&amp;P 500 sectors</li>\n <li>Travel stocks surge broadly</li>\n <li>Nike up after beating quarterly estimates</li>\n <li>Micron rises as it sees chip shortages easing</li>\n <li>Indexes up: Dow 1.6%, S&amp;P 1.78%, Nasdaq 2.4%</li>\n</ul>\n<p>Dec 21 (Reuters) - Wall Street's main indexes ended sharply higher on Tuesday, with strength in travel and tech shares as well as in Nike and Micron Technology following their earnings, as stocks rebounded from a coronavirus-fueled rout the session before.</p>\n<p>The rapidly spreading Omicron variant of the coronavirus has rattled stock markets around the world, triggering volatility in the final month of 2021, which has otherwise been a strong year for equities.</p>\n<p>Gains in massive technology and tech-related stocks such as Microsoft&nbsp;and Amazon&nbsp;lifted indexes on Tuesday, as did increases in economically sensitive groups such as energy. Travel-related stocks surged, including Carnival Corp, Las Vegas Sands&nbsp;and <a href=\"https://laohu8.com/S/EXPE\">Expedia</a> Group.</p>\n<p>“It is clearly a risk-on day,\" said David Joy, chief market strategist at Ameriprise Financial in Boston. \"This is clearly, at least for the day, investors saying, 'You know what, we are going to be able to ride through this Omicron surge and come out the other side in pretty good shape.’”</p>\n<p>The Dow Jones Industrial Average&nbsp;rose 560.54 points, or 1.6%, to 35,492.7, the S&amp;P 500&nbsp;gained 81.21 points, or 1.78%, to 4,649.23 and the Nasdaq Composite&nbsp;added 360.14 points, or 2.4%, to 15,341.09.</p>\n<p>Defensive sectors, such as consumer staples&nbsp;and utilities&nbsp;that have led in December, lagged on Tuesday.</p>\n<p>Nike&nbsp;shares rose 6.1% after the sports apparel company's results beat quarterly estimates for profit and revenue, and it said it was more confident that supply chain issues would ease in its next fiscal year.</p>\n<p>Micron Technology&nbsp;shares jumped 10.5% after the chip company forecast second-quarter sales and profits will beat estimates with shortages easing in 2022. The Philadelphia SE Semiconductor index&nbsp;rose 3.4%.</p>\n<p>“If Micron’s forecast is strong, that tells us broadly speaking that demand is strong across many different industries,” said King Lip, chief strategist at Baker Avenue Asset Management, adding that Micron's products \"go into so many different industrial applications.\"</p>\n<p>General Mills&nbsp;shares fell 4% after the consumer staples company missed Wall Street estimates for quarterly profit.</p>\n<p>The benchmark S&amp;P 500 has gained 23.8% so far in 2021.</p>\n<p>Some investors are wary about a tougher environment for equities as the Federal Reserve is expected to start raising interest rates next year.</p>\n<p>\"It's good to see green going into the next year but if you just take a step back and look at the broader picture, you're seeing financial conditions change,\" said Joshua Chastant, senior investment analyst at GuideStone Capital Management.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 4.08-to-1 ratio; on Nasdaq, a 2.95-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 11 new 52-week highs and no new lows; the Nasdaq Composite recorded 27 new highs and 99 new lows.</p>\n<p>About 10.1 billion shares changed hands in U.S. exchanges, below the daily average of roughly 12 billion over the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street closes up strongly with boost from Nike, Micron, following Omicron slide</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street closes up strongly with boost from Nike, Micron, following Omicron slide\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-22 06:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Energy, tech top-gaining S&amp;P 500 sectors</li>\n <li>Travel stocks surge broadly</li>\n <li>Nike up after beating quarterly estimates</li>\n <li>Micron rises as it sees chip shortages easing</li>\n <li>Indexes up: Dow 1.6%, S&amp;P 1.78%, Nasdaq 2.4%</li>\n</ul>\n<p>Dec 21 (Reuters) - Wall Street's main indexes ended sharply higher on Tuesday, with strength in travel and tech shares as well as in Nike and Micron Technology following their earnings, as stocks rebounded from a coronavirus-fueled rout the session before.</p>\n<p>The rapidly spreading Omicron variant of the coronavirus has rattled stock markets around the world, triggering volatility in the final month of 2021, which has otherwise been a strong year for equities.</p>\n<p>Gains in massive technology and tech-related stocks such as Microsoft&nbsp;and Amazon&nbsp;lifted indexes on Tuesday, as did increases in economically sensitive groups such as energy. Travel-related stocks surged, including Carnival Corp, Las Vegas Sands&nbsp;and <a href=\"https://laohu8.com/S/EXPE\">Expedia</a> Group.</p>\n<p>“It is clearly a risk-on day,\" said David Joy, chief market strategist at Ameriprise Financial in Boston. \"This is clearly, at least for the day, investors saying, 'You know what, we are going to be able to ride through this Omicron surge and come out the other side in pretty good shape.’”</p>\n<p>The Dow Jones Industrial Average&nbsp;rose 560.54 points, or 1.6%, to 35,492.7, the S&amp;P 500&nbsp;gained 81.21 points, or 1.78%, to 4,649.23 and the Nasdaq Composite&nbsp;added 360.14 points, or 2.4%, to 15,341.09.</p>\n<p>Defensive sectors, such as consumer staples&nbsp;and utilities&nbsp;that have led in December, lagged on Tuesday.</p>\n<p>Nike&nbsp;shares rose 6.1% after the sports apparel company's results beat quarterly estimates for profit and revenue, and it said it was more confident that supply chain issues would ease in its next fiscal year.</p>\n<p>Micron Technology&nbsp;shares jumped 10.5% after the chip company forecast second-quarter sales and profits will beat estimates with shortages easing in 2022. The Philadelphia SE Semiconductor index&nbsp;rose 3.4%.</p>\n<p>“If Micron’s forecast is strong, that tells us broadly speaking that demand is strong across many different industries,” said King Lip, chief strategist at Baker Avenue Asset Management, adding that Micron's products \"go into so many different industrial applications.\"</p>\n<p>General Mills&nbsp;shares fell 4% after the consumer staples company missed Wall Street estimates for quarterly profit.</p>\n<p>The benchmark S&amp;P 500 has gained 23.8% so far in 2021.</p>\n<p>Some investors are wary about a tougher environment for equities as the Federal Reserve is expected to start raising interest rates next year.</p>\n<p>\"It's good to see green going into the next year but if you just take a step back and look at the broader picture, you're seeing financial conditions change,\" said Joshua Chastant, senior investment analyst at GuideStone Capital Management.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 4.08-to-1 ratio; on Nasdaq, a 2.95-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 11 new 52-week highs and no new lows; the Nasdaq Composite recorded 27 new highs and 99 new lows.</p>\n<p>About 10.1 billion shares changed hands in U.S. exchanges, below the daily average of roughly 12 billion over the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4146":"鞋类","BK4558":"双十一","BK4566":"资本集团","PSQ":"纳指反向ETF","QLD":"纳指两倍做多ETF","QQQ":"纳指100ETF","TQQQ":"纳指三倍做多ETF","DDM":"道指两倍做多ETF",".DJI":"道琼斯","DOG":"道指反向ETF",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index","BK4561":"索罗斯持仓","SDOW":"道指三倍做空ETF-ProShares","DXD":"道指两倍做空ETF","NKE":"耐克","SQQQ":"纳指三倍做空ETF","MU":"美光科技","BK4534":"瑞士信贷持仓","DJX":"1/100道琼斯","QID":"纳指两倍做空ETF","UDOW":"道指三倍做多ETF-ProShares"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193663561","content_text":"Energy, tech top-gaining S&P 500 sectors\nTravel stocks surge broadly\nNike up after beating quarterly estimates\nMicron rises as it sees chip shortages easing\nIndexes up: Dow 1.6%, S&P 1.78%, Nasdaq 2.4%\n\nDec 21 (Reuters) - Wall Street's main indexes ended sharply higher on Tuesday, with strength in travel and tech shares as well as in Nike and Micron Technology following their earnings, as stocks rebounded from a coronavirus-fueled rout the session before.\nThe rapidly spreading Omicron variant of the coronavirus has rattled stock markets around the world, triggering volatility in the final month of 2021, which has otherwise been a strong year for equities.\nGains in massive technology and tech-related stocks such as Microsoft and Amazon lifted indexes on Tuesday, as did increases in economically sensitive groups such as energy. Travel-related stocks surged, including Carnival Corp, Las Vegas Sands and Expedia Group.\n“It is clearly a risk-on day,\" said David Joy, chief market strategist at Ameriprise Financial in Boston. \"This is clearly, at least for the day, investors saying, 'You know what, we are going to be able to ride through this Omicron surge and come out the other side in pretty good shape.’”\nThe Dow Jones Industrial Average rose 560.54 points, or 1.6%, to 35,492.7, the S&P 500 gained 81.21 points, or 1.78%, to 4,649.23 and the Nasdaq Composite added 360.14 points, or 2.4%, to 15,341.09.\nDefensive sectors, such as consumer staples and utilities that have led in December, lagged on Tuesday.\nNike shares rose 6.1% after the sports apparel company's results beat quarterly estimates for profit and revenue, and it said it was more confident that supply chain issues would ease in its next fiscal year.\nMicron Technology shares jumped 10.5% after the chip company forecast second-quarter sales and profits will beat estimates with shortages easing in 2022. The Philadelphia SE Semiconductor index rose 3.4%.\n“If Micron’s forecast is strong, that tells us broadly speaking that demand is strong across many different industries,” said King Lip, chief strategist at Baker Avenue Asset Management, adding that Micron's products \"go into so many different industrial applications.\"\nGeneral Mills shares fell 4% after the consumer staples company missed Wall Street estimates for quarterly profit.\nThe benchmark S&P 500 has gained 23.8% so far in 2021.\nSome investors are wary about a tougher environment for equities as the Federal Reserve is expected to start raising interest rates next year.\n\"It's good to see green going into the next year but if you just take a step back and look at the broader picture, you're seeing financial conditions change,\" said Joshua Chastant, senior investment analyst at GuideStone Capital Management.\nAdvancing issues outnumbered declining ones on the NYSE by a 4.08-to-1 ratio; on Nasdaq, a 2.95-to-1 ratio favored advancers.\nThe S&P 500 posted 11 new 52-week highs and no new lows; the Nasdaq Composite recorded 27 new highs and 99 new lows.\nAbout 10.1 billion shares changed hands in U.S. exchanges, below the daily average of roughly 12 billion over the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":393,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693229887,"gmtCreate":1640042758760,"gmtModify":1640043205291,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Oo","listText":"Oo","text":"Oo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693229887","repostId":"2193761136","repostType":4,"repost":{"id":"2193761136","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640041206,"share":"https://www.laohu8.com/m/news/2193761136?lang=&edition=full","pubTime":"2021-12-21 07:00","market":"us","language":"en","title":"Wall Street skids on Omicron worry, obstacle to Biden social-spending package","url":"https://stock-news.laohu8.com/highlight/detail?id=2193761136","media":"Reuters","summary":"* Financials, materials lead declines among sectors\n* S&P 500 falls below 50-day moving average\n* Or","content":"<p>* Financials, materials lead declines among sectors</p>\n<p>* S&amp;P 500 falls below 50-day moving average</p>\n<p>* Oracle drops after deal to buy Cerner for $28 bln</p>\n<p>* Indexes down: Dow 1.23%, S&amp;P 1.14%, Nasdaq 1.24%</p>\n<p>Dec 20 (Reuters) - Wall Street's main indexes dropped more than 1% on Monday as investors worried about the Omicron COVID-19 variant potentially undercutting the economic rebound and a critical setback to President Joe Biden's social-spending bill.</p>\n<p>The financials&nbsp;and materials&nbsp;sectors fell most among S&amp;P 500 sectors, while declines in mega-cap tech and tech-related stocks also dragged.</p>\n<p>Coronavirus cases surged in New York City and around the United States over the weekend, dashing hopes for a more normal holiday season. Britain's leader said he would take more steps to slow the spread of Omicron if needed, after the Netherlands began a fourth lockdown and as other European nations considered restrictions.</p>\n<p>\"I think (the stock market) is down over COVID fears and how those fears may extend the continuing supply-chain problems and how that will impact profits ... for companies,” Chuck Carlson, chief executive officer at Horizon Investment Services in Hammond, Indiana.</p>\n<p>The Dow Jones Industrial Average&nbsp;fell 433.28 points, or 1.23%, to 34,932.16, the S&amp;P 500&nbsp;lost 52.62 points, or 1.14%, to 4,568.02 and the Nasdaq Composite&nbsp;dropped 188.74 points, or 1.24%, to 14,980.94.</p>\n<p>Financials fell 1.9% and materials dropped 1.8%. Microsoft&nbsp;and Tesla&nbsp;were the biggest individual weights on the S&amp;P 500, falling 1.2% and 3.5% respectively.</p>\n<p>The indexes finished above their session lows, but the benchmark S&amp;P 500 ended below its 50-day moving average, a key technical level.</p>\n<p>In a further knock to market sentiment, U.S. Senator Joe Manchin said on Sunday he would not support Biden's $1.75 trillion domestic investment bill Build Back Better, dealing it a potentially fatal blow.</p>\n<p>After Manchin's comments, Goldman Sachs trimmed its quarterly U.S. GDP forecasts for 2022.</p>\n<p>The developments came as the Federal Reserve decided last week to end its pandemic-era stimulus faster, with the central bank signaling at least three quarter-percentage-point interest rate hikes by the end of 2022.</p>\n<p>Investors have taken a more defensive stance this month, with sectors such as consumer staples&nbsp;and utilities&nbsp;rising most. Those two groups ended Monday's session with slim gains, the only sectors in positive territory.</p>\n<p>The S&amp;P 500 remains up 21.6% so far in 2021.</p>\n<p>“Given the strength of the market so far this year, in some ways you could see investors take some profits and look for greater clarity in the new year,” said Michael Arone, chief investment strategist at State Street Global Advisors.</p>\n<p>In company news, Oracle Corp&nbsp;shares fell 5.2% after the business software maker said it would buy electronic medical records company Cerner Corp&nbsp;for $28.3 billion.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 4.38-to-1 ratio; on Nasdaq, a 2.70-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted two new 52-week highs and 11 new lows; the Nasdaq Composite recorded 13 new highs and 346 new lows.</p>\n<p>About 11.4 billion shares changed hands in U.S. exchanges, below the 12 billion daily average over the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street skids on Omicron worry, obstacle to Biden social-spending package</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street skids on Omicron worry, obstacle to Biden social-spending package\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-21 07:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Financials, materials lead declines among sectors</p>\n<p>* S&amp;P 500 falls below 50-day moving average</p>\n<p>* Oracle drops after deal to buy Cerner for $28 bln</p>\n<p>* Indexes down: Dow 1.23%, S&amp;P 1.14%, Nasdaq 1.24%</p>\n<p>Dec 20 (Reuters) - Wall Street's main indexes dropped more than 1% on Monday as investors worried about the Omicron COVID-19 variant potentially undercutting the economic rebound and a critical setback to President Joe Biden's social-spending bill.</p>\n<p>The financials&nbsp;and materials&nbsp;sectors fell most among S&amp;P 500 sectors, while declines in mega-cap tech and tech-related stocks also dragged.</p>\n<p>Coronavirus cases surged in New York City and around the United States over the weekend, dashing hopes for a more normal holiday season. Britain's leader said he would take more steps to slow the spread of Omicron if needed, after the Netherlands began a fourth lockdown and as other European nations considered restrictions.</p>\n<p>\"I think (the stock market) is down over COVID fears and how those fears may extend the continuing supply-chain problems and how that will impact profits ... for companies,” Chuck Carlson, chief executive officer at Horizon Investment Services in Hammond, Indiana.</p>\n<p>The Dow Jones Industrial Average&nbsp;fell 433.28 points, or 1.23%, to 34,932.16, the S&amp;P 500&nbsp;lost 52.62 points, or 1.14%, to 4,568.02 and the Nasdaq Composite&nbsp;dropped 188.74 points, or 1.24%, to 14,980.94.</p>\n<p>Financials fell 1.9% and materials dropped 1.8%. Microsoft&nbsp;and Tesla&nbsp;were the biggest individual weights on the S&amp;P 500, falling 1.2% and 3.5% respectively.</p>\n<p>The indexes finished above their session lows, but the benchmark S&amp;P 500 ended below its 50-day moving average, a key technical level.</p>\n<p>In a further knock to market sentiment, U.S. Senator Joe Manchin said on Sunday he would not support Biden's $1.75 trillion domestic investment bill Build Back Better, dealing it a potentially fatal blow.</p>\n<p>After Manchin's comments, Goldman Sachs trimmed its quarterly U.S. GDP forecasts for 2022.</p>\n<p>The developments came as the Federal Reserve decided last week to end its pandemic-era stimulus faster, with the central bank signaling at least three quarter-percentage-point interest rate hikes by the end of 2022.</p>\n<p>Investors have taken a more defensive stance this month, with sectors such as consumer staples&nbsp;and utilities&nbsp;rising most. Those two groups ended Monday's session with slim gains, the only sectors in positive territory.</p>\n<p>The S&amp;P 500 remains up 21.6% so far in 2021.</p>\n<p>“Given the strength of the market so far this year, in some ways you could see investors take some profits and look for greater clarity in the new year,” said Michael Arone, chief investment strategist at State Street Global Advisors.</p>\n<p>In company news, Oracle Corp&nbsp;shares fell 5.2% after the business software maker said it would buy electronic medical records company Cerner Corp&nbsp;for $28.3 billion.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 4.38-to-1 ratio; on Nasdaq, a 2.70-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted two new 52-week highs and 11 new lows; the Nasdaq Composite recorded 13 new highs and 346 new lows.</p>\n<p>About 11.4 billion shares changed hands in U.S. exchanges, below the 12 billion daily average over the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SPXU":"三倍做空标普500ETF","IVV":"标普500指数ETF","OEF":"标普100指数ETF-iShares","BK4559":"巴菲特持仓","QID":"纳指两倍做空ETF",".DJI":"道琼斯","SDS":"两倍做空标普500ETF","BK4550":"红杉资本持仓","UDOW":"道指三倍做多ETF-ProShares","UPRO":"三倍做多标普500ETF","SPY":"标普500ETF",".IXIC":"NASDAQ Composite","SH":"标普500反向ETF","OEX":"标普100",".SPX":"S&P 500 Index","PSQ":"纳指反向ETF","QQQ":"纳指100ETF","QLD":"纳指两倍做多ETF","BK4504":"桥水持仓","DDM":"道指两倍做多ETF","TQQQ":"纳指三倍做多ETF","DOG":"道指反向ETF","DJX":"1/100道琼斯","SSO":"两倍做多标普500ETF","SDOW":"道指三倍做空ETF-ProShares","DXD":"道指两倍做空ETF","SQQQ":"纳指三倍做空ETF","BK4534":"瑞士信贷持仓"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193761136","content_text":"* Financials, materials lead declines among sectors\n* S&P 500 falls below 50-day moving average\n* Oracle drops after deal to buy Cerner for $28 bln\n* Indexes down: Dow 1.23%, S&P 1.14%, Nasdaq 1.24%\nDec 20 (Reuters) - Wall Street's main indexes dropped more than 1% on Monday as investors worried about the Omicron COVID-19 variant potentially undercutting the economic rebound and a critical setback to President Joe Biden's social-spending bill.\nThe financials and materials sectors fell most among S&P 500 sectors, while declines in mega-cap tech and tech-related stocks also dragged.\nCoronavirus cases surged in New York City and around the United States over the weekend, dashing hopes for a more normal holiday season. Britain's leader said he would take more steps to slow the spread of Omicron if needed, after the Netherlands began a fourth lockdown and as other European nations considered restrictions.\n\"I think (the stock market) is down over COVID fears and how those fears may extend the continuing supply-chain problems and how that will impact profits ... for companies,” Chuck Carlson, chief executive officer at Horizon Investment Services in Hammond, Indiana.\nThe Dow Jones Industrial Average fell 433.28 points, or 1.23%, to 34,932.16, the S&P 500 lost 52.62 points, or 1.14%, to 4,568.02 and the Nasdaq Composite dropped 188.74 points, or 1.24%, to 14,980.94.\nFinancials fell 1.9% and materials dropped 1.8%. Microsoft and Tesla were the biggest individual weights on the S&P 500, falling 1.2% and 3.5% respectively.\nThe indexes finished above their session lows, but the benchmark S&P 500 ended below its 50-day moving average, a key technical level.\nIn a further knock to market sentiment, U.S. Senator Joe Manchin said on Sunday he would not support Biden's $1.75 trillion domestic investment bill Build Back Better, dealing it a potentially fatal blow.\nAfter Manchin's comments, Goldman Sachs trimmed its quarterly U.S. GDP forecasts for 2022.\nThe developments came as the Federal Reserve decided last week to end its pandemic-era stimulus faster, with the central bank signaling at least three quarter-percentage-point interest rate hikes by the end of 2022.\nInvestors have taken a more defensive stance this month, with sectors such as consumer staples and utilities rising most. Those two groups ended Monday's session with slim gains, the only sectors in positive territory.\nThe S&P 500 remains up 21.6% so far in 2021.\n“Given the strength of the market so far this year, in some ways you could see investors take some profits and look for greater clarity in the new year,” said Michael Arone, chief investment strategist at State Street Global Advisors.\nIn company news, Oracle Corp shares fell 5.2% after the business software maker said it would buy electronic medical records company Cerner Corp for $28.3 billion.\nDeclining issues outnumbered advancing ones on the NYSE by a 4.38-to-1 ratio; on Nasdaq, a 2.70-to-1 ratio favored decliners.\nThe S&P 500 posted two new 52-week highs and 11 new lows; the Nasdaq Composite recorded 13 new highs and 346 new lows.\nAbout 11.4 billion shares changed hands in U.S. exchanges, below the 12 billion daily average over the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":346,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693220989,"gmtCreate":1640042689248,"gmtModify":1640042878862,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693220989","repostId":"2193761136","repostType":4,"repost":{"id":"2193761136","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640041206,"share":"https://www.laohu8.com/m/news/2193761136?lang=&edition=full","pubTime":"2021-12-21 07:00","market":"us","language":"en","title":"Wall Street skids on Omicron worry, obstacle to Biden social-spending package","url":"https://stock-news.laohu8.com/highlight/detail?id=2193761136","media":"Reuters","summary":"* Financials, materials lead declines among sectors\n* S&P 500 falls below 50-day moving average\n* Or","content":"<p>* Financials, materials lead declines among sectors</p>\n<p>* S&amp;P 500 falls below 50-day moving average</p>\n<p>* Oracle drops after deal to buy Cerner for $28 bln</p>\n<p>* Indexes down: Dow 1.23%, S&amp;P 1.14%, Nasdaq 1.24%</p>\n<p>Dec 20 (Reuters) - Wall Street's main indexes dropped more than 1% on Monday as investors worried about the Omicron COVID-19 variant potentially undercutting the economic rebound and a critical setback to President Joe Biden's social-spending bill.</p>\n<p>The financials&nbsp;and materials&nbsp;sectors fell most among S&amp;P 500 sectors, while declines in mega-cap tech and tech-related stocks also dragged.</p>\n<p>Coronavirus cases surged in New York City and around the United States over the weekend, dashing hopes for a more normal holiday season. Britain's leader said he would take more steps to slow the spread of Omicron if needed, after the Netherlands began a fourth lockdown and as other European nations considered restrictions.</p>\n<p>\"I think (the stock market) is down over COVID fears and how those fears may extend the continuing supply-chain problems and how that will impact profits ... for companies,” Chuck Carlson, chief executive officer at Horizon Investment Services in Hammond, Indiana.</p>\n<p>The Dow Jones Industrial Average&nbsp;fell 433.28 points, or 1.23%, to 34,932.16, the S&amp;P 500&nbsp;lost 52.62 points, or 1.14%, to 4,568.02 and the Nasdaq Composite&nbsp;dropped 188.74 points, or 1.24%, to 14,980.94.</p>\n<p>Financials fell 1.9% and materials dropped 1.8%. Microsoft&nbsp;and Tesla&nbsp;were the biggest individual weights on the S&amp;P 500, falling 1.2% and 3.5% respectively.</p>\n<p>The indexes finished above their session lows, but the benchmark S&amp;P 500 ended below its 50-day moving average, a key technical level.</p>\n<p>In a further knock to market sentiment, U.S. Senator Joe Manchin said on Sunday he would not support Biden's $1.75 trillion domestic investment bill Build Back Better, dealing it a potentially fatal blow.</p>\n<p>After Manchin's comments, Goldman Sachs trimmed its quarterly U.S. GDP forecasts for 2022.</p>\n<p>The developments came as the Federal Reserve decided last week to end its pandemic-era stimulus faster, with the central bank signaling at least three quarter-percentage-point interest rate hikes by the end of 2022.</p>\n<p>Investors have taken a more defensive stance this month, with sectors such as consumer staples&nbsp;and utilities&nbsp;rising most. Those two groups ended Monday's session with slim gains, the only sectors in positive territory.</p>\n<p>The S&amp;P 500 remains up 21.6% so far in 2021.</p>\n<p>“Given the strength of the market so far this year, in some ways you could see investors take some profits and look for greater clarity in the new year,” said Michael Arone, chief investment strategist at State Street Global Advisors.</p>\n<p>In company news, Oracle Corp&nbsp;shares fell 5.2% after the business software maker said it would buy electronic medical records company Cerner Corp&nbsp;for $28.3 billion.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 4.38-to-1 ratio; on Nasdaq, a 2.70-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted two new 52-week highs and 11 new lows; the Nasdaq Composite recorded 13 new highs and 346 new lows.</p>\n<p>About 11.4 billion shares changed hands in U.S. exchanges, below the 12 billion daily average over the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street skids on Omicron worry, obstacle to Biden social-spending package</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street skids on Omicron worry, obstacle to Biden social-spending package\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-21 07:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Financials, materials lead declines among sectors</p>\n<p>* S&amp;P 500 falls below 50-day moving average</p>\n<p>* Oracle drops after deal to buy Cerner for $28 bln</p>\n<p>* Indexes down: Dow 1.23%, S&amp;P 1.14%, Nasdaq 1.24%</p>\n<p>Dec 20 (Reuters) - Wall Street's main indexes dropped more than 1% on Monday as investors worried about the Omicron COVID-19 variant potentially undercutting the economic rebound and a critical setback to President Joe Biden's social-spending bill.</p>\n<p>The financials&nbsp;and materials&nbsp;sectors fell most among S&amp;P 500 sectors, while declines in mega-cap tech and tech-related stocks also dragged.</p>\n<p>Coronavirus cases surged in New York City and around the United States over the weekend, dashing hopes for a more normal holiday season. Britain's leader said he would take more steps to slow the spread of Omicron if needed, after the Netherlands began a fourth lockdown and as other European nations considered restrictions.</p>\n<p>\"I think (the stock market) is down over COVID fears and how those fears may extend the continuing supply-chain problems and how that will impact profits ... for companies,” Chuck Carlson, chief executive officer at Horizon Investment Services in Hammond, Indiana.</p>\n<p>The Dow Jones Industrial Average&nbsp;fell 433.28 points, or 1.23%, to 34,932.16, the S&amp;P 500&nbsp;lost 52.62 points, or 1.14%, to 4,568.02 and the Nasdaq Composite&nbsp;dropped 188.74 points, or 1.24%, to 14,980.94.</p>\n<p>Financials fell 1.9% and materials dropped 1.8%. Microsoft&nbsp;and Tesla&nbsp;were the biggest individual weights on the S&amp;P 500, falling 1.2% and 3.5% respectively.</p>\n<p>The indexes finished above their session lows, but the benchmark S&amp;P 500 ended below its 50-day moving average, a key technical level.</p>\n<p>In a further knock to market sentiment, U.S. Senator Joe Manchin said on Sunday he would not support Biden's $1.75 trillion domestic investment bill Build Back Better, dealing it a potentially fatal blow.</p>\n<p>After Manchin's comments, Goldman Sachs trimmed its quarterly U.S. GDP forecasts for 2022.</p>\n<p>The developments came as the Federal Reserve decided last week to end its pandemic-era stimulus faster, with the central bank signaling at least three quarter-percentage-point interest rate hikes by the end of 2022.</p>\n<p>Investors have taken a more defensive stance this month, with sectors such as consumer staples&nbsp;and utilities&nbsp;rising most. Those two groups ended Monday's session with slim gains, the only sectors in positive territory.</p>\n<p>The S&amp;P 500 remains up 21.6% so far in 2021.</p>\n<p>“Given the strength of the market so far this year, in some ways you could see investors take some profits and look for greater clarity in the new year,” said Michael Arone, chief investment strategist at State Street Global Advisors.</p>\n<p>In company news, Oracle Corp&nbsp;shares fell 5.2% after the business software maker said it would buy electronic medical records company Cerner Corp&nbsp;for $28.3 billion.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 4.38-to-1 ratio; on Nasdaq, a 2.70-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted two new 52-week highs and 11 new lows; the Nasdaq Composite recorded 13 new highs and 346 new lows.</p>\n<p>About 11.4 billion shares changed hands in U.S. exchanges, below the 12 billion daily average over the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SPXU":"三倍做空标普500ETF","IVV":"标普500指数ETF","OEF":"标普100指数ETF-iShares","BK4559":"巴菲特持仓","QID":"纳指两倍做空ETF",".DJI":"道琼斯","SDS":"两倍做空标普500ETF","BK4550":"红杉资本持仓","UDOW":"道指三倍做多ETF-ProShares","UPRO":"三倍做多标普500ETF","SPY":"标普500ETF",".IXIC":"NASDAQ Composite","SH":"标普500反向ETF","OEX":"标普100",".SPX":"S&P 500 Index","PSQ":"纳指反向ETF","QQQ":"纳指100ETF","QLD":"纳指两倍做多ETF","BK4504":"桥水持仓","DDM":"道指两倍做多ETF","TQQQ":"纳指三倍做多ETF","DOG":"道指反向ETF","DJX":"1/100道琼斯","SSO":"两倍做多标普500ETF","SDOW":"道指三倍做空ETF-ProShares","DXD":"道指两倍做空ETF","SQQQ":"纳指三倍做空ETF","BK4534":"瑞士信贷持仓"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193761136","content_text":"* Financials, materials lead declines among sectors\n* S&P 500 falls below 50-day moving average\n* Oracle drops after deal to buy Cerner for $28 bln\n* Indexes down: Dow 1.23%, S&P 1.14%, Nasdaq 1.24%\nDec 20 (Reuters) - Wall Street's main indexes dropped more than 1% on Monday as investors worried about the Omicron COVID-19 variant potentially undercutting the economic rebound and a critical setback to President Joe Biden's social-spending bill.\nThe financials and materials sectors fell most among S&P 500 sectors, while declines in mega-cap tech and tech-related stocks also dragged.\nCoronavirus cases surged in New York City and around the United States over the weekend, dashing hopes for a more normal holiday season. Britain's leader said he would take more steps to slow the spread of Omicron if needed, after the Netherlands began a fourth lockdown and as other European nations considered restrictions.\n\"I think (the stock market) is down over COVID fears and how those fears may extend the continuing supply-chain problems and how that will impact profits ... for companies,” Chuck Carlson, chief executive officer at Horizon Investment Services in Hammond, Indiana.\nThe Dow Jones Industrial Average fell 433.28 points, or 1.23%, to 34,932.16, the S&P 500 lost 52.62 points, or 1.14%, to 4,568.02 and the Nasdaq Composite dropped 188.74 points, or 1.24%, to 14,980.94.\nFinancials fell 1.9% and materials dropped 1.8%. Microsoft and Tesla were the biggest individual weights on the S&P 500, falling 1.2% and 3.5% respectively.\nThe indexes finished above their session lows, but the benchmark S&P 500 ended below its 50-day moving average, a key technical level.\nIn a further knock to market sentiment, U.S. Senator Joe Manchin said on Sunday he would not support Biden's $1.75 trillion domestic investment bill Build Back Better, dealing it a potentially fatal blow.\nAfter Manchin's comments, Goldman Sachs trimmed its quarterly U.S. GDP forecasts for 2022.\nThe developments came as the Federal Reserve decided last week to end its pandemic-era stimulus faster, with the central bank signaling at least three quarter-percentage-point interest rate hikes by the end of 2022.\nInvestors have taken a more defensive stance this month, with sectors such as consumer staples and utilities rising most. Those two groups ended Monday's session with slim gains, the only sectors in positive territory.\nThe S&P 500 remains up 21.6% so far in 2021.\n“Given the strength of the market so far this year, in some ways you could see investors take some profits and look for greater clarity in the new year,” said Michael Arone, chief investment strategist at State Street Global Advisors.\nIn company news, Oracle Corp shares fell 5.2% after the business software maker said it would buy electronic medical records company Cerner Corp for $28.3 billion.\nDeclining issues outnumbered advancing ones on the NYSE by a 4.38-to-1 ratio; on Nasdaq, a 2.70-to-1 ratio favored decliners.\nThe S&P 500 posted two new 52-week highs and 11 new lows; the Nasdaq Composite recorded 13 new highs and 346 new lows.\nAbout 11.4 billion shares changed hands in U.S. exchanges, below the 12 billion daily average over the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":842,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693074103,"gmtCreate":1639956111580,"gmtModify":1639956111933,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693074103","repostId":"2192901606","repostType":4,"repost":{"id":"2192901606","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639955078,"share":"https://www.laohu8.com/m/news/2192901606?lang=&edition=full","pubTime":"2021-12-20 07:04","market":"us","language":"en","title":"Biden electric vehicle push hits setback in U.S Senate","url":"https://stock-news.laohu8.com/highlight/detail?id=2192901606","media":"Reuters","summary":"WASHINGTON, Dec 19 (Reuters) - A bid by the White House to dramatically boost electric vehicle tax c","content":"<p>WASHINGTON, Dec 19 (Reuters) - A bid by the White House to dramatically boost electric vehicle tax credits hit a major roadblock on Sunday when a key Senate Democrat said he would not support a $1.75 trillion domestic investment bill.</p>\n<p>West Virginia's Joe Manchin appeared to deal a fatal blow to President Joe Biden's signature domestic policy bill, known as Build Back Better, which also aims to expand the social safety net and tackle climate change.</p>\n<p>The bill includes increasing the current $7,500 EV tax credit to up to $12,500 for union-made U.S. vehicles as well as creating a credit of up to $4,000 for used vehicles. The bill would also again make General Motors and Tesla Inc</p>\n<p>eligible for tax credits after they hit the 200,000-vehicle cap on the existing $7,500 credit.</p>\n<p>The bill also includes a 30% credit for commercial electric vehicles.</p>\n<p>GM and Ford are both launching electric pickup trucks in 2022 and new tax credits could be crucial to meeting initial sales targets, as well as meeting rising vehicle emissions requirements.</p>\n<p>Biden wants 50% of new U.S. vehicles to be electric or plug-in electric hybrid by 2030. The administration is expected as soon as this week to finalize tougher new vehicle emissions rules through 2026, automakers say.</p>\n<p>Manchin opposes a $4,500 tax credit for union-made vehicles that is part of the $12,500 proposal. He calls the union credit \"wrong\" and \"not American.\"</p>\n<p>The EV tax credits are backed by Biden, many congressional Democrats and the United Auto Workers (UAW) union and would disproportionately benefit Detroit's Big Three automakers - GM, Ford Motor Co&nbsp;and Chrysler parent <a href=\"https://laohu8.com/S/STLA\">Stellantis NV</a> - which assemble their U.S.-made vehicles in union-represented plants.</p>\n<p>Tesla and foreign automakers operating in the United States do not have unions representing assembly workers and many have fought UAW efforts to organize U.S. plants.</p>\n<p>Toyota Motor Corp, which has a plant in West Virginia but whose U.S. employees are not union members, has lobbied against the $4,500 union credit.</p>\n<p>Toyota announced this month it is building a $1.29 billion battery plant in North Carolina, while EV startup Rivian Automotive&nbsp;said on Thursday that it will build a $5 billion plant in Georgia.</p>\n<p>Vehicles would have to be made in the United States starting in 2027 to qualify for any of the $12,500 credit, which includes $500 for U.S. made batteries. It has faced criticism from Canada, Mexico, Japan and the European Union.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biden electric vehicle push hits setback in U.S Senate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiden electric vehicle push hits setback in U.S Senate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-20 07:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>WASHINGTON, Dec 19 (Reuters) - A bid by the White House to dramatically boost electric vehicle tax credits hit a major roadblock on Sunday when a key Senate Democrat said he would not support a $1.75 trillion domestic investment bill.</p>\n<p>West Virginia's Joe Manchin appeared to deal a fatal blow to President Joe Biden's signature domestic policy bill, known as Build Back Better, which also aims to expand the social safety net and tackle climate change.</p>\n<p>The bill includes increasing the current $7,500 EV tax credit to up to $12,500 for union-made U.S. vehicles as well as creating a credit of up to $4,000 for used vehicles. The bill would also again make General Motors and Tesla Inc</p>\n<p>eligible for tax credits after they hit the 200,000-vehicle cap on the existing $7,500 credit.</p>\n<p>The bill also includes a 30% credit for commercial electric vehicles.</p>\n<p>GM and Ford are both launching electric pickup trucks in 2022 and new tax credits could be crucial to meeting initial sales targets, as well as meeting rising vehicle emissions requirements.</p>\n<p>Biden wants 50% of new U.S. vehicles to be electric or plug-in electric hybrid by 2030. The administration is expected as soon as this week to finalize tougher new vehicle emissions rules through 2026, automakers say.</p>\n<p>Manchin opposes a $4,500 tax credit for union-made vehicles that is part of the $12,500 proposal. He calls the union credit \"wrong\" and \"not American.\"</p>\n<p>The EV tax credits are backed by Biden, many congressional Democrats and the United Auto Workers (UAW) union and would disproportionately benefit Detroit's Big Three automakers - GM, Ford Motor Co&nbsp;and Chrysler parent <a href=\"https://laohu8.com/S/STLA\">Stellantis NV</a> - which assemble their U.S.-made vehicles in union-represented plants.</p>\n<p>Tesla and foreign automakers operating in the United States do not have unions representing assembly workers and many have fought UAW efforts to organize U.S. plants.</p>\n<p>Toyota Motor Corp, which has a plant in West Virginia but whose U.S. employees are not union members, has lobbied against the $4,500 union credit.</p>\n<p>Toyota announced this month it is building a $1.29 billion battery plant in North Carolina, while EV startup Rivian Automotive&nbsp;said on Thursday that it will build a $5 billion plant in Georgia.</p>\n<p>Vehicles would have to be made in the United States starting in 2027 to qualify for any of the $12,500 credit, which includes $500 for U.S. made batteries. It has faced criticism from Canada, Mexico, Japan and the European Union.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4550":"红杉资本持仓","03160":"华夏日股对冲","BK4555":"新能源车","BK4533":"AQR资本管理(全球第二大对冲基金)","GM":"通用汽车","TM":"丰田汽车","TSLA":"特斯拉","BK4099":"汽车制造商","BK4551":"寇图资本持仓","F":"福特汽车","BK4548":"巴美列捷福持仓","BK4534":"瑞士信贷持仓","BK4527":"明星科技股","RIVN":"Rivian Automotive, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192901606","content_text":"WASHINGTON, Dec 19 (Reuters) - A bid by the White House to dramatically boost electric vehicle tax credits hit a major roadblock on Sunday when a key Senate Democrat said he would not support a $1.75 trillion domestic investment bill.\nWest Virginia's Joe Manchin appeared to deal a fatal blow to President Joe Biden's signature domestic policy bill, known as Build Back Better, which also aims to expand the social safety net and tackle climate change.\nThe bill includes increasing the current $7,500 EV tax credit to up to $12,500 for union-made U.S. vehicles as well as creating a credit of up to $4,000 for used vehicles. The bill would also again make General Motors and Tesla Inc\neligible for tax credits after they hit the 200,000-vehicle cap on the existing $7,500 credit.\nThe bill also includes a 30% credit for commercial electric vehicles.\nGM and Ford are both launching electric pickup trucks in 2022 and new tax credits could be crucial to meeting initial sales targets, as well as meeting rising vehicle emissions requirements.\nBiden wants 50% of new U.S. vehicles to be electric or plug-in electric hybrid by 2030. The administration is expected as soon as this week to finalize tougher new vehicle emissions rules through 2026, automakers say.\nManchin opposes a $4,500 tax credit for union-made vehicles that is part of the $12,500 proposal. He calls the union credit \"wrong\" and \"not American.\"\nThe EV tax credits are backed by Biden, many congressional Democrats and the United Auto Workers (UAW) union and would disproportionately benefit Detroit's Big Three automakers - GM, Ford Motor Co and Chrysler parent Stellantis NV - which assemble their U.S.-made vehicles in union-represented plants.\nTesla and foreign automakers operating in the United States do not have unions representing assembly workers and many have fought UAW efforts to organize U.S. plants.\nToyota Motor Corp, which has a plant in West Virginia but whose U.S. employees are not union members, has lobbied against the $4,500 union credit.\nToyota announced this month it is building a $1.29 billion battery plant in North Carolina, while EV startup Rivian Automotive said on Thursday that it will build a $5 billion plant in Georgia.\nVehicles would have to be made in the United States starting in 2027 to qualify for any of the $12,500 credit, which includes $500 for U.S. made batteries. It has faced criticism from Canada, Mexico, Japan and the European Union.","news_type":1},"isVote":1,"tweetType":1,"viewCount":182,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699424649,"gmtCreate":1639880134918,"gmtModify":1639880135210,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699424649","repostId":"2192754259","repostType":4,"repost":{"id":"2192754259","pubTimestamp":1639811460,"share":"https://www.laohu8.com/m/news/2192754259?lang=&edition=full","pubTime":"2021-12-18 15:11","market":"us","language":"en","title":"Got $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows","url":"https://stock-news.laohu8.com/highlight/detail?id=2192754259","media":"Motley Fool","summary":"Three names you know are trading within 10% of their 52-week lows. They deserve better.","content":"<p>The major market indexes may be near their recent all-time highs, but your portfolio might have missed the memo. There are a lot of stocks struggling outside of the bellwethers that are heavily weighted in the market gauges, and we're not just talking about small and obscure names.</p>\n<p><b>Disney</b>&nbsp;(NYSE:DIS),<b> <a href=\"https://laohu8.com/S/TWTR\">Twitter</a></b>&nbsp;(NYSE:TWTR), and <b>Toast </b>(NYSE:TOST) are all trading within 10% of their 52-week lows. They are market leaders, but investors just aren't feeling the love for the entertainment powerhouse, the social media kingmaker, and the toast of the town in restaurant tech. Let's see why these are three promising ideas for the next $5,000 you want to invest in the market.</p>\n<h4><a href=\"https://laohu8.com/S/DIS\">Disney</a></h4>\n<p>Disney's theme parks call themselves the happiest or merriest places on Earth, but shareholders aren't feeling the same way these days. The media maven's stock is less than 5% away from the 52-week low it hit earlier this month.</p>\n<p>It's pretty surprising to see Disney as a market laggard this year. It's the dominant theme park operator and film studio on the planet, making it a clear beneficiary of the reopening of the economy in 2021. Unfortunately for shareholders, things are never as easy as they seem. Disney+ subscriber growth has slowed recently, and that's problematic since the platform for premium streaming video was the major reason for Disney climbing in 2020.</p>\n<p>Disney near 52-week lows is still a sobering development. The theme parks continue to draw. The top movies this year are largely Disney's handiwork. Even its cruise lines are finally sailing again. The weight of the world may be on beleaguered CEO Bob Chapek's shoulders, but it's a small world after all.</p>\n<p><b><a href=\"https://laohu8.com/S/TWTR\">Twitter</a></b></p>\n<p>Another shocking name skirting fresh lows is Twitter. The company behind the short-form social platform is in a funk, and even the initial 10% pop that the stock experienced after its CEO stepped down late last month proved fleeting. As of Thursday's close, Twitter is also now just 5% above the fresh low it hit two weeks ago.</p>\n<p>The platform is working. Its daily active users have grown 13% over the past year to 211 million. Ad revenue is growing even faster, and that 41% surge is a testament to both Twitter's engagement and its ability to milk more money out of every user. New leadership should help it continue to evolve, and the recent rollout of premium features for those willing to pay a little to improve the experience should get Twitter moving in the right direction again before long.</p>\n<h4><a href=\"https://laohu8.com/S/TOST\">Toast</a></h4>\n<p>Running a restaurant has changed dramatically just in the past couple of years, and Toast is the no-brainer cloud-based platform that keeps eateries on top of all of the trending revenue streams. It's a one-stop shop for restaurant needs. On the consumer-facing end, it helps process mobile ordering for take-out, manage incoming sales from third-party delivery services, and naturally serve as the point-of-sale for in-restaurant dining. It also helps run customer loyalty programs to keep regulars coming back.</p>\n<p>Toast does even more on the enterprise end, tackling everything from payroll to inventory management. With chains and independent concepts emerging smarter out of the pandemic than they were before, the company simplifies the necessary functions of an eatery in the new normal.</p>\n<p>Despite stellar growth -- revenue has soared 105% through the first nine months of this year -- the recent IPO hit an all-time low on Wednesday. It may be causing indigestion for investors who chased the new stock when it popped to double today's price by early November, but right now it feels more like a dinner bell.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-18 15:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/17/got-5000-these-3-growth-stocks-are-trading-near-th/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The major market indexes may be near their recent all-time highs, but your portfolio might have missed the memo. There are a lot of stocks struggling outside of the bellwethers that are heavily ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/17/got-5000-these-3-growth-stocks-are-trading-near-th/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4554":"元宇宙及AR概念","BK4106":"数据处理与外包服务","TOST":"Toast, Inc.","BK4532":"文艺复兴科技持仓","BK4524":"宅经济概念","QNETCN":"纳斯达克中美互联网老虎指数","BK4551":"寇图资本持仓","BK4508":"社交媒体","BK4108":"电影和娱乐","TWTR":"Twitter","BK4561":"索罗斯持仓","DIS":"迪士尼","BK4077":"互动媒体与服务","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4550":"红杉资本持仓","BK4516":"特朗普概念"},"source_url":"https://www.fool.com/investing/2021/12/17/got-5000-these-3-growth-stocks-are-trading-near-th/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192754259","content_text":"The major market indexes may be near their recent all-time highs, but your portfolio might have missed the memo. There are a lot of stocks struggling outside of the bellwethers that are heavily weighted in the market gauges, and we're not just talking about small and obscure names.\nDisney (NYSE:DIS), Twitter (NYSE:TWTR), and Toast (NYSE:TOST) are all trading within 10% of their 52-week lows. They are market leaders, but investors just aren't feeling the love for the entertainment powerhouse, the social media kingmaker, and the toast of the town in restaurant tech. Let's see why these are three promising ideas for the next $5,000 you want to invest in the market.\nDisney\nDisney's theme parks call themselves the happiest or merriest places on Earth, but shareholders aren't feeling the same way these days. The media maven's stock is less than 5% away from the 52-week low it hit earlier this month.\nIt's pretty surprising to see Disney as a market laggard this year. It's the dominant theme park operator and film studio on the planet, making it a clear beneficiary of the reopening of the economy in 2021. Unfortunately for shareholders, things are never as easy as they seem. Disney+ subscriber growth has slowed recently, and that's problematic since the platform for premium streaming video was the major reason for Disney climbing in 2020.\nDisney near 52-week lows is still a sobering development. The theme parks continue to draw. The top movies this year are largely Disney's handiwork. Even its cruise lines are finally sailing again. The weight of the world may be on beleaguered CEO Bob Chapek's shoulders, but it's a small world after all.\nTwitter\nAnother shocking name skirting fresh lows is Twitter. The company behind the short-form social platform is in a funk, and even the initial 10% pop that the stock experienced after its CEO stepped down late last month proved fleeting. As of Thursday's close, Twitter is also now just 5% above the fresh low it hit two weeks ago.\nThe platform is working. Its daily active users have grown 13% over the past year to 211 million. Ad revenue is growing even faster, and that 41% surge is a testament to both Twitter's engagement and its ability to milk more money out of every user. New leadership should help it continue to evolve, and the recent rollout of premium features for those willing to pay a little to improve the experience should get Twitter moving in the right direction again before long.\nToast\nRunning a restaurant has changed dramatically just in the past couple of years, and Toast is the no-brainer cloud-based platform that keeps eateries on top of all of the trending revenue streams. It's a one-stop shop for restaurant needs. On the consumer-facing end, it helps process mobile ordering for take-out, manage incoming sales from third-party delivery services, and naturally serve as the point-of-sale for in-restaurant dining. It also helps run customer loyalty programs to keep regulars coming back.\nToast does even more on the enterprise end, tackling everything from payroll to inventory management. With chains and independent concepts emerging smarter out of the pandemic than they were before, the company simplifies the necessary functions of an eatery in the new normal.\nDespite stellar growth -- revenue has soared 105% through the first nine months of this year -- the recent IPO hit an all-time low on Wednesday. It may be causing indigestion for investors who chased the new stock when it popped to double today's price by early November, but right now it feels more like a dinner bell.","news_type":1},"isVote":1,"tweetType":1,"viewCount":280,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699291752,"gmtCreate":1639802522770,"gmtModify":1639802523080,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/699291752","repostId":"1116106959","repostType":4,"repost":{"id":"1116106959","pubTimestamp":1639785552,"share":"https://www.laohu8.com/m/news/1116106959?lang=&edition=full","pubTime":"2021-12-18 07:59","market":"us","language":"en","title":"Wall Street ends down after mostly negative week","url":"https://stock-news.laohu8.com/highlight/detail?id=1116106959","media":"Reuters","summary":" - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.The S","content":"<p>(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.</p>\n<p>All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.</p>\n<p>Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&amp;P 500 and Nasdaq.</p>\n<p>The S&amp;P 500 growth index lost 0.7% and the value index declined 1.4%.</p>\n<p>All of the 11 major S&amp;P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.</p>\n<p>Adding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.</p>\n<p>Traders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.</p>\n<p>\"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"</p>\n<p>Heavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&amp;P 500 index gained around 23% in the same period.</p>\n<p>In Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&amp;P 500 lost 1.03% to 4,620.64.</p>\n<p>The Nasdaq Composite dropped 0.07% to 15,169.68.</p>\n<p>On a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.</p>\n<p>With options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.</p>\n<p>For the week, the S&amp;P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.</p>\n<p>In Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.</p>\n<p>FedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends down after mostly negative week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends down after mostly negative week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-18 07:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116106959","content_text":"(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.\nAll three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.\nNvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.\nThe S&P 500 growth index lost 0.7% and the value index declined 1.4%.\nAll of the 11 major S&P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.\nAdding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.\nTraders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.\n\"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"\nHeavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&P 500 index gained around 23% in the same period.\nIn Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&P 500 lost 1.03% to 4,620.64.\nThe Nasdaq Composite dropped 0.07% to 15,169.68.\nOn a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.\nWith options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.\nFor the week, the S&P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.\nIn Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.\nFedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.\nThe S&P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":170,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690549986,"gmtCreate":1639696965984,"gmtModify":1639696966334,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690549986","repostId":"2192920942","repostType":4,"repost":{"id":"2192920942","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639694745,"share":"https://www.laohu8.com/m/news/2192920942?lang=&edition=full","pubTime":"2021-12-17 06:45","market":"us","language":"en","title":"Nasdaq ends sharply lower as investors dump growth stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2192920942","media":"Reuters","summary":"* Fed to end bond purchases, signals rate hikes in 2022\n* Tech is worst among 11 S&P 500 sector inde","content":"<p>* Fed to end bond purchases, signals rate hikes in 2022</p>\n<p>* Tech is worst among 11 S&amp;P 500 sector indexes, financials rally</p>\n<p>* Lennar slips after missing quarterly profit</p>\n<p>* Indexes: Dow -0.08%, S&amp;P 500 -0.87%, Nasdaq -2.47%</p>\n<p>Dec 16 (Reuters) - The Nasdaq ended sharply lower on Thursday as the Federal Reserve's announcement of a faster end to its pandemic-era stimulus pushed investors away from Big Tech and toward more economically sensitive sectors.</p>\n<p>Nvidia,Apple,Microsoft, Amazon&nbsp;and Tesla&nbsp;tumbled between 2.6% and 6.8%, hitting the Nasdaq&nbsp;and the S&amp;P 500, while the Dow Jones Industrial Average declined marginally.</p>\n<p>Most of those heavyweight growth stocks have outperformed the broader market in 2021, with Nvidia up more than 100% year to date.</p>\n<p>The Dow Jones Industrial Average&nbsp;fell 0.08% to end at 35,897.64, while the S&amp;P 500&nbsp;lost 0.87% to 4,668.67.</p>\n<p>The Nasdaq Composite&nbsp;dropped 2.47% to 15,180.44.</p>\n<p>The U.S. central bank said on Wednesday it would end its bond purchases in March and signaled three quarter-percentage-point interest rate hikes by the end of 2022.</p>\n<p>That pleased investors who have increasingly worried about an inflation spike related to the coronavirus pandemic. But on Thursday it contributed to the sell-off in growth stocks.</p>\n<p>The S&amp;P 500 value index&nbsp;climbed 0.7%, while the growth index fell 2.1%, reflecting investors' views that high-growth stocks tend to underperform when interest rates rise. The value index includes stocks seen as more likely to do well during an economic recovery.</p>\n<p>\"You're seeing money come out of growth, as it should. If we are going into an environment where interest rates are going up, growth stocks are going to be less attractive\" said Dennis Dick, a trader at Bright Trading LLC.</p>\n<p>\"There's a lot of uncertainty as we go into 2022... We're going to have a more hawkish Fed that is going to pull away the punch bowl,\" he said.</p>\n<p>Among the 11 major S&amp;P 500 sector indexes, technology&nbsp;slumped 2.9%, while financials&nbsp;rallied 1.2%. Eight of the sectors gained, even as the overall index fell.</p>\n<p>\"The Fed gave the market what it wanted, and today I think investors are turning again to pandemic uncertainty, and they're also cautious going into the end of the year,\" said Lindsey Bell, chief investment strategist at Ally Invest, in Charlotte, North Carolina.</p>\n<p>Recent readings on surging producer and consumer prices, as well as the fast-spreading Omicron variant of the coronavirus, have fueled anxiety. The S&amp;P 500, nonetheless, remains up about 25% in 2021 and it is trading near record highs.</p>\n<p>The CBOE Volatility index, often considered Wall Street's fear gauge, slipped to a three-week low.</p>\n<p>Data showed the number of Americans filing new claims for unemployment benefits increased moderately last week, remaining at levels consistent with tightening labor market conditions.</p>\n<p>Separately, a survey showed production at U.S. factories increased to the highest level in nearly three years in November.</p>\n<p>Lennar Corp&nbsp;fell 4.1% after the homebuilder missed analysts' estimates for quarterly profit as pandemic-led supply chain issues pushed lumber costs higher and delayed house deliveries.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.03-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 69 new 52-week highs and 3 new lows; the Nasdaq Composite recorded 43 new highs and 184 new lows.</p>\n<p>Volume on U.S. exchanges was 11.6 billion shares, in line with the average over the last 20 trading days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nasdaq ends sharply lower as investors dump growth stocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNasdaq ends sharply lower as investors dump growth stocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-17 06:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Fed to end bond purchases, signals rate hikes in 2022</p>\n<p>* Tech is worst among 11 S&amp;P 500 sector indexes, financials rally</p>\n<p>* Lennar slips after missing quarterly profit</p>\n<p>* Indexes: Dow -0.08%, S&amp;P 500 -0.87%, Nasdaq -2.47%</p>\n<p>Dec 16 (Reuters) - The Nasdaq ended sharply lower on Thursday as the Federal Reserve's announcement of a faster end to its pandemic-era stimulus pushed investors away from Big Tech and toward more economically sensitive sectors.</p>\n<p>Nvidia,Apple,Microsoft, Amazon&nbsp;and Tesla&nbsp;tumbled between 2.6% and 6.8%, hitting the Nasdaq&nbsp;and the S&amp;P 500, while the Dow Jones Industrial Average declined marginally.</p>\n<p>Most of those heavyweight growth stocks have outperformed the broader market in 2021, with Nvidia up more than 100% year to date.</p>\n<p>The Dow Jones Industrial Average&nbsp;fell 0.08% to end at 35,897.64, while the S&amp;P 500&nbsp;lost 0.87% to 4,668.67.</p>\n<p>The Nasdaq Composite&nbsp;dropped 2.47% to 15,180.44.</p>\n<p>The U.S. central bank said on Wednesday it would end its bond purchases in March and signaled three quarter-percentage-point interest rate hikes by the end of 2022.</p>\n<p>That pleased investors who have increasingly worried about an inflation spike related to the coronavirus pandemic. But on Thursday it contributed to the sell-off in growth stocks.</p>\n<p>The S&amp;P 500 value index&nbsp;climbed 0.7%, while the growth index fell 2.1%, reflecting investors' views that high-growth stocks tend to underperform when interest rates rise. The value index includes stocks seen as more likely to do well during an economic recovery.</p>\n<p>\"You're seeing money come out of growth, as it should. If we are going into an environment where interest rates are going up, growth stocks are going to be less attractive\" said Dennis Dick, a trader at Bright Trading LLC.</p>\n<p>\"There's a lot of uncertainty as we go into 2022... We're going to have a more hawkish Fed that is going to pull away the punch bowl,\" he said.</p>\n<p>Among the 11 major S&amp;P 500 sector indexes, technology&nbsp;slumped 2.9%, while financials&nbsp;rallied 1.2%. Eight of the sectors gained, even as the overall index fell.</p>\n<p>\"The Fed gave the market what it wanted, and today I think investors are turning again to pandemic uncertainty, and they're also cautious going into the end of the year,\" said Lindsey Bell, chief investment strategist at Ally Invest, in Charlotte, North Carolina.</p>\n<p>Recent readings on surging producer and consumer prices, as well as the fast-spreading Omicron variant of the coronavirus, have fueled anxiety. The S&amp;P 500, nonetheless, remains up about 25% in 2021 and it is trading near record highs.</p>\n<p>The CBOE Volatility index, often considered Wall Street's fear gauge, slipped to a three-week low.</p>\n<p>Data showed the number of Americans filing new claims for unemployment benefits increased moderately last week, remaining at levels consistent with tightening labor market conditions.</p>\n<p>Separately, a survey showed production at U.S. factories increased to the highest level in nearly three years in November.</p>\n<p>Lennar Corp&nbsp;fell 4.1% after the homebuilder missed analysts' estimates for quarterly profit as pandemic-led supply chain issues pushed lumber costs higher and delayed house deliveries.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.03-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 69 new 52-week highs and 3 new lows; the Nasdaq Composite recorded 43 new highs and 184 new lows.</p>\n<p>Volume on U.S. exchanges was 11.6 billion shares, in line with the average over the last 20 trading days.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","BK4553":"喜马拉雅资本持仓","PSQ":"纳指反向ETF","BK4543":"AI","QQQ":"纳指100ETF",".DJI":"道琼斯","BK4503":"景林资产持仓","DDM":"道指两倍做多ETF","TQQQ":"纳指三倍做多ETF",".IXIC":"NASDAQ Composite","BK4505":"高瓴资本持仓",".SPX":"S&P 500 Index","DOG":"道指反向ETF","BK4088":"住宅建筑","BK4504":"桥水持仓","OEX":"标普100","BK4527":"明星科技股","BK4561":"索罗斯持仓","BK4554":"元宇宙及AR概念","BK4534":"瑞士信贷持仓","SSO":"两倍做多标普500ETF","BK4533":"AQR资本管理(全球第二大对冲基金)","DXD":"道指两倍做空ETF","SDOW":"道指三倍做空ETF-ProShares","BK4538":"云计算","BK4549":"软银资本持仓","SQQQ":"纳指三倍做空ETF","BK4559":"巴菲特持仓","BK4099":"汽车制造商","SH":"标普500反向ETF","SDS":"两倍做空标普500ETF","BK4548":"巴美列捷福持仓","BK4515":"5G概念","TSLA":"特斯拉","SPXU":"三倍做空标普500ETF","BK4501":"段永平概念","IVV":"标普500指数ETF","BK4567":"ESG概念","BK4524":"宅经济概念","OEF":"标普100指数ETF-iShares","BK4551":"寇图资本持仓","UPRO":"三倍做多标普500ETF","LEN":"莱纳建筑公司","UDOW":"道指三倍做多ETF-ProShares","AMZN":"亚马逊","NVDA":"英伟达"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192920942","content_text":"* Fed to end bond purchases, signals rate hikes in 2022\n* Tech is worst among 11 S&P 500 sector indexes, financials rally\n* Lennar slips after missing quarterly profit\n* Indexes: Dow -0.08%, S&P 500 -0.87%, Nasdaq -2.47%\nDec 16 (Reuters) - The Nasdaq ended sharply lower on Thursday as the Federal Reserve's announcement of a faster end to its pandemic-era stimulus pushed investors away from Big Tech and toward more economically sensitive sectors.\nNvidia,Apple,Microsoft, Amazon and Tesla tumbled between 2.6% and 6.8%, hitting the Nasdaq and the S&P 500, while the Dow Jones Industrial Average declined marginally.\nMost of those heavyweight growth stocks have outperformed the broader market in 2021, with Nvidia up more than 100% year to date.\nThe Dow Jones Industrial Average fell 0.08% to end at 35,897.64, while the S&P 500 lost 0.87% to 4,668.67.\nThe Nasdaq Composite dropped 2.47% to 15,180.44.\nThe U.S. central bank said on Wednesday it would end its bond purchases in March and signaled three quarter-percentage-point interest rate hikes by the end of 2022.\nThat pleased investors who have increasingly worried about an inflation spike related to the coronavirus pandemic. But on Thursday it contributed to the sell-off in growth stocks.\nThe S&P 500 value index climbed 0.7%, while the growth index fell 2.1%, reflecting investors' views that high-growth stocks tend to underperform when interest rates rise. The value index includes stocks seen as more likely to do well during an economic recovery.\n\"You're seeing money come out of growth, as it should. If we are going into an environment where interest rates are going up, growth stocks are going to be less attractive\" said Dennis Dick, a trader at Bright Trading LLC.\n\"There's a lot of uncertainty as we go into 2022... We're going to have a more hawkish Fed that is going to pull away the punch bowl,\" he said.\nAmong the 11 major S&P 500 sector indexes, technology slumped 2.9%, while financials rallied 1.2%. Eight of the sectors gained, even as the overall index fell.\n\"The Fed gave the market what it wanted, and today I think investors are turning again to pandemic uncertainty, and they're also cautious going into the end of the year,\" said Lindsey Bell, chief investment strategist at Ally Invest, in Charlotte, North Carolina.\nRecent readings on surging producer and consumer prices, as well as the fast-spreading Omicron variant of the coronavirus, have fueled anxiety. The S&P 500, nonetheless, remains up about 25% in 2021 and it is trading near record highs.\nThe CBOE Volatility index, often considered Wall Street's fear gauge, slipped to a three-week low.\nData showed the number of Americans filing new claims for unemployment benefits increased moderately last week, remaining at levels consistent with tightening labor market conditions.\nSeparately, a survey showed production at U.S. factories increased to the highest level in nearly three years in November.\nLennar Corp fell 4.1% after the homebuilder missed analysts' estimates for quarterly profit as pandemic-led supply chain issues pushed lumber costs higher and delayed house deliveries.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.03-to-1 ratio; on Nasdaq, a 1.93-to-1 ratio favored decliners.\nThe S&P 500 posted 69 new 52-week highs and 3 new lows; the Nasdaq Composite recorded 43 new highs and 184 new lows.\nVolume on U.S. exchanges was 11.6 billion shares, in line with the average over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":134,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607772228,"gmtCreate":1639610555881,"gmtModify":1639610556168,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607772228","repostId":"1191840172","repostType":4,"repost":{"id":"1191840172","pubTimestamp":1639608150,"share":"https://www.laohu8.com/m/news/1191840172?lang=&edition=full","pubTime":"2021-12-16 06:42","market":"us","language":"en","title":"Sources: Rivian to build $5B electric truck plant in Georgia","url":"https://stock-news.laohu8.com/highlight/detail?id=1191840172","media":"Associated Press","summary":"ATLANTA (AP) — Electric vehicle maker Rivian Automotive will announce Thursday that it’s building a ","content":"<p>ATLANTA (AP) — Electric vehicle maker Rivian Automotive will announce Thursday that it’s building a $5 billion battery and assembly plant east of Atlanta that’s projected to employ 7,500 workers, sources briefed on the decision told The Associated Press.</p>\n<p>Rivian, based in Irvine, California, is a startup manufacturer of electric trucks and commercial delivery vans, challenging both established automakers like Ford and General Motors and electric vehicle leader Tesla.</p>\n<p>The plant could grow to as many as 10,000 workers, sources said, which would make it among the largest auto assembly complexes in the United States, rivaled by behemoths such as the 11,000-worker BMW complex in Spartanburg, South Carolina, and Ford Motor Co.’s 8,600-worker plant in Louisville, Kentucky.</p>\n<p>Rivian will be the largest industrial announcement in Georgia history, surpassing the 4,400-worker Kia complex that opened in West Point in 2009. Georgia has had a number of failed auto plant recruitments. Rivian will give Georgia Gov. Brian Kemp another point to bolster his claims that he has been an excellent steward of Georgia’s economy, even as faces Republican and Democratic challengers when he runs for reelection next year.</p>\n<p>The city of Fort Worth, Texas, offered Rivian a $440 million incentive package to lure the plant during the summer, while published reports indicate Rivian also considered sites in Arizona and Michigan.</p>\n<p>Rivian told Fort Worth its plant would make 200,000 vehicles per year, with workers paid at least $56,000 a year.</p>\n<p>The Atlanta Journal-Constitution was the first to report Rivian’s decision.</p>\n<p>Founder and CEO Robert Scaringe told Bloomberg Television in November that the ability to recruit good workers was the most important factor in the decision. Rivian’s existing plant in Normal, Illinois, like most auto plants that have opened in recent decades, is not unionized.</p>\n<p>Georgia officials are unlikely to detail the full incentive package offered to Rivian on Thursday, but the company could max out what Georgia calls its “mega project tax credit,” for companies that hire at least 1,800 people or invest at least $450 million. That could be worth $118 million in state income tax credits. Local governments are likely to abate property taxes.</p>\n<p>Kia got more than $450 million in incentives for its plant southwest of Atlanta. Georgia has promised $300 million of incentives to the $2.6 billion, 2,600-worker battery plant being built by SK Innovation in Commerce, Georgia, northeast of Atlanta.</p>\n<p>Rivian, like Tesla, deals with its customers directly instead of through dealers. Its arrival in Georgia could prompt the state to loosen a law that mostly prohibits manufacturers from selling directly.</p>\n<p>Rivian currently plans two models for consumers — the R1T pickup with a base price of $67,500 and the R1S SUV, with a base price of $70,000. The truck was recently named Motor Trend’s 2022 truck of the year.</p>\n<p>Amazon, which owns a slice of the company, has ordered 100,000 delivery vans, launching Rivian into the commercial vehicle business.</p>\n<p>Rivian is flush with cash following a $11.9 billion stock offering Nov. 10 that took the company public, allowing it to finance the new plant. Its market value is nearly $95 billion, more than either General Motors or Ford.</p>\n<p>The company argues that electric vehicle adoption is at the “tipping point” and it is well positioned for success because trucks and SUVs have long been the most profitable vehicles sold. But some analysts question whether it needs another plant besides the former Mitsubishi plant in Illinois, that Rivian bought for $16 million in 2017. Rivian says it has a yearly capacity of 150,000 vehicles, but is looking to expand there as well.</p>\n<p>“It seems like it might be a little premature to invest that much in another large plant just yet,” said Sam Abuelsamid, principal mobility analyst for Guidehouse Insights, who said Rivian also may be looking for a manufacturing site in Europe.</p>\n<p>Given the size of the Georgia plant, Abuelsamid expects it to make other parts for the vehicles, similar to electric vehicle leader Tesla making seats at its factory in Fremont, California.</p>\n<p>Rivian has cash in the bank, but will burn through that quickly unless it starts delivering vehicles and generating cash, jeopardizing its market darling status, Abuelsamid said. The company needs more retail customers and commercial vehicle buyers other than Amazon, he said.</p>\n<p>“If actual deliveries don’t start picking up, the markets could turn against them as they have with some other EV startups not called Tesla,” Abuelsamid said. “Unlike Tesla, Rivian will be facing serious competition in a much shorter time frame than the near- decade head start that Tesla had.”</p>\n<p>Ford and GM plan to start selling their own electric pickup trucks in the next year or two, while Tesla also plans a new pickup. That’s part of a wave of electric vehicle investment, with SK’s $5 billion battery plant northeast of Atlanta just one example. Ford announced in September it would spend $11.4 billion to build three battery factories and an assembly plant in Kentucky and Tennessee.</p>\n<p>The LMC Automotive consulting firm expects U.S. sales of new fully electric vehicles to hit nearly 400,000 this year, nearly double last year’s figures. But they still make up only about 2.6% of sales. The firm expects sales to grow to more than 730,000 next year and more than 2 million by 2025. Even at 2 million, EV sales still would be only about 12% of U.S. new vehicle sales.</p>","source":"lsy1603278176698","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sources: Rivian to build $5B electric truck plant in Georgia</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSources: Rivian to build $5B electric truck plant in Georgia\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 06:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://apnews.com/article/technology-business-united-states-georgia-kentucky-2de39c33395d7353e3401642e5e1faad><strong>Associated Press</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ATLANTA (AP) — Electric vehicle maker Rivian Automotive will announce Thursday that it’s building a $5 billion battery and assembly plant east of Atlanta that’s projected to employ 7,500 workers, ...</p>\n\n<a href=\"https://apnews.com/article/technology-business-united-states-georgia-kentucky-2de39c33395d7353e3401642e5e1faad\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RIVN":"Rivian Automotive, Inc."},"source_url":"https://apnews.com/article/technology-business-united-states-georgia-kentucky-2de39c33395d7353e3401642e5e1faad","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191840172","content_text":"ATLANTA (AP) — Electric vehicle maker Rivian Automotive will announce Thursday that it’s building a $5 billion battery and assembly plant east of Atlanta that’s projected to employ 7,500 workers, sources briefed on the decision told The Associated Press.\nRivian, based in Irvine, California, is a startup manufacturer of electric trucks and commercial delivery vans, challenging both established automakers like Ford and General Motors and electric vehicle leader Tesla.\nThe plant could grow to as many as 10,000 workers, sources said, which would make it among the largest auto assembly complexes in the United States, rivaled by behemoths such as the 11,000-worker BMW complex in Spartanburg, South Carolina, and Ford Motor Co.’s 8,600-worker plant in Louisville, Kentucky.\nRivian will be the largest industrial announcement in Georgia history, surpassing the 4,400-worker Kia complex that opened in West Point in 2009. Georgia has had a number of failed auto plant recruitments. Rivian will give Georgia Gov. Brian Kemp another point to bolster his claims that he has been an excellent steward of Georgia’s economy, even as faces Republican and Democratic challengers when he runs for reelection next year.\nThe city of Fort Worth, Texas, offered Rivian a $440 million incentive package to lure the plant during the summer, while published reports indicate Rivian also considered sites in Arizona and Michigan.\nRivian told Fort Worth its plant would make 200,000 vehicles per year, with workers paid at least $56,000 a year.\nThe Atlanta Journal-Constitution was the first to report Rivian’s decision.\nFounder and CEO Robert Scaringe told Bloomberg Television in November that the ability to recruit good workers was the most important factor in the decision. Rivian’s existing plant in Normal, Illinois, like most auto plants that have opened in recent decades, is not unionized.\nGeorgia officials are unlikely to detail the full incentive package offered to Rivian on Thursday, but the company could max out what Georgia calls its “mega project tax credit,” for companies that hire at least 1,800 people or invest at least $450 million. That could be worth $118 million in state income tax credits. Local governments are likely to abate property taxes.\nKia got more than $450 million in incentives for its plant southwest of Atlanta. Georgia has promised $300 million of incentives to the $2.6 billion, 2,600-worker battery plant being built by SK Innovation in Commerce, Georgia, northeast of Atlanta.\nRivian, like Tesla, deals with its customers directly instead of through dealers. Its arrival in Georgia could prompt the state to loosen a law that mostly prohibits manufacturers from selling directly.\nRivian currently plans two models for consumers — the R1T pickup with a base price of $67,500 and the R1S SUV, with a base price of $70,000. The truck was recently named Motor Trend’s 2022 truck of the year.\nAmazon, which owns a slice of the company, has ordered 100,000 delivery vans, launching Rivian into the commercial vehicle business.\nRivian is flush with cash following a $11.9 billion stock offering Nov. 10 that took the company public, allowing it to finance the new plant. Its market value is nearly $95 billion, more than either General Motors or Ford.\nThe company argues that electric vehicle adoption is at the “tipping point” and it is well positioned for success because trucks and SUVs have long been the most profitable vehicles sold. But some analysts question whether it needs another plant besides the former Mitsubishi plant in Illinois, that Rivian bought for $16 million in 2017. Rivian says it has a yearly capacity of 150,000 vehicles, but is looking to expand there as well.\n“It seems like it might be a little premature to invest that much in another large plant just yet,” said Sam Abuelsamid, principal mobility analyst for Guidehouse Insights, who said Rivian also may be looking for a manufacturing site in Europe.\nGiven the size of the Georgia plant, Abuelsamid expects it to make other parts for the vehicles, similar to electric vehicle leader Tesla making seats at its factory in Fremont, California.\nRivian has cash in the bank, but will burn through that quickly unless it starts delivering vehicles and generating cash, jeopardizing its market darling status, Abuelsamid said. The company needs more retail customers and commercial vehicle buyers other than Amazon, he said.\n“If actual deliveries don’t start picking up, the markets could turn against them as they have with some other EV startups not called Tesla,” Abuelsamid said. “Unlike Tesla, Rivian will be facing serious competition in a much shorter time frame than the near- decade head start that Tesla had.”\nFord and GM plan to start selling their own electric pickup trucks in the next year or two, while Tesla also plans a new pickup. That’s part of a wave of electric vehicle investment, with SK’s $5 billion battery plant northeast of Atlanta just one example. Ford announced in September it would spend $11.4 billion to build three battery factories and an assembly plant in Kentucky and Tennessee.\nThe LMC Automotive consulting firm expects U.S. sales of new fully electric vehicles to hit nearly 400,000 this year, nearly double last year’s figures. But they still make up only about 2.6% of sales. The firm expects sales to grow to more than 730,000 next year and more than 2 million by 2025. Even at 2 million, EV sales still would be only about 12% of U.S. new vehicle sales.","news_type":1},"isVote":1,"tweetType":1,"viewCount":248,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607888320,"gmtCreate":1639525044976,"gmtModify":1639525045299,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607888320","repostId":"2191784951","repostType":4,"repost":{"id":"2191784951","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639522244,"share":"https://www.laohu8.com/m/news/2191784951?lang=&edition=full","pubTime":"2021-12-15 06:50","market":"us","language":"en","title":"Wall Street ends down, investors eye inflation and Omicron","url":"https://stock-news.laohu8.com/highlight/detail?id=2191784951","media":"Reuters","summary":"* Fed policy decision awaited on Wednesday\n* November PPI logs highest rise since 2010\n* Tech leads ","content":"<p>* Fed policy decision awaited on Wednesday</p>\n<p>* November PPI logs highest rise since 2010</p>\n<p>* Tech leads declines, financials rally</p>\n<p>* Indexes: Dow -0.30%, S&amp;P 500 -0.75%, Nasdaq -1.14%</p>\n<p>Dec 14 (Reuters) - Wall Street ended lower on Tuesday after data showed producer prices increased more than expected in November, solidifying expectations the Federal Reserve this week will announce a faster wind-down of asset purchases.</p>\n<p>The fast-spreading Omicron coronavirus variant also dampened investor sentiment after the S&amp;P 500 index hit an all-time closing high late last week.</p>\n<p>Declines were led by megacap tech-related stocks, with <a href=\"https://laohu8.com/S/CRM\">Salesforce</a>.com, Microsoft Corp, <a href=\"https://laohu8.com/S/ADBE\">Adobe</a> and Alphabet Inc pulling down the S&amp;P 500 and Nasdaq.</p>\n<p>Apple Inc ended down 0.8%, but off its session lows, after the iPhone maker said it would require customers and employees to wear masks at its U.S. retail stores as COVID-19 cases surge.</p>\n<p>The Dow Jones Industrial Average fell 0.3% to end at 35,544.18 points, while the S&amp;P 500 lost 0.75% to 4,634.09.</p>\n<p>The Nasdaq Composite dropped 1.14% to 15,237.64.</p>\n<p>Data from the Labor Department showed the producer price index (PPI) for final demand in the 12 months through November shot up 9.6%, clocking its largest gain since November 2010. That followed an 8.8% increase in October.</p>\n<p>About two-thirds of Nasdaq stocks traded below their 200-day moving average, according to Refinitiv data, suggesting many stocks within the index are struggling, even as the overall index remains only about 6% below its November record high close.</p>\n<p>\"COVID plus inflation is the Grinch that stole Christmas,\" said Jake Dollarhide, chief executive officer at Longbow Asset Management. \"I don’t underestimate the fact that there are some big Nasdaq names giving up some of their big gains. When the leaders sell off, it's not a good sign.\"</p>\n<p>Ten of the 11 major S&amp;P 500 sector indexes fell, with tech putting on the worst performance, down 1.6%. Financials gained 0.6% as investors bet on a hawkish tone from the Fed at the end of its two-day meeting on Wednesday.</p>\n<p>Berkshire Hathaway and Bank of America both gained more than 1% and helped keep the S&amp;P 500 from falling further.</p>\n<p>Many investors expect the U.S. central bank to signal a faster wind-down of asset purchases, and thus, a quicker start to interest rate hikes in order to contain the rapid rise in prices.</p>\n<p>\"I would say this meeting is when we start to get some clarity on how they're (the Fed) going to address this idea of inflation that has remained elevated and most likely will remain an issue going into next year,\" said David Keller, chief market strategist at StockCharts.com.</p>\n<p>A Reuters poll of economists sees the central bank hiking interest rates from near zero to 0.25%-0.50% in the third quarter of next year, followed by another in the fourth quarter.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a6ea56cda700f032a3421aa26db08524\" tg-width=\"596\" tg-height=\"500\" width=\"100%\" height=\"auto\"><span>Inflation</span></p>\n<p>Beyond Meat Inc rallied 9.3% after Piper Sandler upgraded the plant-based meat maker's stock to \"neutral\" from \"underweight.\"</p>\n<p>Pfizer gained 0.6% after saying its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and that lab data suggests the drug retains its effectiveness against the Omicron variant.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 2.70-to-1 ratio; on Nasdaq, a 2.59-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and 2 new lows; the Nasdaq Composite recorded 18 new highs and 408 new lows.</p>\n<p>Volume on U.S. exchanges was 10.8 billion shares, compared with the 11.5 billion average over the last 20 trading days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends down, investors eye inflation and Omicron</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends down, investors eye inflation and Omicron\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-15 06:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Fed policy decision awaited on Wednesday</p>\n<p>* November PPI logs highest rise since 2010</p>\n<p>* Tech leads declines, financials rally</p>\n<p>* Indexes: Dow -0.30%, S&amp;P 500 -0.75%, Nasdaq -1.14%</p>\n<p>Dec 14 (Reuters) - Wall Street ended lower on Tuesday after data showed producer prices increased more than expected in November, solidifying expectations the Federal Reserve this week will announce a faster wind-down of asset purchases.</p>\n<p>The fast-spreading Omicron coronavirus variant also dampened investor sentiment after the S&amp;P 500 index hit an all-time closing high late last week.</p>\n<p>Declines were led by megacap tech-related stocks, with <a href=\"https://laohu8.com/S/CRM\">Salesforce</a>.com, Microsoft Corp, <a href=\"https://laohu8.com/S/ADBE\">Adobe</a> and Alphabet Inc pulling down the S&amp;P 500 and Nasdaq.</p>\n<p>Apple Inc ended down 0.8%, but off its session lows, after the iPhone maker said it would require customers and employees to wear masks at its U.S. retail stores as COVID-19 cases surge.</p>\n<p>The Dow Jones Industrial Average fell 0.3% to end at 35,544.18 points, while the S&amp;P 500 lost 0.75% to 4,634.09.</p>\n<p>The Nasdaq Composite dropped 1.14% to 15,237.64.</p>\n<p>Data from the Labor Department showed the producer price index (PPI) for final demand in the 12 months through November shot up 9.6%, clocking its largest gain since November 2010. That followed an 8.8% increase in October.</p>\n<p>About two-thirds of Nasdaq stocks traded below their 200-day moving average, according to Refinitiv data, suggesting many stocks within the index are struggling, even as the overall index remains only about 6% below its November record high close.</p>\n<p>\"COVID plus inflation is the Grinch that stole Christmas,\" said Jake Dollarhide, chief executive officer at Longbow Asset Management. \"I don’t underestimate the fact that there are some big Nasdaq names giving up some of their big gains. When the leaders sell off, it's not a good sign.\"</p>\n<p>Ten of the 11 major S&amp;P 500 sector indexes fell, with tech putting on the worst performance, down 1.6%. Financials gained 0.6% as investors bet on a hawkish tone from the Fed at the end of its two-day meeting on Wednesday.</p>\n<p>Berkshire Hathaway and Bank of America both gained more than 1% and helped keep the S&amp;P 500 from falling further.</p>\n<p>Many investors expect the U.S. central bank to signal a faster wind-down of asset purchases, and thus, a quicker start to interest rate hikes in order to contain the rapid rise in prices.</p>\n<p>\"I would say this meeting is when we start to get some clarity on how they're (the Fed) going to address this idea of inflation that has remained elevated and most likely will remain an issue going into next year,\" said David Keller, chief market strategist at StockCharts.com.</p>\n<p>A Reuters poll of economists sees the central bank hiking interest rates from near zero to 0.25%-0.50% in the third quarter of next year, followed by another in the fourth quarter.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a6ea56cda700f032a3421aa26db08524\" tg-width=\"596\" tg-height=\"500\" width=\"100%\" height=\"auto\"><span>Inflation</span></p>\n<p>Beyond Meat Inc rallied 9.3% after Piper Sandler upgraded the plant-based meat maker's stock to \"neutral\" from \"underweight.\"</p>\n<p>Pfizer gained 0.6% after saying its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and that lab data suggests the drug retains its effectiveness against the Omicron variant.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 2.70-to-1 ratio; on Nasdaq, a 2.59-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and 2 new lows; the Nasdaq Composite recorded 18 new highs and 408 new lows.</p>\n<p>Volume on U.S. exchanges was 10.8 billion shares, compared with the 11.5 billion average over the last 20 trading days.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPXU":"三倍做空标普500ETF","IVV":"标普500指数ETF","BK4550":"红杉资本持仓","OEF":"标普100指数ETF-iShares","SPY":"标普500ETF","BK4079":"房地产服务","UPRO":"三倍做多标普500ETF","BK4504":"桥水持仓",".DJI":"道琼斯","BK4539":"次新股",".IXIC":"NASDAQ Composite","OEX":"标普100",".SPX":"S&P 500 Index","SSO":"两倍做多标普500ETF","BK4534":"瑞士信贷持仓","SDS":"两倍做空标普500ETF","SH":"标普500反向ETF","COMP":"Compass, Inc.","AAPL":"苹果","BK4559":"巴菲特持仓"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191784951","content_text":"* Fed policy decision awaited on Wednesday\n* November PPI logs highest rise since 2010\n* Tech leads declines, financials rally\n* Indexes: Dow -0.30%, S&P 500 -0.75%, Nasdaq -1.14%\nDec 14 (Reuters) - Wall Street ended lower on Tuesday after data showed producer prices increased more than expected in November, solidifying expectations the Federal Reserve this week will announce a faster wind-down of asset purchases.\nThe fast-spreading Omicron coronavirus variant also dampened investor sentiment after the S&P 500 index hit an all-time closing high late last week.\nDeclines were led by megacap tech-related stocks, with Salesforce.com, Microsoft Corp, Adobe and Alphabet Inc pulling down the S&P 500 and Nasdaq.\nApple Inc ended down 0.8%, but off its session lows, after the iPhone maker said it would require customers and employees to wear masks at its U.S. retail stores as COVID-19 cases surge.\nThe Dow Jones Industrial Average fell 0.3% to end at 35,544.18 points, while the S&P 500 lost 0.75% to 4,634.09.\nThe Nasdaq Composite dropped 1.14% to 15,237.64.\nData from the Labor Department showed the producer price index (PPI) for final demand in the 12 months through November shot up 9.6%, clocking its largest gain since November 2010. That followed an 8.8% increase in October.\nAbout two-thirds of Nasdaq stocks traded below their 200-day moving average, according to Refinitiv data, suggesting many stocks within the index are struggling, even as the overall index remains only about 6% below its November record high close.\n\"COVID plus inflation is the Grinch that stole Christmas,\" said Jake Dollarhide, chief executive officer at Longbow Asset Management. \"I don’t underestimate the fact that there are some big Nasdaq names giving up some of their big gains. When the leaders sell off, it's not a good sign.\"\nTen of the 11 major S&P 500 sector indexes fell, with tech putting on the worst performance, down 1.6%. Financials gained 0.6% as investors bet on a hawkish tone from the Fed at the end of its two-day meeting on Wednesday.\nBerkshire Hathaway and Bank of America both gained more than 1% and helped keep the S&P 500 from falling further.\nMany investors expect the U.S. central bank to signal a faster wind-down of asset purchases, and thus, a quicker start to interest rate hikes in order to contain the rapid rise in prices.\n\"I would say this meeting is when we start to get some clarity on how they're (the Fed) going to address this idea of inflation that has remained elevated and most likely will remain an issue going into next year,\" said David Keller, chief market strategist at StockCharts.com.\nA Reuters poll of economists sees the central bank hiking interest rates from near zero to 0.25%-0.50% in the third quarter of next year, followed by another in the fourth quarter.\nInflation\nBeyond Meat Inc rallied 9.3% after Piper Sandler upgraded the plant-based meat maker's stock to \"neutral\" from \"underweight.\"\nPfizer gained 0.6% after saying its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and that lab data suggests the drug retains its effectiveness against the Omicron variant.\nDeclining issues outnumbered advancing ones on the NYSE by a 2.70-to-1 ratio; on Nasdaq, a 2.59-to-1 ratio favored decliners.\nThe S&P 500 posted 15 new 52-week highs and 2 new lows; the Nasdaq Composite recorded 18 new highs and 408 new lows.\nVolume on U.S. exchanges was 10.8 billion shares, compared with the 11.5 billion average over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":106,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604438541,"gmtCreate":1639437638495,"gmtModify":1639437638791,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604438541","repostId":"2191984334","repostType":4,"repost":{"id":"2191984334","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639435732,"share":"https://www.laohu8.com/m/news/2191984334?lang=&edition=full","pubTime":"2021-12-14 06:48","market":"us","language":"en","title":"Wall Street ends down; investors eye Omicron and Fed meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2191984334","media":"Reuters","summary":"* Pfizer to buy Arena Pharma, shares of both companies rise\n* Meme stocks GameStop, AMC slump to mul","content":"<p>* Pfizer to buy Arena Pharma, shares of both companies rise</p>\n<p>*&nbsp;Meme stocks GameStop, AMC slump to multi-month lows</p>\n<p>* Consumer discretionary, energy lead declines</p>\n<p>Dec 13 (Reuters) - Wall Street ended lower on Monday, with shares of Carnival Corp and several airlines tumbling as investors worried about the Omicron coronavirus variant ahead of a Federal Reserve meeting later this week.</p>\n<p>Travel-related stocks fell, with the fast-spreading variant accounting for around 40% of COVID-19 infections in London and at least one death in the United Kingdom.</p>\n<p>Norwegian Cruise Line Holdings, Carnival Corp&nbsp;and Royal Caribbean Cruises&nbsp;all slumped more than 4%, while the S&amp;P 1500 airlines index&nbsp;shed about 3%.</p>\n<p>\"It's transportation, restaurants, all the things that if it got bad enough that we started putting new restrictions on people, it would not be good for them,\" said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta. \"They have all been bid over the past several months by the idea that we were going to get back to business as usual.\"</p>\n<p>Most of the 11 major S&amp;P 500 sector indexes fell, with only defensive sectors, including consumer staples, utilities&nbsp;and real estate&nbsp;gaining.</p>\n<p>The Dow Jones Industrial Average&nbsp;fell 0.89% to end at 35,650.95 points, while the S&amp;P 500&nbsp;lost 0.91% to 4,668.97.</p>\n<p>The Nasdaq Composite&nbsp;dropped 1.39% to 15,413.28.</p>\n<p>Following Monday's dip, the S&amp;P 500 remains up about 24% year to date.</p>\n<p>Apple Inc&nbsp;dipped 2.1%, even after J.P. Morgan raised its price target on the iPhone maker to the highest on Wall Street. The company is close to becoming the first in the world to hit $3 trillion in market value.</p>\n<p>Investors expect an increasingly hawkish tone out of the Federal Reserve's two-day meeting that wraps up on Wednesday. The U.S. central bank is expected to signal a faster wind-down of asset purchases, which could also usher closer a start to interest rate hikes.</p>\n<p>\"Everyone is focused on the Fed this week and what guidance we get in terms of bond purchases and interest rates. There's an expectation that there will be an acceleration of tapering, and there's a little anxiety leading up to that,\" said Ryan Jacob, chief portfolio manager at Jacob Internet Fund.</p>\n<p>A Reuters poll of economists sees the central bank hiking interest rates from near zero to 0.25%-0.50% in the third quarter of next year, followed by another in the fourth quarter.</p>\n<p>Positive updates about vaccines and antibody cocktails to combat the new COVID-19 variant, along with a recent reading on inflation that was in line with consensus, pushed the S&amp;P 500&nbsp;index to a record closing high on Friday.</p>\n<p>Pfizer Inc&nbsp;rose 4.6% after it agreed to acquire Arena Pharmaceuticals&nbsp;in a $6.7 billion all-cash deal. Arena's shares surged 80%.</p>\n<p>Shares of Gamestop&nbsp;and AMC Entertainment&nbsp;tumbled to multi-month lows on Monday as some investors appeared to sour on the names that had produced eye-watering gains earlier in the year.</p>\n<p>Video game retailer GameStop tumbled 13.9% at $136.88, briefly touching its lowest level since April, while movie theater operator AMC slumped 15.3% to $23.24, a level last seen in May.</p>\n<p>Volume on U.S. exchanges was 10.4 billion shares, compared with the 11.4 billion average over the last 20 trading days.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 2.30-to-1 ratio; on Nasdaq, a 2.53-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 52 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 33 new highs and 302 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends down; investors eye Omicron and Fed meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends down; investors eye Omicron and Fed meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-14 06:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Pfizer to buy Arena Pharma, shares of both companies rise</p>\n<p>*&nbsp;Meme stocks GameStop, AMC slump to multi-month lows</p>\n<p>* Consumer discretionary, energy lead declines</p>\n<p>Dec 13 (Reuters) - Wall Street ended lower on Monday, with shares of Carnival Corp and several airlines tumbling as investors worried about the Omicron coronavirus variant ahead of a Federal Reserve meeting later this week.</p>\n<p>Travel-related stocks fell, with the fast-spreading variant accounting for around 40% of COVID-19 infections in London and at least one death in the United Kingdom.</p>\n<p>Norwegian Cruise Line Holdings, Carnival Corp&nbsp;and Royal Caribbean Cruises&nbsp;all slumped more than 4%, while the S&amp;P 1500 airlines index&nbsp;shed about 3%.</p>\n<p>\"It's transportation, restaurants, all the things that if it got bad enough that we started putting new restrictions on people, it would not be good for them,\" said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta. \"They have all been bid over the past several months by the idea that we were going to get back to business as usual.\"</p>\n<p>Most of the 11 major S&amp;P 500 sector indexes fell, with only defensive sectors, including consumer staples, utilities&nbsp;and real estate&nbsp;gaining.</p>\n<p>The Dow Jones Industrial Average&nbsp;fell 0.89% to end at 35,650.95 points, while the S&amp;P 500&nbsp;lost 0.91% to 4,668.97.</p>\n<p>The Nasdaq Composite&nbsp;dropped 1.39% to 15,413.28.</p>\n<p>Following Monday's dip, the S&amp;P 500 remains up about 24% year to date.</p>\n<p>Apple Inc&nbsp;dipped 2.1%, even after J.P. Morgan raised its price target on the iPhone maker to the highest on Wall Street. The company is close to becoming the first in the world to hit $3 trillion in market value.</p>\n<p>Investors expect an increasingly hawkish tone out of the Federal Reserve's two-day meeting that wraps up on Wednesday. The U.S. central bank is expected to signal a faster wind-down of asset purchases, which could also usher closer a start to interest rate hikes.</p>\n<p>\"Everyone is focused on the Fed this week and what guidance we get in terms of bond purchases and interest rates. There's an expectation that there will be an acceleration of tapering, and there's a little anxiety leading up to that,\" said Ryan Jacob, chief portfolio manager at Jacob Internet Fund.</p>\n<p>A Reuters poll of economists sees the central bank hiking interest rates from near zero to 0.25%-0.50% in the third quarter of next year, followed by another in the fourth quarter.</p>\n<p>Positive updates about vaccines and antibody cocktails to combat the new COVID-19 variant, along with a recent reading on inflation that was in line with consensus, pushed the S&amp;P 500&nbsp;index to a record closing high on Friday.</p>\n<p>Pfizer Inc&nbsp;rose 4.6% after it agreed to acquire Arena Pharmaceuticals&nbsp;in a $6.7 billion all-cash deal. Arena's shares surged 80%.</p>\n<p>Shares of Gamestop&nbsp;and AMC Entertainment&nbsp;tumbled to multi-month lows on Monday as some investors appeared to sour on the names that had produced eye-watering gains earlier in the year.</p>\n<p>Video game retailer GameStop tumbled 13.9% at $136.88, briefly touching its lowest level since April, while movie theater operator AMC slumped 15.3% to $23.24, a level last seen in May.</p>\n<p>Volume on U.S. exchanges was 10.4 billion shares, compared with the 11.4 billion average over the last 20 trading days.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 2.30-to-1 ratio; on Nasdaq, a 2.53-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 52 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 33 new highs and 302 new lows.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4568":"美国抗疫概念","UDOW":"道指三倍做多ETF-ProShares","DJX":"1/100道琼斯","BK4517":"邮轮概念","PSQ":"纳指反向ETF","QLD":"纳指两倍做多ETF","QQQ":"纳指100ETF","PFE":"辉瑞","DDM":"道指两倍做多ETF","TQQQ":"纳指三倍做多ETF","BK4142":"酒店、度假村与豪华游轮","DOG":"道指反向ETF","SQQQ":"纳指三倍做空ETF","RCL":"皇家加勒比邮轮","SDOW":"道指三倍做空ETF-ProShares","DXD":"道指两倍做空ETF","NCLH":"挪威邮轮","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4007":"制药","ARNA":"阿里那","CCL":"嘉年华邮轮","QID":"纳指两倍做空ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191984334","content_text":"* Pfizer to buy Arena Pharma, shares of both companies rise\n* Meme stocks GameStop, AMC slump to multi-month lows\n* Consumer discretionary, energy lead declines\nDec 13 (Reuters) - Wall Street ended lower on Monday, with shares of Carnival Corp and several airlines tumbling as investors worried about the Omicron coronavirus variant ahead of a Federal Reserve meeting later this week.\nTravel-related stocks fell, with the fast-spreading variant accounting for around 40% of COVID-19 infections in London and at least one death in the United Kingdom.\nNorwegian Cruise Line Holdings, Carnival Corp and Royal Caribbean Cruises all slumped more than 4%, while the S&P 1500 airlines index shed about 3%.\n\"It's transportation, restaurants, all the things that if it got bad enough that we started putting new restrictions on people, it would not be good for them,\" said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta. \"They have all been bid over the past several months by the idea that we were going to get back to business as usual.\"\nMost of the 11 major S&P 500 sector indexes fell, with only defensive sectors, including consumer staples, utilities and real estate gaining.\nThe Dow Jones Industrial Average fell 0.89% to end at 35,650.95 points, while the S&P 500 lost 0.91% to 4,668.97.\nThe Nasdaq Composite dropped 1.39% to 15,413.28.\nFollowing Monday's dip, the S&P 500 remains up about 24% year to date.\nApple Inc dipped 2.1%, even after J.P. Morgan raised its price target on the iPhone maker to the highest on Wall Street. The company is close to becoming the first in the world to hit $3 trillion in market value.\nInvestors expect an increasingly hawkish tone out of the Federal Reserve's two-day meeting that wraps up on Wednesday. The U.S. central bank is expected to signal a faster wind-down of asset purchases, which could also usher closer a start to interest rate hikes.\n\"Everyone is focused on the Fed this week and what guidance we get in terms of bond purchases and interest rates. There's an expectation that there will be an acceleration of tapering, and there's a little anxiety leading up to that,\" said Ryan Jacob, chief portfolio manager at Jacob Internet Fund.\nA Reuters poll of economists sees the central bank hiking interest rates from near zero to 0.25%-0.50% in the third quarter of next year, followed by another in the fourth quarter.\nPositive updates about vaccines and antibody cocktails to combat the new COVID-19 variant, along with a recent reading on inflation that was in line with consensus, pushed the S&P 500 index to a record closing high on Friday.\nPfizer Inc rose 4.6% after it agreed to acquire Arena Pharmaceuticals in a $6.7 billion all-cash deal. Arena's shares surged 80%.\nShares of Gamestop and AMC Entertainment tumbled to multi-month lows on Monday as some investors appeared to sour on the names that had produced eye-watering gains earlier in the year.\nVideo game retailer GameStop tumbled 13.9% at $136.88, briefly touching its lowest level since April, while movie theater operator AMC slumped 15.3% to $23.24, a level last seen in May.\nVolume on U.S. exchanges was 10.4 billion shares, compared with the 11.4 billion average over the last 20 trading days.\nDeclining issues outnumbered advancing ones on the NYSE by a 2.30-to-1 ratio; on Nasdaq, a 2.53-to-1 ratio favored decliners.\nThe S&P 500 posted 52 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 33 new highs and 302 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":262,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604363240,"gmtCreate":1639351378653,"gmtModify":1639351378943,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604363240","repostId":"2190767133","repostType":4,"repost":{"id":"2190767133","pubTimestamp":1639349926,"share":"https://www.laohu8.com/m/news/2190767133?lang=&edition=full","pubTime":"2021-12-13 06:58","market":"us","language":"en","title":"These 6 overvalued stocks are making the S&P 500 look more pricey than it really is","url":"https://stock-news.laohu8.com/highlight/detail?id=2190767133","media":"MarketWatch","summary":"Why Apple, Amazon and other Big Tech heavyweights won’t be the 2020s’ big market winners.\nAgence Fra","content":"<p>Why Apple, Amazon and other Big Tech heavyweights won’t be the 2020s’ big market winners.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3a10e53dd2e0fa7abb7a4db96068a35a\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>Agence France-Presse/Getty Images</span></p>\n<p>It’s impossible to know which stocks will dominate the stock market in a decade’s time, but we can fairly confidently say which companies will not be on that list: stocks that currently top today’s market-cap ranking — namely Apple,Microsoft,Amazon.com,Alphabet (Google)&nbsp;and Meta Platforms (Facebook).</p>\n<p>That’s because it’s rare for stocks at the top of the market-cap ranking to keep their status a decade later. Not only do they usually fall out of the top 10, they also underperform the market on average over the decade.</p>\n<p>That’s according to an analysis conducted by Research Affiliates, the investment firm headed by Robert Arnott. To show the precarious position of the market’s “top dogs,” he calculated what happened over the decade of the 1980s to the 10 largest publicly traded companies at the beginning of that 10-year period. Eight of the 10 were not on 1990’s top-10 list, and all 10 on 1980’s list underperformed the world stock market over the subsequent decade.</p>\n<p>Arnott found that the 1980s were not unique. He reached a similar result for the top stocks of the 1990s, 2000s, and 2010s. On average, a stock on any of these lists underperformed the market over the subsequent decade. In addition, there was between a 70% and 80% chance that any given stock would not be on the comparable list one decade hence.</p>\n<p>Arnott illustrated these top companies’ underperformance in another way as well: He constructed a hypothetical portfolio that each year owned the world’s 10-largest companies. The performance of this portfolio is plotted in the chart below. Over the 40 years from the end of 1980 through the end of 2020, this portfolio lagged a buy-and-hold by 1.8 annualized percentage points.</p>\n<p><img src=\"https://static.tigerbbs.com/b14dd9a35c20f4ad60a1e26457ef4e14\" tg-width=\"700\" tg-height=\"471\" referrerpolicy=\"no-referrer\"></p>\n<p>Numerous investment lessons can be drawn from Arnott’s fascinating results. One is that cap-weighting is not the optimal weighting scheme for your portfolio. Equal-weighting is one obvious alternative, and it has beaten cap-weighting: since 1971, according to data from S&amp;P Dow Jones Indices, the equal-weighted version of the S&amp;P 500&nbsp;has outperformed the cap-weighted version by 1.5 annualized percentage points.</p>\n<p>Arnott believes there are even better ways of weighting stocks in an index beyond equal weighting. His firm maintains a number of so-called fundamental indices that base a stock’s weight on fundamental characteristics such as sales, cash flow, dividends and book equity value.</p>\n<p>“Just six stocks — Apple, Microsoft, Alphabet, Amazon, Tesla and Meta Platforms — account for 26% of the S&amp;P 500’s total market cap”</p>\n<p>But there’s another investment implication of Arnott’s data that I want to focus on: His results highlight the difficulties determining the valuation of a lopsided market.</p>\n<p>Consider the S&amp;P 500 currently, in which just six stocks — Apple, Microsoft, Alphabet, Amazon, Tesla&nbsp;and Meta Platforms — account for 26% of the index’s total market cap. Imagine a situation in which those six are overvalued while the other 494 stocks, on balance, are more fairly valued. In that case, the valuation ratios for the S&amp;P 500 as a whole could paint a skewed picture.</p>\n<p>This situation isn’t just hypothetical. The largest six stocks currently have an average price/earnings ratio of 62.0, according to FactSet, more than double the average across all stocks in the S&amp;P 500 of 29.1 and almost triple its median P/E ratio of 21.4.</p>\n<p>It’s possible, therefore, that the U.S. stock market isn’t as overvalued as we would otherwise think by focusing on valuation ratios for the S&amp;P 500 as a whole.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 6 overvalued stocks are making the S&P 500 look more pricey than it really is</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 6 overvalued stocks are making the S&P 500 look more pricey than it really is\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-13 06:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/its-a-good-bet-that-apple-amazon-and-other-big-tech-darlings-wont-be-the-2020s-big-market-winners-11639104266?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Why Apple, Amazon and other Big Tech heavyweights won’t be the 2020s’ big market winners.\nAgence France-Presse/Getty Images\nIt’s impossible to know which stocks will dominate the stock market in a ...</p>\n\n<a href=\"https://www.marketwatch.com/story/its-a-good-bet-that-apple-amazon-and-other-big-tech-darlings-wont-be-the-2020s-big-market-winners-11639104266?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SH":"标普500反向ETF","SDS":"两倍做空标普500ETF","BK4559":"巴菲特持仓","AAPL":"苹果","BK4504":"桥水持仓","GOOGL":"谷歌A","SSO":"两倍做多标普500ETF","SPY":"标普500ETF","TSLA":"特斯拉","UPRO":"三倍做多标普500ETF","BK4534":"瑞士信贷持仓","SPXU":"三倍做空标普500ETF","AMZN":"亚马逊","MSFT":"微软",".SPX":"S&P 500 Index","BK4550":"红杉资本持仓"},"source_url":"https://www.marketwatch.com/story/its-a-good-bet-that-apple-amazon-and-other-big-tech-darlings-wont-be-the-2020s-big-market-winners-11639104266?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190767133","content_text":"Why Apple, Amazon and other Big Tech heavyweights won’t be the 2020s’ big market winners.\nAgence France-Presse/Getty Images\nIt’s impossible to know which stocks will dominate the stock market in a decade’s time, but we can fairly confidently say which companies will not be on that list: stocks that currently top today’s market-cap ranking — namely Apple,Microsoft,Amazon.com,Alphabet (Google) and Meta Platforms (Facebook).\nThat’s because it’s rare for stocks at the top of the market-cap ranking to keep their status a decade later. Not only do they usually fall out of the top 10, they also underperform the market on average over the decade.\nThat’s according to an analysis conducted by Research Affiliates, the investment firm headed by Robert Arnott. To show the precarious position of the market’s “top dogs,” he calculated what happened over the decade of the 1980s to the 10 largest publicly traded companies at the beginning of that 10-year period. Eight of the 10 were not on 1990’s top-10 list, and all 10 on 1980’s list underperformed the world stock market over the subsequent decade.\nArnott found that the 1980s were not unique. He reached a similar result for the top stocks of the 1990s, 2000s, and 2010s. On average, a stock on any of these lists underperformed the market over the subsequent decade. In addition, there was between a 70% and 80% chance that any given stock would not be on the comparable list one decade hence.\nArnott illustrated these top companies’ underperformance in another way as well: He constructed a hypothetical portfolio that each year owned the world’s 10-largest companies. The performance of this portfolio is plotted in the chart below. Over the 40 years from the end of 1980 through the end of 2020, this portfolio lagged a buy-and-hold by 1.8 annualized percentage points.\n\nNumerous investment lessons can be drawn from Arnott’s fascinating results. One is that cap-weighting is not the optimal weighting scheme for your portfolio. Equal-weighting is one obvious alternative, and it has beaten cap-weighting: since 1971, according to data from S&P Dow Jones Indices, the equal-weighted version of the S&P 500 has outperformed the cap-weighted version by 1.5 annualized percentage points.\nArnott believes there are even better ways of weighting stocks in an index beyond equal weighting. His firm maintains a number of so-called fundamental indices that base a stock’s weight on fundamental characteristics such as sales, cash flow, dividends and book equity value.\n“Just six stocks — Apple, Microsoft, Alphabet, Amazon, Tesla and Meta Platforms — account for 26% of the S&P 500’s total market cap”\nBut there’s another investment implication of Arnott’s data that I want to focus on: His results highlight the difficulties determining the valuation of a lopsided market.\nConsider the S&P 500 currently, in which just six stocks — Apple, Microsoft, Alphabet, Amazon, Tesla and Meta Platforms — account for 26% of the index’s total market cap. Imagine a situation in which those six are overvalued while the other 494 stocks, on balance, are more fairly valued. In that case, the valuation ratios for the S&P 500 as a whole could paint a skewed picture.\nThis situation isn’t just hypothetical. The largest six stocks currently have an average price/earnings ratio of 62.0, according to FactSet, more than double the average across all stocks in the S&P 500 of 29.1 and almost triple its median P/E ratio of 21.4.\nIt’s possible, therefore, that the U.S. stock market isn’t as overvalued as we would otherwise think by focusing on valuation ratios for the S&P 500 as a whole.","news_type":1},"isVote":1,"tweetType":1,"viewCount":253,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605770391,"gmtCreate":1639272727210,"gmtModify":1639272727528,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605770391","repostId":"2190620320","repostType":4,"isVote":1,"tweetType":1,"viewCount":504,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605567618,"gmtCreate":1639193417897,"gmtModify":1639193418231,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605567618","repostId":"2190205546","repostType":4,"repost":{"id":"2190205546","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639186643,"share":"https://www.laohu8.com/m/news/2190205546?lang=&edition=full","pubTime":"2021-12-11 09:37","market":"us","language":"en","title":"GM eyes $3 billion in investment in Michigan EV plants - source","url":"https://stock-news.laohu8.com/highlight/detail?id=2190205546","media":"Reuters","summary":"Dec 10 (Reuters) - General Motors is considering investments in two electric vehicle-related facilit","content":"<p>Dec 10 (Reuters) - General Motors is considering investments in two electric vehicle-related facilities in Michigan, <a href=\"https://laohu8.com/S/AONE.U\">one</a> with partner LG Energy Solution , that could top $4 billion, according to a source familiar with the plan.</p>\n<p>If approved, GM's share of the total investment in the two Michigan EV projects would be $3 billion.</p>\n<p>GM is looking at a new $2 billion battery plant near Lansing, as well as a $2 billion overhaul of its Orion Township assembly plant north of Detroit, the source said.</p>\n<p>The cost of the Lansing battery plant would be shared with LGES.</p>\n<p>The Orion plant, which now builds the Chevrolet Bolt, would be converted to build products using GM's Ultium EV platform, the source said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GM eyes $3 billion in investment in Michigan EV plants - source</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGM eyes $3 billion in investment in Michigan EV plants - source\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-11 09:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 10 (Reuters) - General Motors is considering investments in two electric vehicle-related facilities in Michigan, <a href=\"https://laohu8.com/S/AONE.U\">one</a> with partner LG Energy Solution , that could top $4 billion, according to a source familiar with the plan.</p>\n<p>If approved, GM's share of the total investment in the two Michigan EV projects would be $3 billion.</p>\n<p>GM is looking at a new $2 billion battery plant near Lansing, as well as a $2 billion overhaul of its Orion Township assembly plant north of Detroit, the source said.</p>\n<p>The cost of the Lansing battery plant would be shared with LGES.</p>\n<p>The Orion plant, which now builds the Chevrolet Bolt, would be converted to build products using GM's Ultium EV platform, the source said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4555":"新能源车","BK4561":"索罗斯持仓","GM":"通用汽车","BK4566":"资本集团","BK4099":"汽车制造商","BK4559":"巴菲特持仓"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190205546","content_text":"Dec 10 (Reuters) - General Motors is considering investments in two electric vehicle-related facilities in Michigan, one with partner LG Energy Solution , that could top $4 billion, according to a source familiar with the plan.\nIf approved, GM's share of the total investment in the two Michigan EV projects would be $3 billion.\nGM is looking at a new $2 billion battery plant near Lansing, as well as a $2 billion overhaul of its Orion Township assembly plant north of Detroit, the source said.\nThe cost of the Lansing battery plant would be shared with LGES.\nThe Orion plant, which now builds the Chevrolet Bolt, would be converted to build products using GM's Ultium EV platform, the source said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":162,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":845831522,"gmtCreate":1636327403217,"gmtModify":1636327403593,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/845831522","repostId":"2181238097","repostType":4,"repost":{"id":"2181238097","pubTimestamp":1636324482,"share":"https://www.laohu8.com/m/news/2181238097?lang=&edition=full","pubTime":"2021-11-08 06:34","market":"us","language":"en","title":"Inflation data, US eases travel restrictions: What to know this week","url":"https://stock-news.laohu8.com/highlight/detail?id=2181238097","media":"Yahoo Finance","summary":"Traders this week will receive another batch of economic data focused on inflation, helping to show whether price pressures have continued further during the economic recovery. Separately, some travel restrictions are set to lift for those coming into the U.S. this week, offering a potential boost to a host of travel-related companies.Wall Street has been closely monitoring the incoming data on inflation during the reopening. Companies have struggled to meet a surge in demand as consumer mobilit","content":"<p><img src=\"https://static.tigerbbs.com/1d007acac6b3eac907b55cc31c798ff1\" tg-width=\"1878\" tg-height=\"2940\" width=\"100%\" height=\"auto\"></p>\n<p>Traders this week will receive another batch of economic data focused on inflation, helping to show whether price pressures have continued further during the economic recovery. Separately, some travel restrictions are set to lift for those coming into the U.S. this week, offering a potential boost to a host of travel-related companies.</p>\n<p>Wall Street has been closely monitoring the incoming data on inflation during the reopening. Companies have struggled to meet a surge in demand as consumer mobility picked up, leading to shortages and a slew of supply-chain related disruptions, which have in turn contributed to rising prices.</p>\n<p>The Bureau of Labor Statistics' Consumer Price Index (CPI) due for release on Wednesday is expected to show that elevated inflation continued into October, with a variety of goods and services for consumers posting ongoing price increases.</p>\n<p>Consensus economists expect that the CPI rose 5.8% in October over last year, accelerating from September's 5.4% annual rate to reach the fastest rise since 1990. And on a month-over-month basis, the CPI likely rose 0.5% in October to pick up from September's 0.4% rate.</p>\n<p>“We will be watching for signs that the inflation problem is peaking,\" wrote David Donabedian, chief investment officer of CIBC Private Wealth U.S., in an email on Friday. \"But our expectation is for continued elevated readings, and we expect to be talking about high inflation six months from now. It is not going away.”</p>\n<p>Excluding more volatile food and energy prices, consensus economists are also expecting a pick-up in core categories. Over last year, the core CPI likely picked up to a 4.3% rate in October, up from September's 4.0% year-on-year increase. That would come in just below July's 4.5% year-over-year increase, which had been the biggest rise in the core rate since 1991.</p>\n<p>Some of the reopening-related categories that had seen a surge in prices earlier in the summer had cooled slightly in September, with the latest Delta variant wave of the pandemic dampening consumer demand for travel and related activities. But expect to see a rebound in October, some economists said.</p>\n<p>\"The acceleration in core CPI is likely to be led by services, with real activity starting to turn higher amid easing COVID concerns. Airline fares were still down nearly 25% from pre-pandemic levels in the September report, and we believe there will be scope for a sharp rebound this month,\" wrote <a href=\"https://laohu8.com/S/BAC\">Bank of America</a> economist Michelle Meyer in a note. \"Transportation services should also be supported by a rebound in car and truck rental prices, and a modest increase in motor vehicle insurance prices. Lodging will be another beneficiary of the increase in travel.\"</p>\n<p><img src=\"https://static.tigerbbs.com/b43701be1303941a051c63d2badfe537\" tg-width=\"6630\" tg-height=\"4353\" referrerpolicy=\"no-referrer\">LOS ANGELES, CA - OCTOBER 21: Shoppers exit <a href=\"https://laohu8.com/S/JWN\">Nordstrom</a> at The Grove on Thursday, Oct. 21, 2021 in Los Angeles, CA. Shoppers are enjoying the beautiful fall day. (Francine Orr / Los Angeles Times via <a href=\"https://laohu8.com/S/GTY\">Getty</a> Images)Francine Orr via Getty Images</p>\n<p>In terms of goods, however, Meyer noted that housing and furnishing, apparel and other supplies retailers may have cut prices in October to help pull forward holiday shopping, which could lead to softer overall gains in prices for these categories in Wednesday's CPI report.</p>\n<p>Still, inflationary pressures have remained much more pronounced and longer-lasting than some economists had anticipated. Supply chain shortages and rising commodities costs have led a variety of individual companies to announce price increases. <a href=\"https://laohu8.com/S/MDLZ\">Mondelez</a> (MDLZ), the maker of Oreo cookies and Ritz Crackers, said it was implementing 7% price increases in the U.S. in order to offset rising costs. <a href=\"https://laohu8.com/S/CLX\">Clorox</a> (CLX) said during its earnings call last week it was going to hike prices across 70% of its portfolio of cleaning and housing supplies by the end of the fiscal year. And the CEOs from a broad range of companies, from cosmetics company E.L.F Beauty (ELF) to outdoor recreational supplies company <a href=\"https://laohu8.com/S/VGL.AU\">Vista</a> Outdoor (VSTO), have recently discussed increasing price across their products in interviews on Yahoo Finance Live.</p>\n<p>For investors, the implications of these sustained inflationary pressures could mean tighter monetary policy and higher rates down the line. Federal Reserve officials tweaked their language on inflation in their monetary policy statement last Wednesday to show that they \"expected\" inflation to be transitory. This marked a departure from their previous assurances over the temporary nature of these price pressures.</p>\n<p>\"We said that supply and demand imbalances related to the pandemic and the reopening of the economy have contributed to sizable price increases, and we said progress on vaccinations and an easing of supply constraints are expected to support continued gains in economic activity and employment as well as a reduction in inflation,\" Federal Reserve Chair Jerome <a href=\"https://laohu8.com/S/POWL\">Powell</a> said during his post-FOMC meeting press conference last week. \"So, we're trying to explain what we mean and also acknowledging more uncertainty about 'transitory.'\"</p>\n<h2>US eases travel restrictions for vaccinated travelers</h2>\n<h2></h2>\n<p>On Monday, the U.S. is set to pare back travel restrictions on international visitors who show proof of vaccination, easing what had been months' worth of limitations on international tourism and inbound travel into the U.S.</p>\n<p>Both air and land border travel will be included in the changes. These restrictions had first been put in place in the early days of the pandemic during the Trump administration in March 2020, and were upheld by the Biden administration since January. Visitors from a plethora of countries had been impacted by these travel restrictions into the U.S. since the start of the pandemic, including from much of Europe and <a href=\"https://laohu8.com/S/CAAS\">China</a>. Foreign nationals entering the U.S. under the new rules will need to show proof of vaccination, and a negative COVID-19 test taken within three days if they are traveling by air.\"</p>\n<p>The easing of these restrictions lifts a weight on a number of companies within the airline and lodging industries. And already, a number of CEOs of these companies have underscored the potential pent-up demand that this would unlock.</p>\n<p>Airbnb CEO Brian Chesky was <a href=\"https://laohu8.com/S/AONE.U\">one</a> such executive who pointed to the near-immediate reaction among consumers following the initial announcement of the easing restrictions by the White House last month.</p>\n<p>\"On Oct. 15, I believe it was that date that President Biden announced the reopening of the borders and asked the travelers come to <a href=\"https://laohu8.com/S/UBNK\">United</a> States. Within <a href=\"https://laohu8.com/S/AONE.U\">one</a> week of that announcement, we saw a 44% spike in nights booked for stays crossing borders coming into <a href=\"https://laohu8.com/S/UBCP\">United</a> States on Airbnb for stays Nov. 9 and later, which is when the borders were opened,\" said Chesky during the company's earnings call last week.</p>\n<p>This could also, however, cause some extended wait times and travel disruptions in the short-term, some executives warned.</p>\n<p>\"It's going to be a bit sloppy at first. I can assure you, there will be lines unfortunately... but we'll get it sorted out,\" Ed Bastian, CEO of Delta, reportedly said at a travel event last month.</p>\n<p>Data from the Transportation Security Administration (TSA) has showed a pick-up in the number of travelers checked in at U.S. airports over the past several months, pointing to a further jump in demand. On Nov. 4, traveler throughput was at more than 1.9 million, rising sharply from the 867,105 on the comparable day in 2020, but still coming in below the more than 2.5 million travelers counted on the comparable day of 2019.</p>\n<h2>Economic calendar</h2>\n<ul>\n <li><p><b>Monday: </b><i>No notable reports scheduled for release </i></p></li>\n <li><p><b>Tuesday: </b>NFIB Small Business Optimism index, October (99.3 expected, 99.1 in September); PPI Final Demand, month over month, October (0.6% expected, 0.5% in September); PPI excluding food and energy, month over month, October (0.5% expected, 0.2% in September); PPI Final Demand, year over year, October (8.6% expected, 8.6% in September), PPI excluding food and energy, year over year, October (6.8% expected, 6.8% in September)</p></li>\n <li><p><b>Wednesday: </b>MBA Mortgage Applications, week ended Nov. 5 (-3.3% during prior week); Initial jobless claims, week ended Nov. 6 (265,000 expected, 269,000 during prior week); Continuing claims, week ended Oct. 30 (2.105 million during prior week); Consumer Price Index, month over month, October (0.4% expected, 0.2% in September); Consumer Price Index, year over year, October (5.8% expected, 5.4% in September); Consumer Price Index excluding food and energy, year over year, October (4.3%. expected, 4.0% in September); Wholesale Inventories, month over month, September final (1.1% expected, 1.1% in prior print); Monthly budget statement, October (-$61.5 billion in September)</p></li>\n <li><p><b>Thursday:</b> <i>No notable reports scheduled for release</i></p></li>\n <li><p><b>Friday: </b>JOLTS Job Openings, September (10.439 million in August); University of Michigan Sentiment, November preliminary (72.4 expected, 71.7 in October)</p></li>\n</ul>\n<h2>Earnings calendar</h2>\n<ul>\n <li><p><b>Monday: </b><a href=\"https://laohu8.com/S/COTY\">Coty</a> Inc. (COTY) before market open; Clover Health Investment Corp. (CLOV), <a href=\"https://laohu8.com/S/REAL\">The RealReal</a> (REAL), Lemonade (LMND), Roblox (RBLX), <a href=\"https://laohu8.com/S/PYPL\">PayPal</a> (PYPL), <a href=\"https://laohu8.com/S/SPCE\">Virgin Galactic</a> Holdings (SPCE), TripAdvisors (TRIP), SmileDirectClub (SDC), <a href=\"https://laohu8.com/S/AMC\">AMC Entertainment</a> Holdings (AMC), <a href=\"https://laohu8.com/S/ZNGA\">Zynga</a> (ZNGA) after market close</p></li>\n <li><p><b>Tuesday: </b>Blue Apron (APRN), <a href=\"https://laohu8.com/S/WKHS\">Workhorse</a> Group (WKHS), Palantir (PLTR) before market open; DoorDash (DASH), Poshmark (POSH), Coinbase (COIN), Vroom Inc. (VRM), fuboTV (FUBO), <a href=\"https://laohu8.com/S/PLUG\">Plug Power</a> (PLUG), <a href=\"https://laohu8.com/S/WYNN\">Wynn</a> Resorts (WYNN), Nio (NIO) after market close</p></li>\n <li><p><b>Wednesday: </b>Disney (DIS), Opendoor Technologies (OPEN), Compass (COMP), Bumble (BMBL), Wish (WISH), Affirm Holdings (AFRM), <a href=\"https://laohu8.com/S/GNBC\">Green</a> Thumb Industries (GTII), SoFi Technologies (SOFI), Beyond Meat (BYND), Figs (FIGS), 23andMe Holdings (ME) after market close</p></li>\n <li><p><b>Thursday: </b>Tapestry (TPR), Yeti Holdings (YETI), Organon &amp; Co. (OGN) before market open; <a href=\"https://laohu8.com/S/BLNKW\">Blink Charging Co.</a> (BLNK) after market close</p></li>\n <li><p><b>Friday: </b>Bakkt Holdings (BKKT), Warby Parker (WRBY) before market open</p></li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Inflation data, US eases travel restrictions: What to know this week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInflation data, US eases travel restrictions: What to know this week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-08 06:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/inflation-data-us-eases-travel-restrictions-for-vaccinated-visitors-what-to-know-this-week-180012846.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Traders this week will receive another batch of economic data focused on inflation, helping to show whether price pressures have continued further during the economic recovery. Separately, some travel...</p>\n\n<a href=\"https://finance.yahoo.com/news/inflation-data-us-eases-travel-restrictions-for-vaccinated-visitors-what-to-know-this-week-180012846.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/d3c2aece4b9a50fa60771d3a0b4727f3","relate_stocks":{"LUV":"西南航空",".DJI":"道琼斯","SPY.AU":"SPDR® S&P 500® ETF Trust","AAL":"美国航空","DAL":"达美航空",".IXIC":"NASDAQ Composite","JBLU":"捷蓝航空",".SPX":"S&P 500 Index"},"source_url":"https://finance.yahoo.com/news/inflation-data-us-eases-travel-restrictions-for-vaccinated-visitors-what-to-know-this-week-180012846.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2181238097","content_text":"Traders this week will receive another batch of economic data focused on inflation, helping to show whether price pressures have continued further during the economic recovery. Separately, some travel restrictions are set to lift for those coming into the U.S. this week, offering a potential boost to a host of travel-related companies.\nWall Street has been closely monitoring the incoming data on inflation during the reopening. Companies have struggled to meet a surge in demand as consumer mobility picked up, leading to shortages and a slew of supply-chain related disruptions, which have in turn contributed to rising prices.\nThe Bureau of Labor Statistics' Consumer Price Index (CPI) due for release on Wednesday is expected to show that elevated inflation continued into October, with a variety of goods and services for consumers posting ongoing price increases.\nConsensus economists expect that the CPI rose 5.8% in October over last year, accelerating from September's 5.4% annual rate to reach the fastest rise since 1990. And on a month-over-month basis, the CPI likely rose 0.5% in October to pick up from September's 0.4% rate.\n“We will be watching for signs that the inflation problem is peaking,\" wrote David Donabedian, chief investment officer of CIBC Private Wealth U.S., in an email on Friday. \"But our expectation is for continued elevated readings, and we expect to be talking about high inflation six months from now. It is not going away.”\nExcluding more volatile food and energy prices, consensus economists are also expecting a pick-up in core categories. Over last year, the core CPI likely picked up to a 4.3% rate in October, up from September's 4.0% year-on-year increase. That would come in just below July's 4.5% year-over-year increase, which had been the biggest rise in the core rate since 1991.\nSome of the reopening-related categories that had seen a surge in prices earlier in the summer had cooled slightly in September, with the latest Delta variant wave of the pandemic dampening consumer demand for travel and related activities. But expect to see a rebound in October, some economists said.\n\"The acceleration in core CPI is likely to be led by services, with real activity starting to turn higher amid easing COVID concerns. Airline fares were still down nearly 25% from pre-pandemic levels in the September report, and we believe there will be scope for a sharp rebound this month,\" wrote Bank of America economist Michelle Meyer in a note. \"Transportation services should also be supported by a rebound in car and truck rental prices, and a modest increase in motor vehicle insurance prices. Lodging will be another beneficiary of the increase in travel.\"\nLOS ANGELES, CA - OCTOBER 21: Shoppers exit Nordstrom at The Grove on Thursday, Oct. 21, 2021 in Los Angeles, CA. Shoppers are enjoying the beautiful fall day. (Francine Orr / Los Angeles Times via Getty Images)Francine Orr via Getty Images\nIn terms of goods, however, Meyer noted that housing and furnishing, apparel and other supplies retailers may have cut prices in October to help pull forward holiday shopping, which could lead to softer overall gains in prices for these categories in Wednesday's CPI report.\nStill, inflationary pressures have remained much more pronounced and longer-lasting than some economists had anticipated. Supply chain shortages and rising commodities costs have led a variety of individual companies to announce price increases. Mondelez (MDLZ), the maker of Oreo cookies and Ritz Crackers, said it was implementing 7% price increases in the U.S. in order to offset rising costs. Clorox (CLX) said during its earnings call last week it was going to hike prices across 70% of its portfolio of cleaning and housing supplies by the end of the fiscal year. And the CEOs from a broad range of companies, from cosmetics company E.L.F Beauty (ELF) to outdoor recreational supplies company Vista Outdoor (VSTO), have recently discussed increasing price across their products in interviews on Yahoo Finance Live.\nFor investors, the implications of these sustained inflationary pressures could mean tighter monetary policy and higher rates down the line. Federal Reserve officials tweaked their language on inflation in their monetary policy statement last Wednesday to show that they \"expected\" inflation to be transitory. This marked a departure from their previous assurances over the temporary nature of these price pressures.\n\"We said that supply and demand imbalances related to the pandemic and the reopening of the economy have contributed to sizable price increases, and we said progress on vaccinations and an easing of supply constraints are expected to support continued gains in economic activity and employment as well as a reduction in inflation,\" Federal Reserve Chair Jerome Powell said during his post-FOMC meeting press conference last week. \"So, we're trying to explain what we mean and also acknowledging more uncertainty about 'transitory.'\"\nUS eases travel restrictions for vaccinated travelers\n\nOn Monday, the U.S. is set to pare back travel restrictions on international visitors who show proof of vaccination, easing what had been months' worth of limitations on international tourism and inbound travel into the U.S.\nBoth air and land border travel will be included in the changes. These restrictions had first been put in place in the early days of the pandemic during the Trump administration in March 2020, and were upheld by the Biden administration since January. Visitors from a plethora of countries had been impacted by these travel restrictions into the U.S. since the start of the pandemic, including from much of Europe and China. Foreign nationals entering the U.S. under the new rules will need to show proof of vaccination, and a negative COVID-19 test taken within three days if they are traveling by air.\"\nThe easing of these restrictions lifts a weight on a number of companies within the airline and lodging industries. And already, a number of CEOs of these companies have underscored the potential pent-up demand that this would unlock.\nAirbnb CEO Brian Chesky was one such executive who pointed to the near-immediate reaction among consumers following the initial announcement of the easing restrictions by the White House last month.\n\"On Oct. 15, I believe it was that date that President Biden announced the reopening of the borders and asked the travelers come to United States. Within one week of that announcement, we saw a 44% spike in nights booked for stays crossing borders coming into United States on Airbnb for stays Nov. 9 and later, which is when the borders were opened,\" said Chesky during the company's earnings call last week.\nThis could also, however, cause some extended wait times and travel disruptions in the short-term, some executives warned.\n\"It's going to be a bit sloppy at first. I can assure you, there will be lines unfortunately... but we'll get it sorted out,\" Ed Bastian, CEO of Delta, reportedly said at a travel event last month.\nData from the Transportation Security Administration (TSA) has showed a pick-up in the number of travelers checked in at U.S. airports over the past several months, pointing to a further jump in demand. On Nov. 4, traveler throughput was at more than 1.9 million, rising sharply from the 867,105 on the comparable day in 2020, but still coming in below the more than 2.5 million travelers counted on the comparable day of 2019.\nEconomic calendar\n\nMonday: No notable reports scheduled for release \nTuesday: NFIB Small Business Optimism index, October (99.3 expected, 99.1 in September); PPI Final Demand, month over month, October (0.6% expected, 0.5% in September); PPI excluding food and energy, month over month, October (0.5% expected, 0.2% in September); PPI Final Demand, year over year, October (8.6% expected, 8.6% in September), PPI excluding food and energy, year over year, October (6.8% expected, 6.8% in September)\nWednesday: MBA Mortgage Applications, week ended Nov. 5 (-3.3% during prior week); Initial jobless claims, week ended Nov. 6 (265,000 expected, 269,000 during prior week); Continuing claims, week ended Oct. 30 (2.105 million during prior week); Consumer Price Index, month over month, October (0.4% expected, 0.2% in September); Consumer Price Index, year over year, October (5.8% expected, 5.4% in September); Consumer Price Index excluding food and energy, year over year, October (4.3%. expected, 4.0% in September); Wholesale Inventories, month over month, September final (1.1% expected, 1.1% in prior print); Monthly budget statement, October (-$61.5 billion in September)\nThursday: No notable reports scheduled for release\nFriday: JOLTS Job Openings, September (10.439 million in August); University of Michigan Sentiment, November preliminary (72.4 expected, 71.7 in October)\n\nEarnings calendar\n\nMonday: Coty Inc. (COTY) before market open; Clover Health Investment Corp. (CLOV), The RealReal (REAL), Lemonade (LMND), Roblox (RBLX), PayPal (PYPL), Virgin Galactic Holdings (SPCE), TripAdvisors (TRIP), SmileDirectClub (SDC), AMC Entertainment Holdings (AMC), Zynga (ZNGA) after market close\nTuesday: Blue Apron (APRN), Workhorse Group (WKHS), Palantir (PLTR) before market open; DoorDash (DASH), Poshmark (POSH), Coinbase (COIN), Vroom Inc. (VRM), fuboTV (FUBO), Plug Power (PLUG), Wynn Resorts (WYNN), Nio (NIO) after market close\nWednesday: Disney (DIS), Opendoor Technologies (OPEN), Compass (COMP), Bumble (BMBL), Wish (WISH), Affirm Holdings (AFRM), Green Thumb Industries (GTII), SoFi Technologies (SOFI), Beyond Meat (BYND), Figs (FIGS), 23andMe Holdings (ME) after market close\nThursday: Tapestry (TPR), Yeti Holdings (YETI), Organon & Co. (OGN) before market open; Blink Charging Co. (BLNK) after market close\nFriday: Bakkt Holdings (BKKT), Warby Parker (WRBY) before market open","news_type":1},"isVote":1,"tweetType":1,"viewCount":53,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698216293,"gmtCreate":1640404122349,"gmtModify":1640404122705,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698216293","repostId":"2193917872","repostType":4,"repost":{"id":"2193917872","pubTimestamp":1640398248,"share":"https://www.laohu8.com/m/news/2193917872?lang=&edition=full","pubTime":"2021-12-25 10:10","market":"us","language":"en","title":"3 Best Buffett Stocks to Buy for the Long Haul","url":"https://stock-news.laohu8.com/highlight/detail?id=2193917872","media":"Motley Fool","summary":"Each of these three big pharma stocks are featured in Berkshire Hathaway's massive portfolio.","content":"<p>Since Warren Buffett took full control of <b>Berkshire Hathaway</b> in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of writing.</p>\n<p>The Oracle of Omaha's reputation of buying the highest quality businesses means that many individual investors could also benefit from adding these stocks to their portfolios. Here are three healthcare stocks that Buffett owns, which you may also want to consider buying and holding for the long run.</p>\n<h2>1. Johnson &amp; Johnson</h2>\n<p>The first pharma stock within Berkshire's portfolio to contemplate purchasing is <b>Johnson &amp; Johnson</b> (NYSE:JNJ). While the stock is one of Buffett's smallest holdings, valued at just under $55 million, this doesn't take away from its 59 consecutive years of dividend increases that make the stock a Dividend King.</p>\n<p>J&amp;J will be spinning off its slower-growing and less profitable consumer health segment in the next 18 to 24 months, which should allow the company to focus on its faster-growing, more profitable pharmaceutical segment.</p>\n<p>J&amp;J has a strong existing drug portfolio, which should be able to make up for the upcoming 2025 to 2026 patent expirations for its top-selling drug known, Stelara. Year to date, the immunology drug made up just 9.9% of J&amp;J's $69 billion in net sales.</p>\n<p>These drugs include the immunology blockbuster Tremfya, which received its first of three U.S. Food and Drug Administration (FDA) approvals to date in July 2017. Another drug that was recently approved by the FDA was the oncology blockbuster called Darzalex, which received its first of nine FDA approvals to date in November 2015. These two drugs have grown their year-to-date revenue at high-40% clips year over year and should remain under patent most of this decade.</p>\n<p>J&amp;J's enviable existing drug portfolio and its nearly four dozen indications in late-stage clinical trials explain why analysts anticipate that the stock will deliver 8% annual non-GAAP (adjusted) earnings per share (EPS) growth over the next five years.</p>\n<p>Income investors can scoop up J&amp;J's 2.5% dividend yield at a forward P/E ratio of just 16.2 times, which makes the steady healthcare stock a great buy for the long term.</p>\n<h2>2. Bristol Myers Squibb</h2>\n<p>Another Buffett stock that could be a great fit in your portfolio is <b>Bristol Myers Squibb</b> (NYSE:BMY). Berkshire's Bristol Myers Squibb stake totals nearly $1.4 billion, making it one of the largest healthcare holdings in Berkshire's portfolio.</p>\n<p>Bristol Myers Squibb's oncology blockbusters Revlimid and Opdivo and the anticoagulant blockbuster co-owned with <b>Pfizer</b> (NYSE:PFE) named Eliquis each face patent expirations later this decade. While looming patent expirations on three drugs that account for approximately two-thirds of your company's total revenue sounds frightening, this is nothing new; it's just the nature of Bristol Myers Squibb's industry.</p>\n<p>What matters most is that a company is proactive in developing and acquiring its next generation of blockbuster drugs to absorb key patent expirations. With more than 50 compounds in over 40 different disease areas currently in development at Bristol Myers Squibb, this is exactly what the company has been doing for years now.</p>\n<p>As a result, analysts are projecting that Bristol Myers Squibb will be able to generate 6% annual earnings growth through the next five years.</p>\n<p>Yield-hungry investors can buy Bristol Myers Squibb's market-crushing 3.5% yield at a ridiculously cheap forward P/E ratio of 7.9, which is what makes the stock a buy for those looking to hedge against inflation.</p>\n<h2>3. AbbVie</h2>\n<p>Finally, a Buffett stock that'd also be a good fit for income investors is <b>AbbVie</b> (NYSE:ABBV). Berkshire currently holds about $1.9 billion worth of AbbVie stock.</p>\n<p>It's well known at this point that the biopharmaceutical's top-selling drug in the world, Humira, will be facing intense biosimilar competition in the U.S. beginning in 2023. Even though the immunology drug's U.S. sales made up 31% of AbbVie's $41.24 billion total year-to-date sales, the company's pipeline should be able to stabilize and grow its net revenue beyond 2023.</p>\n<p>AbbVie has 54 compounds in various stages of clinical trials, which is why analysts are forecasting that the stock will grow its adjusted EPS 4.5% annually in the next five years.</p>\n<p>AbbVie's massive 4.4% dividend yield can be picked up at a forward P/E ratio of only 9.3.&nbsp;This is an attractive valuation for a stock with the ability to fight off inflation with healthy dividend hikes.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Best Buffett Stocks to Buy for the Long Haul</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Best Buffett Stocks to Buy for the Long Haul\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-25 10:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Since Warren Buffett took full control of Berkshire Hathaway in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ABBV":"艾伯维公司","BMY":"施贵宝","JNJ":"强生"},"source_url":"https://www.fool.com/investing/2021/12/24/3-best-buffett-stocks-to-buy-for-the-long-haul/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193917872","content_text":"Since Warren Buffett took full control of Berkshire Hathaway in 1965, it became a diversified holding company with investments in publicly traded companies totaling nearly $345 billion at the time of writing.\nThe Oracle of Omaha's reputation of buying the highest quality businesses means that many individual investors could also benefit from adding these stocks to their portfolios. Here are three healthcare stocks that Buffett owns, which you may also want to consider buying and holding for the long run.\n1. Johnson & Johnson\nThe first pharma stock within Berkshire's portfolio to contemplate purchasing is Johnson & Johnson (NYSE:JNJ). While the stock is one of Buffett's smallest holdings, valued at just under $55 million, this doesn't take away from its 59 consecutive years of dividend increases that make the stock a Dividend King.\nJ&J will be spinning off its slower-growing and less profitable consumer health segment in the next 18 to 24 months, which should allow the company to focus on its faster-growing, more profitable pharmaceutical segment.\nJ&J has a strong existing drug portfolio, which should be able to make up for the upcoming 2025 to 2026 patent expirations for its top-selling drug known, Stelara. Year to date, the immunology drug made up just 9.9% of J&J's $69 billion in net sales.\nThese drugs include the immunology blockbuster Tremfya, which received its first of three U.S. Food and Drug Administration (FDA) approvals to date in July 2017. Another drug that was recently approved by the FDA was the oncology blockbuster called Darzalex, which received its first of nine FDA approvals to date in November 2015. These two drugs have grown their year-to-date revenue at high-40% clips year over year and should remain under patent most of this decade.\nJ&J's enviable existing drug portfolio and its nearly four dozen indications in late-stage clinical trials explain why analysts anticipate that the stock will deliver 8% annual non-GAAP (adjusted) earnings per share (EPS) growth over the next five years.\nIncome investors can scoop up J&J's 2.5% dividend yield at a forward P/E ratio of just 16.2 times, which makes the steady healthcare stock a great buy for the long term.\n2. Bristol Myers Squibb\nAnother Buffett stock that could be a great fit in your portfolio is Bristol Myers Squibb (NYSE:BMY). Berkshire's Bristol Myers Squibb stake totals nearly $1.4 billion, making it one of the largest healthcare holdings in Berkshire's portfolio.\nBristol Myers Squibb's oncology blockbusters Revlimid and Opdivo and the anticoagulant blockbuster co-owned with Pfizer (NYSE:PFE) named Eliquis each face patent expirations later this decade. While looming patent expirations on three drugs that account for approximately two-thirds of your company's total revenue sounds frightening, this is nothing new; it's just the nature of Bristol Myers Squibb's industry.\nWhat matters most is that a company is proactive in developing and acquiring its next generation of blockbuster drugs to absorb key patent expirations. With more than 50 compounds in over 40 different disease areas currently in development at Bristol Myers Squibb, this is exactly what the company has been doing for years now.\nAs a result, analysts are projecting that Bristol Myers Squibb will be able to generate 6% annual earnings growth through the next five years.\nYield-hungry investors can buy Bristol Myers Squibb's market-crushing 3.5% yield at a ridiculously cheap forward P/E ratio of 7.9, which is what makes the stock a buy for those looking to hedge against inflation.\n3. AbbVie\nFinally, a Buffett stock that'd also be a good fit for income investors is AbbVie (NYSE:ABBV). Berkshire currently holds about $1.9 billion worth of AbbVie stock.\nIt's well known at this point that the biopharmaceutical's top-selling drug in the world, Humira, will be facing intense biosimilar competition in the U.S. beginning in 2023. Even though the immunology drug's U.S. sales made up 31% of AbbVie's $41.24 billion total year-to-date sales, the company's pipeline should be able to stabilize and grow its net revenue beyond 2023.\nAbbVie has 54 compounds in various stages of clinical trials, which is why analysts are forecasting that the stock will grow its adjusted EPS 4.5% annually in the next five years.\nAbbVie's massive 4.4% dividend yield can be picked up at a forward P/E ratio of only 9.3. This is an attractive valuation for a stock with the ability to fight off inflation with healthy dividend hikes.","news_type":1},"isVote":1,"tweetType":1,"viewCount":712,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699291752,"gmtCreate":1639802522770,"gmtModify":1639802523080,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/699291752","repostId":"1116106959","repostType":4,"repost":{"id":"1116106959","pubTimestamp":1639785552,"share":"https://www.laohu8.com/m/news/1116106959?lang=&edition=full","pubTime":"2021-12-18 07:59","market":"us","language":"en","title":"Wall Street ends down after mostly negative week","url":"https://stock-news.laohu8.com/highlight/detail?id=1116106959","media":"Reuters","summary":" - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.The S","content":"<p>(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.</p>\n<p>All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.</p>\n<p>Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&amp;P 500 and Nasdaq.</p>\n<p>The S&amp;P 500 growth index lost 0.7% and the value index declined 1.4%.</p>\n<p>All of the 11 major S&amp;P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.</p>\n<p>Adding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.</p>\n<p>Traders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.</p>\n<p>\"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"</p>\n<p>Heavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&amp;P 500 index gained around 23% in the same period.</p>\n<p>In Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&amp;P 500 lost 1.03% to 4,620.64.</p>\n<p>The Nasdaq Composite dropped 0.07% to 15,169.68.</p>\n<p>On a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.</p>\n<p>With options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.</p>\n<p>For the week, the S&amp;P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.</p>\n<p>In Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.</p>\n<p>FedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends down after mostly negative week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends down after mostly negative week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-18 07:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116106959","content_text":"(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.\nAll three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.\nNvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.\nThe S&P 500 growth index lost 0.7% and the value index declined 1.4%.\nAll of the 11 major S&P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.\nAdding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.\nTraders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.\n\"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"\nHeavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&P 500 index gained around 23% in the same period.\nIn Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&P 500 lost 1.03% to 4,620.64.\nThe Nasdaq Composite dropped 0.07% to 15,169.68.\nOn a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.\nWith options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.\nFor the week, the S&P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.\nIn Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.\nFedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.\nThe S&P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":170,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605010435,"gmtCreate":1639092270786,"gmtModify":1639092271084,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/605010435","repostId":"2190364585","repostType":4,"repost":{"id":"2190364585","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1639091100,"share":"https://www.laohu8.com/m/news/2190364585?lang=&edition=full","pubTime":"2021-12-10 07:05","market":"us","language":"en","title":"Broadcom stock rallies nearly 7% on earnings beat, $10 billion share buyback program","url":"https://stock-news.laohu8.com/highlight/detail?id=2190364585","media":"Dow Jones","summary":"New buyback program lasts until end of 2022 with Broadcom sitting on $12 billion in cash\nBroadcom In","content":"<p>New buyback program lasts until end of 2022 with Broadcom sitting on $12 billion in cash</p>\n<p>Broadcom Inc. shares rallied in the extended session Thursday after the chip and software company topped Wall Street estimates for the quarter and announced an aggressive new share buyback program.</p>\n<p>Broadcom <a href=\"https://laohu8.com/S/AVGO\">$(AVGO)$</a> shares surged&nbsp;nearly 7% after hours, following a 0.9% decline in the regular session to close at $583.42.</p>\n<p><img src=\"https://static.tigerbbs.com/a53757c7d36cd86e809af11348fa5162\" tg-width=\"717\" tg-height=\"597\" referrerpolicy=\"no-referrer\"></p>\n<p>The company reported fiscal fourth-quarter net income of $1.91 billion, or $4.45 a share, compared with $1.25 billion, or $2.93 a share, in the year-ago period. Adjusted earnings, which exclude stock-based compensation and other items, were $7.81 a share, compared with $6.35 a share in the year-ago quarter.</p>\n<p>Revenue rose to $7.41 billion from $6.47 billion in the year-ago quarter. Analysts surveyed by FactSet had expected earnings of $7.74 a share on revenue of $7.36 billion, based on Broadcom's forecast revenue of about $7.35 billion.</p>\n<p>The company reported a 76% gain in chip sales to $5.63 billion from the year-ago period, and a 24% rise in infrastructure software sales to $1.77 billion. Analysts had forecast chip sales of $5.6 billion and infrastructure software sales of $1.73 billion.</p>\n<p>\"Broadcom concluded the year with record fourth quarter results driven by a rebound in enterprise, and continued strength from cloud and service provider demand,\" said Hock Tan, Broadcom president and chief executive, in a statement. \"Our infrastructure software growth continues to be steady with our focus on strategic customers.\"</p>\n<p>Broadcom forecast revenue of about $7.6 billion for the fiscal first quarter, while analysts had estimated revenue of $7.24 billion.</p>\n<p>Broadcom also said its board authorized a new $10 billion share buyback program that is effective until the end of 2022. The company reported cash and cash equivalents of $12.16 billion at the end of its fiscal year.</p>\n<p>Over the past 12 months, shares of Broadcom have gained 40%. In comparison, the S&amp;P 500 index has advanced 27%, the tech-heavy Nasdaq Composite Index has risen 26%, while the PHLX Semiconductor Index has grown 42% over that time.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Broadcom stock rallies nearly 7% on earnings beat, $10 billion share buyback program</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBroadcom stock rallies nearly 7% on earnings beat, $10 billion share buyback program\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-12-10 07:05</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>New buyback program lasts until end of 2022 with Broadcom sitting on $12 billion in cash</p>\n<p>Broadcom Inc. shares rallied in the extended session Thursday after the chip and software company topped Wall Street estimates for the quarter and announced an aggressive new share buyback program.</p>\n<p>Broadcom <a href=\"https://laohu8.com/S/AVGO\">$(AVGO)$</a> shares surged&nbsp;nearly 7% after hours, following a 0.9% decline in the regular session to close at $583.42.</p>\n<p><img src=\"https://static.tigerbbs.com/a53757c7d36cd86e809af11348fa5162\" tg-width=\"717\" tg-height=\"597\" referrerpolicy=\"no-referrer\"></p>\n<p>The company reported fiscal fourth-quarter net income of $1.91 billion, or $4.45 a share, compared with $1.25 billion, or $2.93 a share, in the year-ago period. Adjusted earnings, which exclude stock-based compensation and other items, were $7.81 a share, compared with $6.35 a share in the year-ago quarter.</p>\n<p>Revenue rose to $7.41 billion from $6.47 billion in the year-ago quarter. Analysts surveyed by FactSet had expected earnings of $7.74 a share on revenue of $7.36 billion, based on Broadcom's forecast revenue of about $7.35 billion.</p>\n<p>The company reported a 76% gain in chip sales to $5.63 billion from the year-ago period, and a 24% rise in infrastructure software sales to $1.77 billion. Analysts had forecast chip sales of $5.6 billion and infrastructure software sales of $1.73 billion.</p>\n<p>\"Broadcom concluded the year with record fourth quarter results driven by a rebound in enterprise, and continued strength from cloud and service provider demand,\" said Hock Tan, Broadcom president and chief executive, in a statement. \"Our infrastructure software growth continues to be steady with our focus on strategic customers.\"</p>\n<p>Broadcom forecast revenue of about $7.6 billion for the fiscal first quarter, while analysts had estimated revenue of $7.24 billion.</p>\n<p>Broadcom also said its board authorized a new $10 billion share buyback program that is effective until the end of 2022. The company reported cash and cash equivalents of $12.16 billion at the end of its fiscal year.</p>\n<p>Over the past 12 months, shares of Broadcom have gained 40%. In comparison, the S&amp;P 500 index has advanced 27%, the tech-heavy Nasdaq Composite Index has risen 26%, while the PHLX Semiconductor Index has grown 42% over that time.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190364585","content_text":"New buyback program lasts until end of 2022 with Broadcom sitting on $12 billion in cash\nBroadcom Inc. shares rallied in the extended session Thursday after the chip and software company topped Wall Street estimates for the quarter and announced an aggressive new share buyback program.\nBroadcom $(AVGO)$ shares surged nearly 7% after hours, following a 0.9% decline in the regular session to close at $583.42.\n\nThe company reported fiscal fourth-quarter net income of $1.91 billion, or $4.45 a share, compared with $1.25 billion, or $2.93 a share, in the year-ago period. Adjusted earnings, which exclude stock-based compensation and other items, were $7.81 a share, compared with $6.35 a share in the year-ago quarter.\nRevenue rose to $7.41 billion from $6.47 billion in the year-ago quarter. Analysts surveyed by FactSet had expected earnings of $7.74 a share on revenue of $7.36 billion, based on Broadcom's forecast revenue of about $7.35 billion.\nThe company reported a 76% gain in chip sales to $5.63 billion from the year-ago period, and a 24% rise in infrastructure software sales to $1.77 billion. Analysts had forecast chip sales of $5.6 billion and infrastructure software sales of $1.73 billion.\n\"Broadcom concluded the year with record fourth quarter results driven by a rebound in enterprise, and continued strength from cloud and service provider demand,\" said Hock Tan, Broadcom president and chief executive, in a statement. \"Our infrastructure software growth continues to be steady with our focus on strategic customers.\"\nBroadcom forecast revenue of about $7.6 billion for the fiscal first quarter, while analysts had estimated revenue of $7.24 billion.\nBroadcom also said its board authorized a new $10 billion share buyback program that is effective until the end of 2022. The company reported cash and cash equivalents of $12.16 billion at the end of its fiscal year.\nOver the past 12 months, shares of Broadcom have gained 40%. In comparison, the S&P 500 index has advanced 27%, the tech-heavy Nasdaq Composite Index has risen 26%, while the PHLX Semiconductor Index has grown 42% over that time.","news_type":1},"isVote":1,"tweetType":1,"viewCount":126,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874091047,"gmtCreate":1637709746938,"gmtModify":1637709747087,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/874091047","repostId":"2185336565","repostType":4,"repost":{"id":"2185336565","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1637708522,"share":"https://www.laohu8.com/m/news/2185336565?lang=&edition=full","pubTime":"2021-11-24 07:02","market":"us","language":"en","title":"Nasdaq ends lower for second day as Big Tech loses ground","url":"https://stock-news.laohu8.com/highlight/detail?id=2185336565","media":"Reuters","summary":"Nov 23  - The Nasdaq ended lower for a second straight session on Tuesday, while the S&P 500 rose, as rising Treasury yields prompted investors to sell Tesla and other Big Tech names and buy stocks with lower valuations.The S&P 500 growth index dipped 0.3% and the value index climbed 0.8%.Treasury yields extended gains as investors ramped up expectations of interest rate hikes next year after Jerome Powell was nominated by President Joe Biden as fed chair for a second term.Tesla fell over 4% and","content":"<p>* Banks extend gains as yields rise</p>\n<p>* Factory activity expands in November</p>\n<p>* Tesla and Microsoft give back recent gains</p>\n<p>Nov 23 (Reuters) - The Nasdaq ended lower for a second straight session on Tuesday, while the S&amp;P 500 rose, as rising Treasury yields prompted investors to sell Tesla and other Big Tech names and buy stocks with lower valuations.</p>\n<p>The S&amp;P 500 growth index dipped 0.3% and the value index climbed 0.8%.</p>\n<p>Treasury yields extended gains as investors ramped up expectations of interest rate hikes next year after Jerome Powell was nominated by President Joe Biden as fed chair for a second term.</p>\n<p>Tesla fell over 4% and Microsoft lost 0.6%, with the two companies dragging on the Nasdaq more than any other stocks. Rising interest rates tend to make growth stocks less attractive to investors.</p>\n<p>“The market is being whipsawed by a holiday shortened week, and it’s taking its cue from the recent uptick in interest rates, giving investors additional reasons to take profits in an overvalued market,” said Sam Stovall, chief investment strategist of CFRA Research in New York.</p>\n<p>With banks benefiting from higher interest rates, the S&amp;P 500 banks index jumped 2%, with Goldman Sachs, JPMorgan and Bank of America all rallying.</p>\n<p>The S&amp;P 500 energy index soared 3% and was the best-performing sector. Oil prices rose to a one-week high after a move by the United States and other consumer nations to release tens of millions of barrels of oil from reserves to try to cool the market fell short of some expectations.</p>\n<p>An IHS Markit survey showed U.S. business activity slowed moderately in November amid labor shortages and raw material delays, but remained comfortably in expansion territory on strength in the manufacturing sector.</p>\n<p>The Dow Jones Industrial Average rose 0.55% to end at 35,813.8 points, while the S&amp;P 500 gained 0.17% to 4,690.7.</p>\n<p>The Nasdaq Composite dropped 0.5% to 15,775.14.</p>\n<p>After closing on Friday at its highest level ever, the Nasdaq has now lost about 1.8%. It remains up 22% year to date.</p>\n<p>The CBOE volatility index briefly rose to a more than one-month high earlier on Tuesday.</p>\n<p>The U.S. stock market will be closed on Thursday for the Thanksgiving holiday, and it finishes early on Friday.</p>\n<p><a href=\"https://laohu8.com/S/ZM\">Zoom</a> Video Communications Inc slumped almost 15% after its third-quarter revenue growth rate slowed as demand for its video-conferencing tools eased from pandemic-fueled heights last year.</p>\n<p>Best Buy Co Inc slid 12% after the electronics retailer forecast fourth-quarter comparable sales below expectations due to supply chain issues.</p>\n<p>Chipmakers Micron Technology and Western Digital Corp&nbsp;rose 1.85% and 6.3%, respectively, after Mizuho Bank upgraded the stocks to \"buy\" from \"neutral\".</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.27-to-1 ratio; on Nasdaq, a 1.39-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 17 new 52-week highs and 6 new lows; the Nasdaq Composite recorded 66 new highs and 497 new lows.</p>\n<p>Volume on U.S. exchanges was 11.3 billion shares, compared with the 11.1 billion average for the full session over the last 20 trading days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nasdaq ends lower for second day as Big Tech loses ground</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNasdaq ends lower for second day as Big Tech loses ground\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-11-24 07:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Banks extend gains as yields rise</p>\n<p>* Factory activity expands in November</p>\n<p>* Tesla and Microsoft give back recent gains</p>\n<p>Nov 23 (Reuters) - The Nasdaq ended lower for a second straight session on Tuesday, while the S&amp;P 500 rose, as rising Treasury yields prompted investors to sell Tesla and other Big Tech names and buy stocks with lower valuations.</p>\n<p>The S&amp;P 500 growth index dipped 0.3% and the value index climbed 0.8%.</p>\n<p>Treasury yields extended gains as investors ramped up expectations of interest rate hikes next year after Jerome Powell was nominated by President Joe Biden as fed chair for a second term.</p>\n<p>Tesla fell over 4% and Microsoft lost 0.6%, with the two companies dragging on the Nasdaq more than any other stocks. Rising interest rates tend to make growth stocks less attractive to investors.</p>\n<p>“The market is being whipsawed by a holiday shortened week, and it’s taking its cue from the recent uptick in interest rates, giving investors additional reasons to take profits in an overvalued market,” said Sam Stovall, chief investment strategist of CFRA Research in New York.</p>\n<p>With banks benefiting from higher interest rates, the S&amp;P 500 banks index jumped 2%, with Goldman Sachs, JPMorgan and Bank of America all rallying.</p>\n<p>The S&amp;P 500 energy index soared 3% and was the best-performing sector. Oil prices rose to a one-week high after a move by the United States and other consumer nations to release tens of millions of barrels of oil from reserves to try to cool the market fell short of some expectations.</p>\n<p>An IHS Markit survey showed U.S. business activity slowed moderately in November amid labor shortages and raw material delays, but remained comfortably in expansion territory on strength in the manufacturing sector.</p>\n<p>The Dow Jones Industrial Average rose 0.55% to end at 35,813.8 points, while the S&amp;P 500 gained 0.17% to 4,690.7.</p>\n<p>The Nasdaq Composite dropped 0.5% to 15,775.14.</p>\n<p>After closing on Friday at its highest level ever, the Nasdaq has now lost about 1.8%. It remains up 22% year to date.</p>\n<p>The CBOE volatility index briefly rose to a more than one-month high earlier on Tuesday.</p>\n<p>The U.S. stock market will be closed on Thursday for the Thanksgiving holiday, and it finishes early on Friday.</p>\n<p><a href=\"https://laohu8.com/S/ZM\">Zoom</a> Video Communications Inc slumped almost 15% after its third-quarter revenue growth rate slowed as demand for its video-conferencing tools eased from pandemic-fueled heights last year.</p>\n<p>Best Buy Co Inc slid 12% after the electronics retailer forecast fourth-quarter comparable sales below expectations due to supply chain issues.</p>\n<p>Chipmakers Micron Technology and Western Digital Corp&nbsp;rose 1.85% and 6.3%, respectively, after Mizuho Bank upgraded the stocks to \"buy\" from \"neutral\".</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.27-to-1 ratio; on Nasdaq, a 1.39-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 17 new 52-week highs and 6 new lows; the Nasdaq Composite recorded 66 new highs and 497 new lows.</p>\n<p>Volume on U.S. exchanges was 11.3 billion shares, compared with the 11.1 billion average for the full session over the last 20 trading days.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","UDOW":"道指三倍做多ETF-ProShares","SPY":"标普500ETF","BK4567":"ESG概念","UPRO":"三倍做多标普500ETF","BK4534":"瑞士信贷持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","MSFT":"微软","BK4525":"远程办公概念","BK4566":"资本集团","PSQ":"纳指反向ETF","BK4532":"文艺复兴科技持仓","QQQ":"纳指100ETF","QLD":"纳指两倍做多ETF","DJX":"1/100道琼斯","BK4535":"淡马锡持仓","BK4559":"巴菲特持仓","BK4527":"明星科技股","BK4538":"云计算","TQQQ":"纳指三倍做多ETF","DDM":"道指两倍做多ETF","BK4550":"红杉资本持仓","TSLA":"特斯拉","DOG":"道指反向ETF",".SPX":"S&P 500 Index","BK4503":"景林资产持仓","SSO":"两倍做多标普500ETF","DXD":"道指两倍做空ETF","SDOW":"道指三倍做空ETF-ProShares","BK4097":"系统软件","QID":"纳指两倍做空ETF","BK4504":"桥水持仓","SDS":"两倍做空标普500ETF","SQQQ":"纳指三倍做空ETF","SH":"标普500反向ETF","BK4548":"巴美列捷福持仓",".DJI":"道琼斯","SPXU":"三倍做空标普500ETF","IVV":"标普500指数ETF","BK4528":"SaaS概念","BK4516":"特朗普概念","OEF":"标普100指数ETF-iShares",".IXIC":"NASDAQ Composite","BK4554":"元宇宙及AR概念","OEX":"标普100"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2185336565","content_text":"* Banks extend gains as yields rise\n* Factory activity expands in November\n* Tesla and Microsoft give back recent gains\nNov 23 (Reuters) - The Nasdaq ended lower for a second straight session on Tuesday, while the S&P 500 rose, as rising Treasury yields prompted investors to sell Tesla and other Big Tech names and buy stocks with lower valuations.\nThe S&P 500 growth index dipped 0.3% and the value index climbed 0.8%.\nTreasury yields extended gains as investors ramped up expectations of interest rate hikes next year after Jerome Powell was nominated by President Joe Biden as fed chair for a second term.\nTesla fell over 4% and Microsoft lost 0.6%, with the two companies dragging on the Nasdaq more than any other stocks. Rising interest rates tend to make growth stocks less attractive to investors.\n“The market is being whipsawed by a holiday shortened week, and it’s taking its cue from the recent uptick in interest rates, giving investors additional reasons to take profits in an overvalued market,” said Sam Stovall, chief investment strategist of CFRA Research in New York.\nWith banks benefiting from higher interest rates, the S&P 500 banks index jumped 2%, with Goldman Sachs, JPMorgan and Bank of America all rallying.\nThe S&P 500 energy index soared 3% and was the best-performing sector. Oil prices rose to a one-week high after a move by the United States and other consumer nations to release tens of millions of barrels of oil from reserves to try to cool the market fell short of some expectations.\nAn IHS Markit survey showed U.S. business activity slowed moderately in November amid labor shortages and raw material delays, but remained comfortably in expansion territory on strength in the manufacturing sector.\nThe Dow Jones Industrial Average rose 0.55% to end at 35,813.8 points, while the S&P 500 gained 0.17% to 4,690.7.\nThe Nasdaq Composite dropped 0.5% to 15,775.14.\nAfter closing on Friday at its highest level ever, the Nasdaq has now lost about 1.8%. It remains up 22% year to date.\nThe CBOE volatility index briefly rose to a more than one-month high earlier on Tuesday.\nThe U.S. stock market will be closed on Thursday for the Thanksgiving holiday, and it finishes early on Friday.\nZoom Video Communications Inc slumped almost 15% after its third-quarter revenue growth rate slowed as demand for its video-conferencing tools eased from pandemic-fueled heights last year.\nBest Buy Co Inc slid 12% after the electronics retailer forecast fourth-quarter comparable sales below expectations due to supply chain issues.\nChipmakers Micron Technology and Western Digital Corp rose 1.85% and 6.3%, respectively, after Mizuho Bank upgraded the stocks to \"buy\" from \"neutral\".\nDeclining issues outnumbered advancing ones on the NYSE by a 1.27-to-1 ratio; on Nasdaq, a 1.39-to-1 ratio favored decliners.\nThe S&P 500 posted 17 new 52-week highs and 6 new lows; the Nasdaq Composite recorded 66 new highs and 497 new lows.\nVolume on U.S. exchanges was 11.3 billion shares, compared with the 11.1 billion average for the full session over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":21,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872097983,"gmtCreate":1637372917406,"gmtModify":1637372917803,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/872097983","repostId":"1147615281","repostType":4,"repost":{"id":"1147615281","pubTimestamp":1637364985,"share":"https://www.laohu8.com/m/news/1147615281?lang=&edition=full","pubTime":"2021-11-20 07:36","market":"us","language":"en","title":"Pfizer Stock Leaps, Moderna Surges As FDA Approves Adult COVID Booster Shots","url":"https://stock-news.laohu8.com/highlight/detail?id=1147615281","media":"The Street","summary":"The Food & Drug Administration approved booster shots of both the Pfizer and Moderna Covid vaccines ","content":"<p>The Food &amp; Drug Administration approved booster shots of both the Pfizer and Moderna Covid vaccines for all American adults Friday.</p>\n<p>$Pfizer Inc&nbsp;(<b>PFE</b>)$ shares jumped higher Friday, while $Moderna&nbsp;(<b>MRNA</b>)$&nbsp;surged alongside it, after the U.S. Food &amp; Drug Administration approved the use of their Covid booster shots in all American adults.</p>\n<p>The booster dose, the FDA said, can come six months after the completion of the two-shot series of both the Pfizer and Moderna vaccines following a review of&nbsp;Emergency Use Authorization approvals for both drugmakers.&nbsp;The FDA approved Pfizer's COVID vaccine, known as 'Comiranty', for booster shots inolder and at risk Americans in late September, one month after asimilar nod for Moderna's in&nbsp;immunocompromised individuals.</p>\n<p>A panel advising the Centers for Disease Control and Prevention will meet later Friday to assess the booster shot application as President Joe Biden continues to push for broader take-up of the vaccines heading into the winter months.</p>\n<p>That move followed a dire warning from outgoing German Chancellor Angela Merkel, who called the Covid situation \"dramatic\" as infections surge and fatalities rise.</p>\n<p>The lockdown, as well as fresh restrictions on movement and businesses in Germany, pushed the euro to a mid-July low of 1.1289 against the U.S. dollar and clipped bets on near-term energy demand in the world's biggest economic bloc.</p>\n<p>“As we near the two-year mark in our fight against COVID-19, we have reached another critical milestone with the expanded authorization of a booster dose of our COVID-19 vaccine in individuals 18 years and older,” said Pfizer CEO Albert Bourla. “With boosters, more adults will now have the opportunity to help preserve a high-level of protection against this disease. We are grateful to the FDA for their rigorous review, and the action taken today that we hope will help accelerate our path out of this pandemic.”</p>\n<p>Earlier this week, Pfizer agreed to sell 10 million doses of its developing Covid antiviral pill Paxlovid,&nbsp;which is currently being reviewed for Emergency Use Approval by the FDA, to the United States Department of Health and Human Services for around $5.3 billion.</p>\n<p>At $530 per tablet, the cost is around 25% cheaper than the $700 price agreed with Merck &amp; Co.&nbsp;(<b>MRK</b>)&nbsp;last month to buy1.7 million doses its 'molnupiravir' treatmentof \"mild-to-moderate Covid in adults who are at risk for progressing to severe forms of disease, or hospitalization.</p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Stock Leaps, Moderna Surges As FDA Approves Adult COVID Booster Shots</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Stock Leaps, Moderna Surges As FDA Approves Adult COVID Booster Shots\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-20 07:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/markets/pfizer-stock-leaps-moderna-surges-as-fda-approves-covid-boosters><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Food & Drug Administration approved booster shots of both the Pfizer and Moderna Covid vaccines for all American adults Friday.\n$Pfizer Inc (PFE)$ shares jumped higher Friday, while $Moderna (MRNA...</p>\n\n<a href=\"https://www.thestreet.com/markets/pfizer-stock-leaps-moderna-surges-as-fda-approves-covid-boosters\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc."},"source_url":"https://www.thestreet.com/markets/pfizer-stock-leaps-moderna-surges-as-fda-approves-covid-boosters","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147615281","content_text":"The Food & Drug Administration approved booster shots of both the Pfizer and Moderna Covid vaccines for all American adults Friday.\n$Pfizer Inc (PFE)$ shares jumped higher Friday, while $Moderna (MRNA)$ surged alongside it, after the U.S. Food & Drug Administration approved the use of their Covid booster shots in all American adults.\nThe booster dose, the FDA said, can come six months after the completion of the two-shot series of both the Pfizer and Moderna vaccines following a review of Emergency Use Authorization approvals for both drugmakers. The FDA approved Pfizer's COVID vaccine, known as 'Comiranty', for booster shots inolder and at risk Americans in late September, one month after asimilar nod for Moderna's in immunocompromised individuals.\nA panel advising the Centers for Disease Control and Prevention will meet later Friday to assess the booster shot application as President Joe Biden continues to push for broader take-up of the vaccines heading into the winter months.\nThat move followed a dire warning from outgoing German Chancellor Angela Merkel, who called the Covid situation \"dramatic\" as infections surge and fatalities rise.\nThe lockdown, as well as fresh restrictions on movement and businesses in Germany, pushed the euro to a mid-July low of 1.1289 against the U.S. dollar and clipped bets on near-term energy demand in the world's biggest economic bloc.\n“As we near the two-year mark in our fight against COVID-19, we have reached another critical milestone with the expanded authorization of a booster dose of our COVID-19 vaccine in individuals 18 years and older,” said Pfizer CEO Albert Bourla. “With boosters, more adults will now have the opportunity to help preserve a high-level of protection against this disease. We are grateful to the FDA for their rigorous review, and the action taken today that we hope will help accelerate our path out of this pandemic.”\nEarlier this week, Pfizer agreed to sell 10 million doses of its developing Covid antiviral pill Paxlovid, which is currently being reviewed for Emergency Use Approval by the FDA, to the United States Department of Health and Human Services for around $5.3 billion.\nAt $530 per tablet, the cost is around 25% cheaper than the $700 price agreed with Merck & Co. (MRK) last month to buy1.7 million doses its 'molnupiravir' treatmentof \"mild-to-moderate Covid in adults who are at risk for progressing to severe forms of disease, or hospitalization.","news_type":1},"isVote":1,"tweetType":1,"viewCount":15,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":847138024,"gmtCreate":1636500349043,"gmtModify":1636500349450,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Okkk","listText":"Okkk","text":"Okkk","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847138024","repostId":"1151391763","repostType":4,"repost":{"id":"1151391763","pubTimestamp":1636499929,"share":"https://www.laohu8.com/m/news/1151391763?lang=&edition=full","pubTime":"2021-11-10 07:18","market":"us","language":"en","title":"After-Hours Stock Movers: Coinbase, DoorDash, Upstart Holdings and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1151391763","media":"StreetInsider","summary":"After-Hours Stock Movers:\nPoshmark Inc. (NASDAQ:POSH)25.3% LOWER; reported Q3 EPS of ($0.09), $0.02 ","content":"<p>After-Hours Stock Movers:</p>\n<p>Poshmark Inc. (NASDAQ:POSH)25.3% LOWER; reported Q3 EPS of ($0.09), $0.02 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $79.7 million versus the consensus estimate of $82.69 million. Poshmark Inc. sees Q4 2021 revenue of $80-82 million, versus the consensus of $85.1 million.</p>\n<p>PubMatic Inc. (NASDAQ:PUBM)23% HIGHER; reported Q3 EPS of $0.24, $0.15 better than the analyst estimate of $0.09. Revenue for the quarter came in at $58.1 million versus the consensus estimate of $52.55 million. PubMatic Inc. sees Q4 2021 revenue of $74-76 million, versus the consensus of $62.24 million. PubMatic Inc. sees FY2021 revenue of $225-227 million, versus the consensus of $208.02 million. PubMatic Inc. sees FY2022 revenue of $281 million, versus the consensus of $260.22 million.</p>\n<p><a href=\"https://laohu8.com/S/RNG\">RingCentral</a>, Inc. (NYSE:RNG)22.7% HIGHER; reported Q3 EPS of $0.36, $0.03 better than the analyst estimate of $0.33. Revenue for the quarter came in at $415 million versus the consensus estimate of $393.42 million. <a href=\"https://laohu8.com/S/RNG\">RingCentral</a>, Inc. sees Q4 2021 revenue of $433.5-434.5 million, versus the consensus of $420.6 million.</p>\n<p><a href=\"https://laohu8.com/S/DASH\">DoorDash, Inc.</a> (NYSE:DASH)22.4% HIGHER; announced they and certain stockholders of Wolt have entered into a definitive agreement whereby DoorDash willacquireWolt in an all-stock transaction.</p>\n<p>Upstart Holdings (NASDAQ:UPST)21% LOWER; reported Q3 EPS of $0.60, $0.25 better than the analyst estimate of $0.35. Revenue for the quarter came in at $228.5 million versus the consensus estimate of $214.9 million. Upstart Holdings sees Q4 2021 revenue of $255-265 million, versus the consensus of $226.6 million.</p>\n<p><a href=\"https://laohu8.com/S/DOCS\">Doximity, Inc.</a> (NYSE:DOCS)15% LOWER; reported <a href=\"https://laohu8.com/S/QTWO\">Q2</a> EPS of $0.19, $0.09 better than the analyst estimate of $0.10. Revenue for the quarter came in at $79.4 million versus the consensus estimate of $73.5 million. <a href=\"https://laohu8.com/S/DOCS\">Doximity, Inc.</a> sees Q3 2022 revenue of $85.8-86.8 million, versus the consensus of $74.66 million. Doximity, Inc. sees FY2022 revenue of $326.1-328.1 million, versus the consensus of $299.41 million.</p>\n<p>Coinbase (NASDAQ:COIN)11% LOWER; reported Q3 EPS of $1.62, $0.05 better than the analyst estimate of $1.57. Revenue for the quarter came in at $1.31 billion versus the consensus estimate of $1.56 billion.</p>\n<p><a href=\"https://laohu8.com/S/U\">Unity Software Inc.</a> (NYSE:U)9% LOWER; reported Q3 EPS of ($0.06), $0.01 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $286.3 million versus the consensus estimate of $264.21 million. <a href=\"https://laohu8.com/S/UNTY\">Unity</a> Software Inc. sees Q4 2021 revenue of $285-290 million, versus the consensus of $287.3 million. <a href=\"https://laohu8.com/S/U\">Unity Software Inc.</a> sees FY2021 revenue of $1.08-1.085 billion, versus the consensus of $1.06 billion.</p>\n<p>Toast (NYSE:TOST)6.6% LOWER; reported Q3 revenues of $486.4 million versus the consensus estimate of $429.97 million. Toast sees Q4 2021 revenue of $465-495 million, versus the consensus of $440.53 million. Toast sees FY2021 revenue of $1.655-1.685 billion, versus the consensus of $1.57 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Coinbase, DoorDash, Upstart Holdings and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Coinbase, DoorDash, Upstart Holdings and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-10 07:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19188152><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nPoshmark Inc. (NASDAQ:POSH)25.3% LOWER; reported Q3 EPS of ($0.09), $0.02 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $79.7 million versus ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19188152\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DASH":"DoorDash, Inc.","UPST":"Upstart Holdings, Inc.","COIN":"Coinbase Global, Inc."},"source_url":"https://www.streetinsider.com/dr/news.php?id=19188152","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151391763","content_text":"After-Hours Stock Movers:\nPoshmark Inc. (NASDAQ:POSH)25.3% LOWER; reported Q3 EPS of ($0.09), $0.02 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $79.7 million versus the consensus estimate of $82.69 million. Poshmark Inc. sees Q4 2021 revenue of $80-82 million, versus the consensus of $85.1 million.\nPubMatic Inc. (NASDAQ:PUBM)23% HIGHER; reported Q3 EPS of $0.24, $0.15 better than the analyst estimate of $0.09. Revenue for the quarter came in at $58.1 million versus the consensus estimate of $52.55 million. PubMatic Inc. sees Q4 2021 revenue of $74-76 million, versus the consensus of $62.24 million. PubMatic Inc. sees FY2021 revenue of $225-227 million, versus the consensus of $208.02 million. PubMatic Inc. sees FY2022 revenue of $281 million, versus the consensus of $260.22 million.\nRingCentral, Inc. (NYSE:RNG)22.7% HIGHER; reported Q3 EPS of $0.36, $0.03 better than the analyst estimate of $0.33. Revenue for the quarter came in at $415 million versus the consensus estimate of $393.42 million. RingCentral, Inc. sees Q4 2021 revenue of $433.5-434.5 million, versus the consensus of $420.6 million.\nDoorDash, Inc. (NYSE:DASH)22.4% HIGHER; announced they and certain stockholders of Wolt have entered into a definitive agreement whereby DoorDash willacquireWolt in an all-stock transaction.\nUpstart Holdings (NASDAQ:UPST)21% LOWER; reported Q3 EPS of $0.60, $0.25 better than the analyst estimate of $0.35. Revenue for the quarter came in at $228.5 million versus the consensus estimate of $214.9 million. Upstart Holdings sees Q4 2021 revenue of $255-265 million, versus the consensus of $226.6 million.\nDoximity, Inc. (NYSE:DOCS)15% LOWER; reported Q2 EPS of $0.19, $0.09 better than the analyst estimate of $0.10. Revenue for the quarter came in at $79.4 million versus the consensus estimate of $73.5 million. Doximity, Inc. sees Q3 2022 revenue of $85.8-86.8 million, versus the consensus of $74.66 million. Doximity, Inc. sees FY2022 revenue of $326.1-328.1 million, versus the consensus of $299.41 million.\nCoinbase (NASDAQ:COIN)11% LOWER; reported Q3 EPS of $1.62, $0.05 better than the analyst estimate of $1.57. Revenue for the quarter came in at $1.31 billion versus the consensus estimate of $1.56 billion.\nUnity Software Inc. (NYSE:U)9% LOWER; reported Q3 EPS of ($0.06), $0.01 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $286.3 million versus the consensus estimate of $264.21 million. Unity Software Inc. sees Q4 2021 revenue of $285-290 million, versus the consensus of $287.3 million. Unity Software Inc. sees FY2021 revenue of $1.08-1.085 billion, versus the consensus of $1.06 billion.\nToast (NYSE:TOST)6.6% LOWER; reported Q3 revenues of $486.4 million versus the consensus estimate of $429.97 million. Toast sees Q4 2021 revenue of $465-495 million, versus the consensus of $440.53 million. Toast sees FY2021 revenue of $1.655-1.685 billion, versus the consensus of $1.57 billion.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846184608,"gmtCreate":1636068313710,"gmtModify":1636068314115,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Oo","listText":"Oo","text":"Oo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/846184608","repostId":"1128227989","repostType":4,"repost":{"id":"1128227989","pubTimestamp":1636067303,"share":"https://www.laohu8.com/m/news/1128227989?lang=&edition=full","pubTime":"2021-11-05 07:08","market":"us","language":"en","title":"S&P 500, Nasdaq extend record streaks, with boost from chip, growth shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1128227989","media":"Reuters","summary":" - The S&P 500 and Nasdaq rose on Thursday, extending their streaks of record high closes to six sessions, as chipmaker stocks surged following Qualcomm’s strong financial forecast and investors digested the Federal Reserve’s decision to start reducing its monthly bond purchases.The Dow Jones Industrial Average posted a slim loss, ending its streak of record closes at four. Declines in shares of banks JPMorgan Chase & Co and Goldman Sachs Group weighed on the blue-chip index.Financials dropped 1","content":"<p>(Reuters) - The S&amp;P 500 and Nasdaq rose on Thursday, extending their streaks of record high closes to six sessions, as chipmaker stocks surged following Qualcomm’s strong financial forecast and investors digested the Federal Reserve’s decision to start reducing its monthly bond purchases.</p>\n<p>The Dow Jones Industrial Average posted a slim loss, ending its streak of record closes at four. Declines in shares of banks JPMorgan Chase &amp; Co and Goldman Sachs Group weighed on the blue-chip index.</p>\n<p>Financials dropped 1.3%, most among S&amp;P 500 sectors, as U.S. Treasury yields fell, with the market unwinding expectations of quicker Fed rate hikes a day after the central bank signaled it was in no hurry to do so.</p>\n<p>“The growth side of the market is seeing more positive results today as they are benefiting from the falling yields that are developing,” said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.</p>\n<p>“The market had been positioning for higher yields in general given the Fed announcement of tapering. As we walked in today, there has been a reversal in that.”</p>\n<p>The Dow Jones Industrial Average fell 33.35 points, or 0.09%, to 36,124.23, the S&amp;P 500 gained 19.49 points, or 0.42%, to 4,680.06 and the Nasdaq Composite added 128.72 points, or 0.81%, to 15,940.31.</p>\n<p>The S&amp;P 500 growth index rose 1.2% while the S&amp;P 500 value index fell 0.5%.</p>\n<p>Among S&amp;P 500 sectors, tech and consumer discretionary led the way, both rising about 1.5%.</p>\n<p>Qualcomm shares jumped 12.7% as the company forecast better-than-expected profits and revenue for its current quarter on soaring demand for chips used in phones, cars and other internet-connected devices.</p>\n<p>The Philadelphia SE Semiconductor index climbed 3.5%, with Nvidia soaring 12%.</p>\n<p>Better-than-expected third-quarter earnings have helped lift sentiment for equities. With about 420 companies having reported, S&amp;P 500 earnings are expected to have climbed 41.2% in the third quarter from a year earlier, according to Refinitiv IBES.</p>\n<p>“The corporate earnings story remains quite bright,” said Craig Fehr, investment strategist at Edward Jones.</p>\n<p>“The market is rewarding companies that are beating and upping their outlook, and the market is punishing companies that are missing their estimates in the quarter and more importantly, perhaps, signaling a more sour outlook.”</p>\n<p>Moderna shares tumbled about 18% as the company slashed the 2021 sales forecast for its COVID-19 vaccine by as much as $5 billion, grappling to fill vials and distribute them to meet unprecedented world demand. Moderna shares weighed on the S&amp;P 500 healthcare sector, which fell 0.8%.</p>\n<p>Data showed the number of Americans filing new claims for unemployment benefits fell to the lowest level in nearly 20 months last week, suggesting the economy was regaining momentum. Investors will get a critical view of the economy with the monthly jobs report on Friday.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.12-to-1 ratio; on Nasdaq, a 1.24-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 75 new 52-week highs and five new lows; the Nasdaq Composite recorded 224 new highs and 38 new lows.</p>\n<p>About 11.3 billion shares changed hands in U.S. exchanges, above the 10.4 billion daily average over the last 20 sessions.</p>","source":"lsy1601381805984","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500, Nasdaq extend record streaks, with boost from chip, growth shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500, Nasdaq extend record streaks, with boost from chip, growth shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-05 07:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/article/usa-stocks/us-stocks-sp-500-nasdaq-extend-record-streaks-with-boost-from-chip-growth-shares-idUSL1N2RV2T0><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - The S&P 500 and Nasdaq rose on Thursday, extending their streaks of record high closes to six sessions, as chipmaker stocks surged following Qualcomm’s strong financial forecast and ...</p>\n\n<a href=\"https://www.reuters.com/article/usa-stocks/us-stocks-sp-500-nasdaq-extend-record-streaks-with-boost-from-chip-growth-shares-idUSL1N2RV2T0\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","UPRO":"三倍做多标普500ETF",".IXIC":"NASDAQ Composite","SSO":"两倍做多标普500ETF",".SPX":"S&P 500 Index","SPXU":"三倍做空标普500ETF","IVV":"标普500指数ETF","OEX":"标普100","SDS":"两倍做空标普500ETF","SH":"标普500反向ETF","OEF":"标普100指数ETF-iShares",".DJI":"道琼斯"},"source_url":"https://www.reuters.com/article/usa-stocks/us-stocks-sp-500-nasdaq-extend-record-streaks-with-boost-from-chip-growth-shares-idUSL1N2RV2T0","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128227989","content_text":"(Reuters) - The S&P 500 and Nasdaq rose on Thursday, extending their streaks of record high closes to six sessions, as chipmaker stocks surged following Qualcomm’s strong financial forecast and investors digested the Federal Reserve’s decision to start reducing its monthly bond purchases.\nThe Dow Jones Industrial Average posted a slim loss, ending its streak of record closes at four. Declines in shares of banks JPMorgan Chase & Co and Goldman Sachs Group weighed on the blue-chip index.\nFinancials dropped 1.3%, most among S&P 500 sectors, as U.S. Treasury yields fell, with the market unwinding expectations of quicker Fed rate hikes a day after the central bank signaled it was in no hurry to do so.\n“The growth side of the market is seeing more positive results today as they are benefiting from the falling yields that are developing,” said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.\n“The market had been positioning for higher yields in general given the Fed announcement of tapering. As we walked in today, there has been a reversal in that.”\nThe Dow Jones Industrial Average fell 33.35 points, or 0.09%, to 36,124.23, the S&P 500 gained 19.49 points, or 0.42%, to 4,680.06 and the Nasdaq Composite added 128.72 points, or 0.81%, to 15,940.31.\nThe S&P 500 growth index rose 1.2% while the S&P 500 value index fell 0.5%.\nAmong S&P 500 sectors, tech and consumer discretionary led the way, both rising about 1.5%.\nQualcomm shares jumped 12.7% as the company forecast better-than-expected profits and revenue for its current quarter on soaring demand for chips used in phones, cars and other internet-connected devices.\nThe Philadelphia SE Semiconductor index climbed 3.5%, with Nvidia soaring 12%.\nBetter-than-expected third-quarter earnings have helped lift sentiment for equities. With about 420 companies having reported, S&P 500 earnings are expected to have climbed 41.2% in the third quarter from a year earlier, according to Refinitiv IBES.\n“The corporate earnings story remains quite bright,” said Craig Fehr, investment strategist at Edward Jones.\n“The market is rewarding companies that are beating and upping their outlook, and the market is punishing companies that are missing their estimates in the quarter and more importantly, perhaps, signaling a more sour outlook.”\nModerna shares tumbled about 18% as the company slashed the 2021 sales forecast for its COVID-19 vaccine by as much as $5 billion, grappling to fill vials and distribute them to meet unprecedented world demand. Moderna shares weighed on the S&P 500 healthcare sector, which fell 0.8%.\nData showed the number of Americans filing new claims for unemployment benefits fell to the lowest level in nearly 20 months last week, suggesting the economy was regaining momentum. Investors will get a critical view of the economy with the monthly jobs report on Friday.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.12-to-1 ratio; on Nasdaq, a 1.24-to-1 ratio favored decliners.\nThe S&P 500 posted 75 new 52-week highs and five new lows; the Nasdaq Composite recorded 224 new highs and 38 new lows.\nAbout 11.3 billion shares changed hands in U.S. exchanges, above the 10.4 billion daily average over the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":21,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604438541,"gmtCreate":1639437638495,"gmtModify":1639437638791,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604438541","repostId":"2191984334","repostType":4,"repost":{"id":"2191984334","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639435732,"share":"https://www.laohu8.com/m/news/2191984334?lang=&edition=full","pubTime":"2021-12-14 06:48","market":"us","language":"en","title":"Wall Street ends down; investors eye Omicron and Fed meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2191984334","media":"Reuters","summary":"* Pfizer to buy Arena Pharma, shares of both companies rise\n* Meme stocks GameStop, AMC slump to mul","content":"<p>* Pfizer to buy Arena Pharma, shares of both companies rise</p>\n<p>*&nbsp;Meme stocks GameStop, AMC slump to multi-month lows</p>\n<p>* Consumer discretionary, energy lead declines</p>\n<p>Dec 13 (Reuters) - Wall Street ended lower on Monday, with shares of Carnival Corp and several airlines tumbling as investors worried about the Omicron coronavirus variant ahead of a Federal Reserve meeting later this week.</p>\n<p>Travel-related stocks fell, with the fast-spreading variant accounting for around 40% of COVID-19 infections in London and at least one death in the United Kingdom.</p>\n<p>Norwegian Cruise Line Holdings, Carnival Corp&nbsp;and Royal Caribbean Cruises&nbsp;all slumped more than 4%, while the S&amp;P 1500 airlines index&nbsp;shed about 3%.</p>\n<p>\"It's transportation, restaurants, all the things that if it got bad enough that we started putting new restrictions on people, it would not be good for them,\" said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta. \"They have all been bid over the past several months by the idea that we were going to get back to business as usual.\"</p>\n<p>Most of the 11 major S&amp;P 500 sector indexes fell, with only defensive sectors, including consumer staples, utilities&nbsp;and real estate&nbsp;gaining.</p>\n<p>The Dow Jones Industrial Average&nbsp;fell 0.89% to end at 35,650.95 points, while the S&amp;P 500&nbsp;lost 0.91% to 4,668.97.</p>\n<p>The Nasdaq Composite&nbsp;dropped 1.39% to 15,413.28.</p>\n<p>Following Monday's dip, the S&amp;P 500 remains up about 24% year to date.</p>\n<p>Apple Inc&nbsp;dipped 2.1%, even after J.P. Morgan raised its price target on the iPhone maker to the highest on Wall Street. The company is close to becoming the first in the world to hit $3 trillion in market value.</p>\n<p>Investors expect an increasingly hawkish tone out of the Federal Reserve's two-day meeting that wraps up on Wednesday. The U.S. central bank is expected to signal a faster wind-down of asset purchases, which could also usher closer a start to interest rate hikes.</p>\n<p>\"Everyone is focused on the Fed this week and what guidance we get in terms of bond purchases and interest rates. There's an expectation that there will be an acceleration of tapering, and there's a little anxiety leading up to that,\" said Ryan Jacob, chief portfolio manager at Jacob Internet Fund.</p>\n<p>A Reuters poll of economists sees the central bank hiking interest rates from near zero to 0.25%-0.50% in the third quarter of next year, followed by another in the fourth quarter.</p>\n<p>Positive updates about vaccines and antibody cocktails to combat the new COVID-19 variant, along with a recent reading on inflation that was in line with consensus, pushed the S&amp;P 500&nbsp;index to a record closing high on Friday.</p>\n<p>Pfizer Inc&nbsp;rose 4.6% after it agreed to acquire Arena Pharmaceuticals&nbsp;in a $6.7 billion all-cash deal. Arena's shares surged 80%.</p>\n<p>Shares of Gamestop&nbsp;and AMC Entertainment&nbsp;tumbled to multi-month lows on Monday as some investors appeared to sour on the names that had produced eye-watering gains earlier in the year.</p>\n<p>Video game retailer GameStop tumbled 13.9% at $136.88, briefly touching its lowest level since April, while movie theater operator AMC slumped 15.3% to $23.24, a level last seen in May.</p>\n<p>Volume on U.S. exchanges was 10.4 billion shares, compared with the 11.4 billion average over the last 20 trading days.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 2.30-to-1 ratio; on Nasdaq, a 2.53-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 52 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 33 new highs and 302 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends down; investors eye Omicron and Fed meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends down; investors eye Omicron and Fed meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-14 06:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Pfizer to buy Arena Pharma, shares of both companies rise</p>\n<p>*&nbsp;Meme stocks GameStop, AMC slump to multi-month lows</p>\n<p>* Consumer discretionary, energy lead declines</p>\n<p>Dec 13 (Reuters) - Wall Street ended lower on Monday, with shares of Carnival Corp and several airlines tumbling as investors worried about the Omicron coronavirus variant ahead of a Federal Reserve meeting later this week.</p>\n<p>Travel-related stocks fell, with the fast-spreading variant accounting for around 40% of COVID-19 infections in London and at least one death in the United Kingdom.</p>\n<p>Norwegian Cruise Line Holdings, Carnival Corp&nbsp;and Royal Caribbean Cruises&nbsp;all slumped more than 4%, while the S&amp;P 1500 airlines index&nbsp;shed about 3%.</p>\n<p>\"It's transportation, restaurants, all the things that if it got bad enough that we started putting new restrictions on people, it would not be good for them,\" said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta. \"They have all been bid over the past several months by the idea that we were going to get back to business as usual.\"</p>\n<p>Most of the 11 major S&amp;P 500 sector indexes fell, with only defensive sectors, including consumer staples, utilities&nbsp;and real estate&nbsp;gaining.</p>\n<p>The Dow Jones Industrial Average&nbsp;fell 0.89% to end at 35,650.95 points, while the S&amp;P 500&nbsp;lost 0.91% to 4,668.97.</p>\n<p>The Nasdaq Composite&nbsp;dropped 1.39% to 15,413.28.</p>\n<p>Following Monday's dip, the S&amp;P 500 remains up about 24% year to date.</p>\n<p>Apple Inc&nbsp;dipped 2.1%, even after J.P. Morgan raised its price target on the iPhone maker to the highest on Wall Street. The company is close to becoming the first in the world to hit $3 trillion in market value.</p>\n<p>Investors expect an increasingly hawkish tone out of the Federal Reserve's two-day meeting that wraps up on Wednesday. The U.S. central bank is expected to signal a faster wind-down of asset purchases, which could also usher closer a start to interest rate hikes.</p>\n<p>\"Everyone is focused on the Fed this week and what guidance we get in terms of bond purchases and interest rates. There's an expectation that there will be an acceleration of tapering, and there's a little anxiety leading up to that,\" said Ryan Jacob, chief portfolio manager at Jacob Internet Fund.</p>\n<p>A Reuters poll of economists sees the central bank hiking interest rates from near zero to 0.25%-0.50% in the third quarter of next year, followed by another in the fourth quarter.</p>\n<p>Positive updates about vaccines and antibody cocktails to combat the new COVID-19 variant, along with a recent reading on inflation that was in line with consensus, pushed the S&amp;P 500&nbsp;index to a record closing high on Friday.</p>\n<p>Pfizer Inc&nbsp;rose 4.6% after it agreed to acquire Arena Pharmaceuticals&nbsp;in a $6.7 billion all-cash deal. Arena's shares surged 80%.</p>\n<p>Shares of Gamestop&nbsp;and AMC Entertainment&nbsp;tumbled to multi-month lows on Monday as some investors appeared to sour on the names that had produced eye-watering gains earlier in the year.</p>\n<p>Video game retailer GameStop tumbled 13.9% at $136.88, briefly touching its lowest level since April, while movie theater operator AMC slumped 15.3% to $23.24, a level last seen in May.</p>\n<p>Volume on U.S. exchanges was 10.4 billion shares, compared with the 11.4 billion average over the last 20 trading days.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 2.30-to-1 ratio; on Nasdaq, a 2.53-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 52 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 33 new highs and 302 new lows.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4568":"美国抗疫概念","UDOW":"道指三倍做多ETF-ProShares","DJX":"1/100道琼斯","BK4517":"邮轮概念","PSQ":"纳指反向ETF","QLD":"纳指两倍做多ETF","QQQ":"纳指100ETF","PFE":"辉瑞","DDM":"道指两倍做多ETF","TQQQ":"纳指三倍做多ETF","BK4142":"酒店、度假村与豪华游轮","DOG":"道指反向ETF","SQQQ":"纳指三倍做空ETF","RCL":"皇家加勒比邮轮","SDOW":"道指三倍做空ETF-ProShares","DXD":"道指两倍做空ETF","NCLH":"挪威邮轮","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4007":"制药","ARNA":"阿里那","CCL":"嘉年华邮轮","QID":"纳指两倍做空ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191984334","content_text":"* Pfizer to buy Arena Pharma, shares of both companies rise\n* Meme stocks GameStop, AMC slump to multi-month lows\n* Consumer discretionary, energy lead declines\nDec 13 (Reuters) - Wall Street ended lower on Monday, with shares of Carnival Corp and several airlines tumbling as investors worried about the Omicron coronavirus variant ahead of a Federal Reserve meeting later this week.\nTravel-related stocks fell, with the fast-spreading variant accounting for around 40% of COVID-19 infections in London and at least one death in the United Kingdom.\nNorwegian Cruise Line Holdings, Carnival Corp and Royal Caribbean Cruises all slumped more than 4%, while the S&P 1500 airlines index shed about 3%.\n\"It's transportation, restaurants, all the things that if it got bad enough that we started putting new restrictions on people, it would not be good for them,\" said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta. \"They have all been bid over the past several months by the idea that we were going to get back to business as usual.\"\nMost of the 11 major S&P 500 sector indexes fell, with only defensive sectors, including consumer staples, utilities and real estate gaining.\nThe Dow Jones Industrial Average fell 0.89% to end at 35,650.95 points, while the S&P 500 lost 0.91% to 4,668.97.\nThe Nasdaq Composite dropped 1.39% to 15,413.28.\nFollowing Monday's dip, the S&P 500 remains up about 24% year to date.\nApple Inc dipped 2.1%, even after J.P. Morgan raised its price target on the iPhone maker to the highest on Wall Street. The company is close to becoming the first in the world to hit $3 trillion in market value.\nInvestors expect an increasingly hawkish tone out of the Federal Reserve's two-day meeting that wraps up on Wednesday. The U.S. central bank is expected to signal a faster wind-down of asset purchases, which could also usher closer a start to interest rate hikes.\n\"Everyone is focused on the Fed this week and what guidance we get in terms of bond purchases and interest rates. There's an expectation that there will be an acceleration of tapering, and there's a little anxiety leading up to that,\" said Ryan Jacob, chief portfolio manager at Jacob Internet Fund.\nA Reuters poll of economists sees the central bank hiking interest rates from near zero to 0.25%-0.50% in the third quarter of next year, followed by another in the fourth quarter.\nPositive updates about vaccines and antibody cocktails to combat the new COVID-19 variant, along with a recent reading on inflation that was in line with consensus, pushed the S&P 500 index to a record closing high on Friday.\nPfizer Inc rose 4.6% after it agreed to acquire Arena Pharmaceuticals in a $6.7 billion all-cash deal. Arena's shares surged 80%.\nShares of Gamestop and AMC Entertainment tumbled to multi-month lows on Monday as some investors appeared to sour on the names that had produced eye-watering gains earlier in the year.\nVideo game retailer GameStop tumbled 13.9% at $136.88, briefly touching its lowest level since April, while movie theater operator AMC slumped 15.3% to $23.24, a level last seen in May.\nVolume on U.S. exchanges was 10.4 billion shares, compared with the 11.4 billion average over the last 20 trading days.\nDeclining issues outnumbered advancing ones on the NYSE by a 2.30-to-1 ratio; on Nasdaq, a 2.53-to-1 ratio favored decliners.\nThe S&P 500 posted 52 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 33 new highs and 302 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":262,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609073171,"gmtCreate":1638228379688,"gmtModify":1638228380082,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Oko","listText":"Oko","text":"Oko","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609073171","repostId":"2187306464","repostType":4,"repost":{"id":"2187306464","pubTimestamp":1638222370,"share":"https://www.laohu8.com/m/news/2187306464?lang=&edition=full","pubTime":"2021-11-30 05:46","market":"us","language":"en","title":"US STOCKS-Wall Street rebounds after virus-related sell-off","url":"https://stock-news.laohu8.com/highlight/detail?id=2187306464","media":"Reuters","summary":"Wall Street stocks closed higher on Monday, regaining some of the ground they lost in Friday's sell-off, as investors were hopeful that the Omicron coronavirus variant would not lead to lockdowns after reassurance from U.S. President Joe Biden.The Nasdaq led gains among the major averages with help from the technology sector, while the S&P and the Dow advanced after suffering their biggest one-day percentage declines in months in Friday's holiday-shortened session as investors worried that the l","content":"<p>Wall Street stocks closed higher on Monday, regaining some of the ground they lost in Friday's sell-off, as investors were hopeful that the Omicron coronavirus variant would not lead to lockdowns after reassurance from U.S. President Joe Biden.</p>\n<p>The Nasdaq led gains among the major averages with help from the technology sector, while the S&amp;P and the Dow advanced after suffering their biggest one-day percentage declines in months in Friday's holiday-shortened session as investors worried that the latest COVID-19 variant would cause economic disruption.</p>\n<p>Biden said on Monday that Omicron-related lockdowns were off the table for now and he urged Americans not to panic about the variant. However, he did recommend vaccination and mask wearing indoors to combat the virus and said the United States was working with pharmaceutical companies to make contingency plans if new vaccines were needed.</p>\n<p>Those comments and indications from drug companies that they are taking the variant seriously were reassuring for investors, who had been anxious about the potential for further COVID restrictions.</p>\n<p>\"Friday was a major de-risking event. You had the market go back to its worst fears of COVID spreading and the return of lockdowns,\" said Edward Moya, senior market analyst at OANDA.</p>\n<p>\"Now you're starting to see there is some optimism when you listen to the President, when you listen to the Pfizer CEO. The Omicron panic is easing, and we're into a period of wait and see.\"</p>\n<p>Vaccine makers such as Pfizer, its partner BioNTech and their rivals Moderna and Johnson &amp; Johnson said Monday they are working on vaccines that specifically target Omicron in case existing shots are not effective against the variant.</p>\n<p>\"It's not like the start of the pandemic all over again,\" said Carol Schleif, deputy chief investment officer for the BMO family office in Minneapolis who also noted that after Friday's knee-jerk reaction, investors have been trained this year to buy the dip. \"People are willing to just take a deep breath and try to reassess, be a little more patient.\"</p>\n<p>The Dow Jones Industrial Average rose 236.6 points, or 0.68%, to 35,135.94, the S&amp;P 500 gained 60.65 points, or 1.32%, to 4,655.27 and the Nasdaq Composite added 291.18 points, or 1.88%, to 15,782.83.</p>\n<p>Among the S&amp;P's 11 major sectors, technology was the leading percentage gainer, up 2.6%, followed by the consumer discretionary sector, which closed up 1.6%, with boosts from Amazon.com and Tesla Inc.</p>\n<p>Other big boosts from single stocks in the S&amp;P came from Microsoft and Apple Inc, which gained ground after HSBC raised its price target for the iPhone maker.</p>\n<p>While the Dow advanced, it underperformed its peers with pressure from Merck &amp; Co Inc, which closed down 5.4%. The drugmaker extended losses from Friday when updated data from a study of its experimental COVID-19 pill showed lower efficacy in reducing risk of hospitalization and deaths than previously reported.</p>\n<p>Britain said it would offer a COVID-19 booster vaccine to all adults and give second doses to children aged between 12 and 15, in light of concern about the spread of the Omicron variant. It also said Moderna and Pfizer vaccines were the preferred boosters.</p>\n<p>After the U.S. market close, the U.S. Centers for Disease Control and Prevention said everyone aged 18 years and older should get boosters six months after Pfizer or Moderna COVID vaccines or two months after a Johnson &amp; Johnson shot.</p>\n<p>Moderna rose 11.8% on the day, while Pfizer fell almost 3% and Johnson &amp; Johnson rose 0.34%.</p>\n<p>The Philadelphia semiconductor index outperformed the broader market with a 4% gain as chipstocks rose broadly. Nvidia provided the biggest boost with a 5.9% gain.</p>\n<p>Tesla's shares gained 5% after a report that chief Elon Musk urged employees to reduce the cost of vehicle deliveries.</p>\n<p>Twitter Inc closed down 2.7%, reversing early gains after the social media firm said CEO Jack Dorsey will step down and be succeeded by Chief Technology Officer Parag Agrawal. Dorsey had been in the unusual position of having the CEO job at two major technology companies, the second being digital payments firm Square Inc.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.31-to-1 ratio; on Nasdaq, a 1.35-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 16 new 52-week highs and 21 new lows; the Nasdaq Composite recorded 39 new highs and 344 new lows.</p>\n<p>On U.S. exchanges, 11.13 billion shares changed hands on Monday compared with the 10.84 billion average for the last 20 sessions. </p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US STOCKS-Wall Street rebounds after virus-related sell-off</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS STOCKS-Wall Street rebounds after virus-related sell-off\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-30 05:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/us-stocks-wall-street-rebounds-214610786.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Wall Street stocks closed higher on Monday, regaining some of the ground they lost in Friday's sell-off, as investors were hopeful that the Omicron coronavirus variant would not lead to lockdowns ...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-wall-street-rebounds-214610786.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","PFE":"辉瑞","BK4534":"瑞士信贷持仓","BK4559":"巴菲特持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","MRNA":"Moderna, Inc.","BK4568":"美国抗疫概念","BK4007":"制药","BK4504":"桥水持仓","COMP":"Compass, Inc.","BK4532":"文艺复兴科技持仓"},"source_url":"https://finance.yahoo.com/news/us-stocks-wall-street-rebounds-214610786.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2187306464","content_text":"Wall Street stocks closed higher on Monday, regaining some of the ground they lost in Friday's sell-off, as investors were hopeful that the Omicron coronavirus variant would not lead to lockdowns after reassurance from U.S. President Joe Biden.\nThe Nasdaq led gains among the major averages with help from the technology sector, while the S&P and the Dow advanced after suffering their biggest one-day percentage declines in months in Friday's holiday-shortened session as investors worried that the latest COVID-19 variant would cause economic disruption.\nBiden said on Monday that Omicron-related lockdowns were off the table for now and he urged Americans not to panic about the variant. However, he did recommend vaccination and mask wearing indoors to combat the virus and said the United States was working with pharmaceutical companies to make contingency plans if new vaccines were needed.\nThose comments and indications from drug companies that they are taking the variant seriously were reassuring for investors, who had been anxious about the potential for further COVID restrictions.\n\"Friday was a major de-risking event. You had the market go back to its worst fears of COVID spreading and the return of lockdowns,\" said Edward Moya, senior market analyst at OANDA.\n\"Now you're starting to see there is some optimism when you listen to the President, when you listen to the Pfizer CEO. The Omicron panic is easing, and we're into a period of wait and see.\"\nVaccine makers such as Pfizer, its partner BioNTech and their rivals Moderna and Johnson & Johnson said Monday they are working on vaccines that specifically target Omicron in case existing shots are not effective against the variant.\n\"It's not like the start of the pandemic all over again,\" said Carol Schleif, deputy chief investment officer for the BMO family office in Minneapolis who also noted that after Friday's knee-jerk reaction, investors have been trained this year to buy the dip. \"People are willing to just take a deep breath and try to reassess, be a little more patient.\"\nThe Dow Jones Industrial Average rose 236.6 points, or 0.68%, to 35,135.94, the S&P 500 gained 60.65 points, or 1.32%, to 4,655.27 and the Nasdaq Composite added 291.18 points, or 1.88%, to 15,782.83.\nAmong the S&P's 11 major sectors, technology was the leading percentage gainer, up 2.6%, followed by the consumer discretionary sector, which closed up 1.6%, with boosts from Amazon.com and Tesla Inc.\nOther big boosts from single stocks in the S&P came from Microsoft and Apple Inc, which gained ground after HSBC raised its price target for the iPhone maker.\nWhile the Dow advanced, it underperformed its peers with pressure from Merck & Co Inc, which closed down 5.4%. The drugmaker extended losses from Friday when updated data from a study of its experimental COVID-19 pill showed lower efficacy in reducing risk of hospitalization and deaths than previously reported.\nBritain said it would offer a COVID-19 booster vaccine to all adults and give second doses to children aged between 12 and 15, in light of concern about the spread of the Omicron variant. It also said Moderna and Pfizer vaccines were the preferred boosters.\nAfter the U.S. market close, the U.S. Centers for Disease Control and Prevention said everyone aged 18 years and older should get boosters six months after Pfizer or Moderna COVID vaccines or two months after a Johnson & Johnson shot.\nModerna rose 11.8% on the day, while Pfizer fell almost 3% and Johnson & Johnson rose 0.34%.\nThe Philadelphia semiconductor index outperformed the broader market with a 4% gain as chipstocks rose broadly. Nvidia provided the biggest boost with a 5.9% gain.\nTesla's shares gained 5% after a report that chief Elon Musk urged employees to reduce the cost of vehicle deliveries.\nTwitter Inc closed down 2.7%, reversing early gains after the social media firm said CEO Jack Dorsey will step down and be succeeded by Chief Technology Officer Parag Agrawal. Dorsey had been in the unusual position of having the CEO job at two major technology companies, the second being digital payments firm Square Inc.\nAdvancing issues outnumbered declining ones on the NYSE by a 1.31-to-1 ratio; on Nasdaq, a 1.35-to-1 ratio favored decliners.\nThe S&P 500 posted 16 new 52-week highs and 21 new lows; the Nasdaq Composite recorded 39 new highs and 344 new lows.\nOn U.S. exchanges, 11.13 billion shares changed hands on Monday compared with the 10.84 billion average for the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":85,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":827548598,"gmtCreate":1634513093237,"gmtModify":1634513093619,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/827548598","repostId":"1185155570","repostType":4,"repost":{"id":"1185155570","pubTimestamp":1634511079,"share":"https://www.laohu8.com/m/news/1185155570?lang=&edition=full","pubTime":"2021-10-18 06:51","market":"us","language":"en","title":"Tesla, AT&T, Netflix, ASML, Snap and Other Stocks for Investors to Watch This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1185155570","media":"Barrons","summary":"Seventy-two S&P 500 companies report earnings this week, as third-quarter earnings season ramps up. ","content":"<p>Seventy-two&nbsp;S&amp;P 500&nbsp;companies report earnings this week,&nbsp;as third-quarter earnings season ramps up. Several big U.S. banks got things off to a strong start last week. This week’s earnings highlights&nbsp;will include&nbsp;results from notable companies in telecom, consumer staples, energy, technology, health care, and the airline industry.</p>\n<p><img src=\"https://static.tigerbbs.com/685ba1e7f4763c12a3c0159fc2469ded\" tg-width=\"1878\" tg-height=\"2461\" width=\"100%\" height=\"auto\"></p>\n<p>Albertsons and&nbsp;State Street&nbsp;get the ball rolling on Monday.Procter &amp; Gamble,Halliburton,and&nbsp;Johnson &amp; Johnson&nbsp;are Tuesday morning’s highlights, followed by&nbsp;Netflix&nbsp;and&nbsp;United Airlines Holdings&nbsp;after the market closes.</p>\n<p>On Wednesday,Verizon Communications,IBM,and Tesla will get the most attention.AT&amp;T, American Airlines Group,Southwest Airlines,and&nbsp;Chipotle Mexican Grill&nbsp;report on Thursday, then&nbsp;American Express,Schlumberger,and&nbsp;Honeywell International&nbsp;close the week on Friday.</p>\n<p>Economic data highlights this week include the Conference Board’s Leading Economic Index for September on Thursday and&nbsp;IHS Markit’s&nbsp;Manufacturing and Services Purchasing Managers’ indexes for October on Friday. All are seen easing back from their prior months’ levels.</p>\n<p>Other releases this week include the Federal Reserve’s most recent Beige Book, describing economic conditions across the U.S., and a pair of September housing-market indicators: The Census Bureau reports new residential construction data on Tuesday and the National Association of Realtors reports existing-home sales on Thursday.</p>\n<p><b>Monday 10/18</b></p>\n<p><b>The Federal Reserve</b>&nbsp;releases industrial production data for September. Economists are looking for a 0.20% rise after a 0.4% increase in August. Capacity utilization is expected at 76.5% for September, roughly in line with August’s 76.4%.</p>\n<p>Albertsons, Philips, Steel Dynamics, and State Street are among companies releasing quarterly financial results.</p>\n<p><b>Tuesday 10/19</b></p>\n<p><b>The Census Bureau</b> reports new residential construction data for September. Economists forecast a seasonally adjusted annual rate of 1.623 million housing starts, compared with 1.615 million in August.</p>\n<p>Halliburton, Procter &amp; Gamble, Johnson &amp; Johnson, Synchrony, Travelers, Philip Morris International, Kansas City Southern, WD-40, Interactive Brokers Group, Netflix, ManpowerGroup, Dover, and Canadian National Railway are among companies hosting earnings conference calls.</p>\n<p><b>Wednesday 10/20</b></p>\n<p><b>The Federal Reserve</b> releases its beige book about current economic conditions across the central bank’s 12 districts.</p>\n<p>Abbott Laboratories, Biogen, NextEra Energy, ASML Holding, Nasdaq, Canadian Pacific Railway, Verizon Communications, CSX, Lam Research, Tesla, IBM, and Anthem discuss quarterly financial results.</p>\n<p><b>Thursday 10/21</b></p>\n<p><b>The National Association</b> of Realtors reports existing-home sales for September. Economists forecast a seasonally adjusted annual rate of 6.10 million homes sold, compared with 5.88 million homes in August.</p>\n<p>Dow, Freeport-McMoRan, Genuine Parts, Southwest Airlines, Valero Energy, Blackstone, Quest Diagnostics, Snap-on, Tractor Supply, Barclays, Danaher, AT&amp;T, Nucor, American Airlines Group, AutoNation, Valero Energy, SL Green Realty, Intel, Snap, Boston Beer, Mattel, and Chipotle Mexican Grill host earnings conference calls to discuss quarterly results.</p>\n<p><b>The Philadelphia Fed</b>&nbsp;diffusion index, a measure of overall manufacturing activity, is expected to fall to 24 in October from September’s 30.7 reading.</p>\n<p><b>The Conference Board</b>&nbsp;releases its Leading Economic Index for September. Expectations are for a 0.50% rise, after August’s 0.90% gain.</p>\n<p><b>Friday 10/22</b></p>\n<p><b>IHS Markit releases</b>&nbsp;the Manufacturing and Services Purchasing Managers’ indexes for October. Consensus estimate for the Manufacturing PMI is 60.3, while the Services PMI is expected to be 54.7, compared with 60.7 and 54.9, respectively, in September.</p>\n<p>Whirlpool, Honeywell, Cleveland-Cliffs, Celanese, HCA Healthcare, Schlumberger, Seagate Technology Holdings, VF Corp., and American Express host investor conference calls.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla, AT&T, Netflix, ASML, Snap and Other Stocks for Investors to Watch This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla, AT&T, Netflix, ASML, Snap and Other Stocks for Investors to Watch This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-18 06:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/tesla-at-t-netflix-chipotle-and-other-stocks-for-investors-to-watch-this-week-51634497206?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Seventy-two S&P 500 companies report earnings this week, as third-quarter earnings season ramps up. Several big U.S. banks got things off to a strong start last week. This week’s earnings highlights ...</p>\n\n<a href=\"https://www.barrons.com/articles/tesla-at-t-netflix-chipotle-and-other-stocks-for-investors-to-watch-this-week-51634497206?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"T":"美国电话电报","JNJ":"强生","UAL":"联合大陆航空","AXP":"美国运通",".SPX":"S&P 500 Index","AAL":"美国航空","IBM":"IBM","CMG":"墨式烧烤","HAL":"哈里伯顿","LUV":"西南航空","TSLA":"特斯拉","NFLX":"奈飞","INTC":"英特尔",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://www.barrons.com/articles/tesla-at-t-netflix-chipotle-and-other-stocks-for-investors-to-watch-this-week-51634497206?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185155570","content_text":"Seventy-two S&P 500 companies report earnings this week, as third-quarter earnings season ramps up. Several big U.S. banks got things off to a strong start last week. This week’s earnings highlights will include results from notable companies in telecom, consumer staples, energy, technology, health care, and the airline industry.\n\nAlbertsons and State Street get the ball rolling on Monday.Procter & Gamble,Halliburton,and Johnson & Johnson are Tuesday morning’s highlights, followed by Netflix and United Airlines Holdings after the market closes.\nOn Wednesday,Verizon Communications,IBM,and Tesla will get the most attention.AT&T, American Airlines Group,Southwest Airlines,and Chipotle Mexican Grill report on Thursday, then American Express,Schlumberger,and Honeywell International close the week on Friday.\nEconomic data highlights this week include the Conference Board’s Leading Economic Index for September on Thursday and IHS Markit’s Manufacturing and Services Purchasing Managers’ indexes for October on Friday. All are seen easing back from their prior months’ levels.\nOther releases this week include the Federal Reserve’s most recent Beige Book, describing economic conditions across the U.S., and a pair of September housing-market indicators: The Census Bureau reports new residential construction data on Tuesday and the National Association of Realtors reports existing-home sales on Thursday.\nMonday 10/18\nThe Federal Reserve releases industrial production data for September. Economists are looking for a 0.20% rise after a 0.4% increase in August. Capacity utilization is expected at 76.5% for September, roughly in line with August’s 76.4%.\nAlbertsons, Philips, Steel Dynamics, and State Street are among companies releasing quarterly financial results.\nTuesday 10/19\nThe Census Bureau reports new residential construction data for September. Economists forecast a seasonally adjusted annual rate of 1.623 million housing starts, compared with 1.615 million in August.\nHalliburton, Procter & Gamble, Johnson & Johnson, Synchrony, Travelers, Philip Morris International, Kansas City Southern, WD-40, Interactive Brokers Group, Netflix, ManpowerGroup, Dover, and Canadian National Railway are among companies hosting earnings conference calls.\nWednesday 10/20\nThe Federal Reserve releases its beige book about current economic conditions across the central bank’s 12 districts.\nAbbott Laboratories, Biogen, NextEra Energy, ASML Holding, Nasdaq, Canadian Pacific Railway, Verizon Communications, CSX, Lam Research, Tesla, IBM, and Anthem discuss quarterly financial results.\nThursday 10/21\nThe National Association of Realtors reports existing-home sales for September. Economists forecast a seasonally adjusted annual rate of 6.10 million homes sold, compared with 5.88 million homes in August.\nDow, Freeport-McMoRan, Genuine Parts, Southwest Airlines, Valero Energy, Blackstone, Quest Diagnostics, Snap-on, Tractor Supply, Barclays, Danaher, AT&T, Nucor, American Airlines Group, AutoNation, Valero Energy, SL Green Realty, Intel, Snap, Boston Beer, Mattel, and Chipotle Mexican Grill host earnings conference calls to discuss quarterly results.\nThe Philadelphia Fed diffusion index, a measure of overall manufacturing activity, is expected to fall to 24 in October from September’s 30.7 reading.\nThe Conference Board releases its Leading Economic Index for September. Expectations are for a 0.50% rise, after August’s 0.90% gain.\nFriday 10/22\nIHS Markit releases the Manufacturing and Services Purchasing Managers’ indexes for October. Consensus estimate for the Manufacturing PMI is 60.3, while the Services PMI is expected to be 54.7, compared with 60.7 and 54.9, respectively, in September.\nWhirlpool, Honeywell, Cleveland-Cliffs, Celanese, HCA Healthcare, Schlumberger, Seagate Technology Holdings, VF Corp., and American Express host investor conference calls.","news_type":1},"isVote":1,"tweetType":1,"viewCount":25,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":867408412,"gmtCreate":1633305591902,"gmtModify":1633305592211,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/867408412","repostId":"1145081858","repostType":4,"repost":{"id":"1145081858","pubTimestamp":1633271769,"share":"https://www.laohu8.com/m/news/1145081858?lang=&edition=full","pubTime":"2021-10-03 22:36","market":"us","language":"en","title":"Top Performing ETFs For September 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=1145081858","media":"The Street","summary":"Energy funds dominate as the cyclical reflation trade returns.","content":"<p>September will almost certainly be a month that most equity investors would soon forget. The S&amp;P 500's (SPY) loss of 4% was the first monthly loss for the large-cap index since January 2021 and the biggest monthly loss since the March 2020 COVID bear market that saw a loss of 12%.</p>\n<p>Tech stocks, which investors have often sought out in times of uncertainty, performed even worse by falling 6%. Long-term Treasuries also fell by more than 2% creating one of those unusual environments where stocks and bonds were both falling at the same time. It's essentially a reversal of the behavior we saw after the March interest rate peak where both groups actually gained more than 10% at the same time.</p>\n<p>One group that didn't suffer, however, was energy. Not every cyclical sector enjoyed the same success - industrials and materials have still been laggards - but the broad energy sector gained more than 10%. A few factors are at play here. OPEC has been hesitant to fully open up the crude oil production floodgates and that's helped keep the supply/demand curve imbalanced. It's gotten to the point now where there is a legitimate energy supply crunch that could last into the winter months. Energy prices are skyrocketing and that's been good for explorers and drillers, but it's creating a mini-crisis worldwide that could take some time to unwind. Add in the ongoing supply chain bottlenecks and we've got an unstable macro backdrop.</p>\n<p>Global energy demand, however, is expected to continue looking strong, especially as we get closer to the holiday travel season. The Fed has essentially confirmed that the U.S. economic recovery (with a few hiccups) is mostly on track to the point where the central bank is likely going to begin withdrawing some of its support later this year. The government's inability to reach a resolution on the debt ceiling about two weeks before it's scheduled to run out of money will likely add to volatility in the 4th quarter and the struggles for U.S. equities reflect a lack of optimism.</p>\n<p>Here's the list of the top performing ETFs for the month of September 2021.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b98338b73b9e0d8cbbf746866e4dd038\" tg-width=\"1200\" tg-height=\"404\" width=\"100%\" height=\"auto\"><span>Top Performing ETFs for September 2021</span></p>\n<p>Every ETF on this list, with the exception of only a few, are tied to the energy sector in some way. Energy prices, crude oil and natural gas in particular, have been rising quickly and that's reflected in the gains of commodity-linked products, including the<b>United States Natural Gas Fund (UNG)</b>, the<b>United States 12 Month Natural Gas Fund (UNL)</b>, the<b>United States Brent Oil Fund (BNO)</b>, the<b>Invesco DB Oil Fund (DBO)</b>, the<b>United States Oil Fund (USO)</b>, the<b>Invesco DB Energy Fund (DBE)</b>and the<b>United States 12 Month Oil Fund (USL)</b>. In case you were wondering, the \"12 month\" funds spread out their exposures to contracts with expirations from 1 to 12 months out. The others, at least before the energy market crash last year, mostly focused on the nearest-month expiration contracts but have since expanded their strategies to avoid the chances such a debacle happens again. Natural gas prices, in particular, have been taking off as some forecasters have begun predicting a cold snap for this winter. Crude oil prices are settled in around $75 a barrel today, but a spike towards $100, while unlikely, is still not out of the question.</p>\n<p>On the equity side, we've got all sorts of funds focused on specific areas of the energy space and the broad sector in general. The<b>Energy Select Sector SPDR ETF (XLE)</b>is the biggest name, but the<b>Invesco S&amp;P 500 Equal Weight Energy ETF (RYE)</b>, the<b>Fidelity MSCI Energy ETF (FENY)</b>, the<b>Vanguard Energy ETF (VDE)</b>and the<b>iShares Energy ETF (IYE)</b>are all represented with gains of at least 8%.</p>\n<p>The explorers were the best performing subgroup to be found within energy, but clean energy ETFs are nowhere to be found. Among the winners: the<b>VanEck Vectors Unconventional Oil &amp; Gas ETF (FRAK)</b>, the<b>Invesco Dynamic Energy Exploration &amp; Production ETF (PXE)</b>, the<b>SPDR S&amp;P Oil &amp; Gas Exploration &amp; Production ETF (XOP)</b>and the<b>iShares U.S. Oil &amp; Gas Explorers &amp; Producers ETF (IEO)</b>all delivered gains of at least 15% on the month.</p>\n<p>A fund that has made regular appearances on both the top and performing ETF lists, the<b>Breakwave Dry Bulk Shipping ETF (BDRY)</b>, is back on the leaderboard again with a 27% gain. Supply chain issues, again, are the main driver as ships still remain stranded in harbors for weeks at a time waiting to dock and delivery their loads. Shipping issues, which were originally expected to be only short-term in nature, I think could easily last into summer 2022 or beyond. Shipping costs are likely to remain sky high and that could play into BDRY's hands, but expect a LOT of volatility in this fund for a while.</p>\n<p>Other ETFs worth noting:</p>\n<p>Uranium ETFs have taken advantage of soaring prices over the past two months. The price of an ounce of uranium went from $30 in mid-August to as high as $50 recently before pulling back to its current level around $43. The<b>Global X Uranium ETF (URA)</b>is the best-known name of the group, returning more than 13%, but the<b>North Shore Global Uranium Mining ETF (URNM)</b>, a fund that has been around for nearly 2 years but is comparatively smaller, was the bigger winner logging a 22% return.</p>\n<p>China ETFs have done poorly,but that didn't stop the<b>Global X MSCI China Utilities ETF (CHIU)</b>from logging a 10% gain. The outperformance of a defensive sector, such as utilities, isn't surprising but the degree of outperformance perhaps is. CHIU nearly matched the monthly performance of the<b>Global X MSCI China Energy ETF (CHIE)</b>in September.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Performing ETFs For September 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Performing ETFs For September 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-03 22:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/etffocus/market-intelligence/top-performing-etfs-for-september-2021><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>September will almost certainly be a month that most equity investors would soon forget. The S&P 500's (SPY) loss of 4% was the first monthly loss for the large-cap index since January 2021 and the ...</p>\n\n<a href=\"https://www.thestreet.com/etffocus/market-intelligence/top-performing-etfs-for-september-2021\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"XOP":"油气开采指数ETF-SPDR S&P","UNG":"美国天然气基金","UNL":"United States 12 Month Natural Gas Fund LP","USO":"美国原油ETF"},"source_url":"https://www.thestreet.com/etffocus/market-intelligence/top-performing-etfs-for-september-2021","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1145081858","content_text":"September will almost certainly be a month that most equity investors would soon forget. The S&P 500's (SPY) loss of 4% was the first monthly loss for the large-cap index since January 2021 and the biggest monthly loss since the March 2020 COVID bear market that saw a loss of 12%.\nTech stocks, which investors have often sought out in times of uncertainty, performed even worse by falling 6%. Long-term Treasuries also fell by more than 2% creating one of those unusual environments where stocks and bonds were both falling at the same time. It's essentially a reversal of the behavior we saw after the March interest rate peak where both groups actually gained more than 10% at the same time.\nOne group that didn't suffer, however, was energy. Not every cyclical sector enjoyed the same success - industrials and materials have still been laggards - but the broad energy sector gained more than 10%. A few factors are at play here. OPEC has been hesitant to fully open up the crude oil production floodgates and that's helped keep the supply/demand curve imbalanced. It's gotten to the point now where there is a legitimate energy supply crunch that could last into the winter months. Energy prices are skyrocketing and that's been good for explorers and drillers, but it's creating a mini-crisis worldwide that could take some time to unwind. Add in the ongoing supply chain bottlenecks and we've got an unstable macro backdrop.\nGlobal energy demand, however, is expected to continue looking strong, especially as we get closer to the holiday travel season. The Fed has essentially confirmed that the U.S. economic recovery (with a few hiccups) is mostly on track to the point where the central bank is likely going to begin withdrawing some of its support later this year. The government's inability to reach a resolution on the debt ceiling about two weeks before it's scheduled to run out of money will likely add to volatility in the 4th quarter and the struggles for U.S. equities reflect a lack of optimism.\nHere's the list of the top performing ETFs for the month of September 2021.\nTop Performing ETFs for September 2021\nEvery ETF on this list, with the exception of only a few, are tied to the energy sector in some way. Energy prices, crude oil and natural gas in particular, have been rising quickly and that's reflected in the gains of commodity-linked products, including theUnited States Natural Gas Fund (UNG), theUnited States 12 Month Natural Gas Fund (UNL), theUnited States Brent Oil Fund (BNO), theInvesco DB Oil Fund (DBO), theUnited States Oil Fund (USO), theInvesco DB Energy Fund (DBE)and theUnited States 12 Month Oil Fund (USL). In case you were wondering, the \"12 month\" funds spread out their exposures to contracts with expirations from 1 to 12 months out. The others, at least before the energy market crash last year, mostly focused on the nearest-month expiration contracts but have since expanded their strategies to avoid the chances such a debacle happens again. Natural gas prices, in particular, have been taking off as some forecasters have begun predicting a cold snap for this winter. Crude oil prices are settled in around $75 a barrel today, but a spike towards $100, while unlikely, is still not out of the question.\nOn the equity side, we've got all sorts of funds focused on specific areas of the energy space and the broad sector in general. TheEnergy Select Sector SPDR ETF (XLE)is the biggest name, but theInvesco S&P 500 Equal Weight Energy ETF (RYE), theFidelity MSCI Energy ETF (FENY), theVanguard Energy ETF (VDE)and theiShares Energy ETF (IYE)are all represented with gains of at least 8%.\nThe explorers were the best performing subgroup to be found within energy, but clean energy ETFs are nowhere to be found. Among the winners: theVanEck Vectors Unconventional Oil & Gas ETF (FRAK), theInvesco Dynamic Energy Exploration & Production ETF (PXE), theSPDR S&P Oil & Gas Exploration & Production ETF (XOP)and theiShares U.S. Oil & Gas Explorers & Producers ETF (IEO)all delivered gains of at least 15% on the month.\nA fund that has made regular appearances on both the top and performing ETF lists, theBreakwave Dry Bulk Shipping ETF (BDRY), is back on the leaderboard again with a 27% gain. Supply chain issues, again, are the main driver as ships still remain stranded in harbors for weeks at a time waiting to dock and delivery their loads. Shipping issues, which were originally expected to be only short-term in nature, I think could easily last into summer 2022 or beyond. Shipping costs are likely to remain sky high and that could play into BDRY's hands, but expect a LOT of volatility in this fund for a while.\nOther ETFs worth noting:\nUranium ETFs have taken advantage of soaring prices over the past two months. The price of an ounce of uranium went from $30 in mid-August to as high as $50 recently before pulling back to its current level around $43. TheGlobal X Uranium ETF (URA)is the best-known name of the group, returning more than 13%, but theNorth Shore Global Uranium Mining ETF (URNM), a fund that has been around for nearly 2 years but is comparatively smaller, was the bigger winner logging a 22% return.\nChina ETFs have done poorly,but that didn't stop theGlobal X MSCI China Utilities ETF (CHIU)from logging a 10% gain. The outperformance of a defensive sector, such as utilities, isn't surprising but the degree of outperformance perhaps is. CHIU nearly matched the monthly performance of theGlobal X MSCI China Energy ETF (CHIE)in September.","news_type":1},"isVote":1,"tweetType":1,"viewCount":7,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":867161297,"gmtCreate":1633227259948,"gmtModify":1633227260251,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Okk","listText":"Okk","text":"Okk","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/867161297","repostId":"2172643049","repostType":4,"repost":{"id":"2172643049","pubTimestamp":1633222044,"share":"https://www.laohu8.com/m/news/2172643049?lang=&edition=full","pubTime":"2021-10-03 08:47","market":"us","language":"en","title":"2 Ridiculously Cheap Growth Stocks to Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2172643049","media":"Motley Fool","summary":"Though these companies have recorded solid financials of late, investors are overlooking them.","content":"<p>Growth stocks can sometimes trade at inflated valuations because of their attractive long-term potential. So if you get the opportunity to invest in a growth stock that isn't trading at a premium but rather at a discount, you should definitely consider adding it to your portfolio.</p>\n<p><a href=\"https://laohu8.com/S/TWOA.U\">Two</a> unloved growth stocks that trade at low multiples of future earnings and look incredibly cheap right now are <b>Bristol Myers Squibb</b> (NYSE:BMY) and&nbsp;<b>ViacomCBS </b>(NASDAQ:VIAC).<img src=\"https://static.tigerbbs.com/a1531106e22f32af06a047425395b675\" tg-width=\"700\" tg-height=\"393\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h2>1. Bristol Myers Squibb</h2>\n<p>Healthcare giant Bristol Myers Squibb is a stock that investors could easily be overlooking right now. From afar, its financials look horrible. For the trailing 12 months, the company incurred a net loss of $5 billion. So investors relying on stock screeners to try and find good buys could easily overlook Bristol Myers -- and they have. Year to date, shares of the healthcare stock are down about 2% while the <b>S&amp;P 500</b> has soared 16%.</p>\n<p>But investors who dig a little deeper will find a slightly different story. The huge loss is in fact due to a massive research and development charge of more than $11 billion that the company incurred for its acquisition of MyoKardia, a clinical-stage biopharmaceutical company that develops cardiovascular medicine. That negatively impacted the fourth quarter of last year and is still impacting the trailing 12-month numbers.</p>\n<p>In the past two quarters, however, the company has been firmly in the black. Through the first six months of 2021, Bristol Myers' revenue of $22.8 billion has risen 9% year over year, and its net earnings have flipped from a $846 million loss in 2020 to a $3.1 billion profit.</p>\n<p>Meanwhile, with free cash flow of $11.7 billion over the past four quarters, its dividend also looks rock-solid. The company has paid out $4.2 billion during that time while also making stock repurchases of $4.5 billion. This serves as further proof that accounting income alone can't be relied on to assess the health of a company's operations. Cash flow is arguably a much more important indicator than net income -- and by that metric, Bristol Myers is doing just fine.</p>\n<p>So a closer look at Bristol Myers suggests the company is a much safer buy than its numbers may appear at first glance. A forward price-to-earnings (P/E) ratio can be useful for companies when a bad quarter or two have weighed on their numbers. And by that measure, Bristol Myers only trades at a P/E of 8 — incredibly cheap compared to other healthcare stocks, such as <b>Merck</b> (NYSE:MRK) and <b>Amgen </b>(NASDAQ:AMGN), which both trade at about 13 times their future profits.</p>\n<p>Finally, there's the 3.3% dividend yield, which is more than twice as much as the S&amp;P 500's 1.3%. Whether you're a growth investor or love a good dividend, this is an underrated healthcare stock that should be on your radar.</p>\n<h2>2. ViacomCBS</h2>\n<p>Another stock that's trading at a low valuation is ViacomCBS. At a forward P/E multiple of just 10, it's nowhere near the premium that investors are paying for other companies in the entertainment and streaming business, such as <b>Netflix</b> (NASDAQ:NFLX)&nbsp;and <b>Walt Disney </b>(NYSE:DIS) -- trading at 56 and 70 times their forward profits, respectively.</p>\n<p>Admittedly, ViacomCBS' Paramount+ streaming service isn't as popular, and that could be a reason investors aren't giving the stock as much of a chance. Overall, the company has a total of 42 million global streaming subscribers (including Paramount+ and other smaller services such as Pluto TV). By comparison, Netflix has more than 200 million subscribers while Disney+ now has 116 million.</p>\n<p>But Paramount+ doesn't have to be the top streaming service for ViacomCBS to be an attractive buy. In its latest quarter ended June 30, the company reported that streaming revenue grew 92% to $983 million from the year-ago period and advertising revenue rose 24% to $2.1 billion.</p>\n<p>The lone blemish for the company was its \"licensing and other\" segment, which fell 36% to $1.2 billion -- hurt by the absence of theatrical releases during the pandemic. That kept the company's sales growth relatively modest last quarter, rising 8% to $6.6 billion. However, as the economy continues to recover from the pandemic, those numbers should get stronger.</p>\n<p>Meanwhile, ViacomCBS also offers investors an above-average dividend yield of 2.4%. And with free cash of $2.6 billion over the past 12 months, it is generating more than enough to cover the $601 million in dividends it paid out during that time.</p>\n<p>So, while Paramount+ may be an afterthought for some investors looking to go into top streaming stocks, that in fact could be an opportunity. ViacomCBS shares still fly under the radar -- up just 8% this year. As subscribers continue to increase and revenues improve, it may just be a matter of time before the stock takes off.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Ridiculously Cheap Growth Stocks to Buy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Ridiculously Cheap Growth Stocks to Buy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-03 08:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/02/2-ridiculously-cheap-growth-stocks-to-buy/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Growth stocks can sometimes trade at inflated valuations because of their attractive long-term potential. So if you get the opportunity to invest in a growth stock that isn't trading at a premium but ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/02/2-ridiculously-cheap-growth-stocks-to-buy/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QNETCN":"纳斯达克中美互联网老虎指数","NFLX":"奈飞"},"source_url":"https://www.fool.com/investing/2021/10/02/2-ridiculously-cheap-growth-stocks-to-buy/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2172643049","content_text":"Growth stocks can sometimes trade at inflated valuations because of their attractive long-term potential. So if you get the opportunity to invest in a growth stock that isn't trading at a premium but rather at a discount, you should definitely consider adding it to your portfolio.\nTwo unloved growth stocks that trade at low multiples of future earnings and look incredibly cheap right now are Bristol Myers Squibb (NYSE:BMY) and ViacomCBS (NASDAQ:VIAC).\nImage source: Getty Images.\n1. Bristol Myers Squibb\nHealthcare giant Bristol Myers Squibb is a stock that investors could easily be overlooking right now. From afar, its financials look horrible. For the trailing 12 months, the company incurred a net loss of $5 billion. So investors relying on stock screeners to try and find good buys could easily overlook Bristol Myers -- and they have. Year to date, shares of the healthcare stock are down about 2% while the S&P 500 has soared 16%.\nBut investors who dig a little deeper will find a slightly different story. The huge loss is in fact due to a massive research and development charge of more than $11 billion that the company incurred for its acquisition of MyoKardia, a clinical-stage biopharmaceutical company that develops cardiovascular medicine. That negatively impacted the fourth quarter of last year and is still impacting the trailing 12-month numbers.\nIn the past two quarters, however, the company has been firmly in the black. Through the first six months of 2021, Bristol Myers' revenue of $22.8 billion has risen 9% year over year, and its net earnings have flipped from a $846 million loss in 2020 to a $3.1 billion profit.\nMeanwhile, with free cash flow of $11.7 billion over the past four quarters, its dividend also looks rock-solid. The company has paid out $4.2 billion during that time while also making stock repurchases of $4.5 billion. This serves as further proof that accounting income alone can't be relied on to assess the health of a company's operations. Cash flow is arguably a much more important indicator than net income -- and by that metric, Bristol Myers is doing just fine.\nSo a closer look at Bristol Myers suggests the company is a much safer buy than its numbers may appear at first glance. A forward price-to-earnings (P/E) ratio can be useful for companies when a bad quarter or two have weighed on their numbers. And by that measure, Bristol Myers only trades at a P/E of 8 — incredibly cheap compared to other healthcare stocks, such as Merck (NYSE:MRK) and Amgen (NASDAQ:AMGN), which both trade at about 13 times their future profits.\nFinally, there's the 3.3% dividend yield, which is more than twice as much as the S&P 500's 1.3%. Whether you're a growth investor or love a good dividend, this is an underrated healthcare stock that should be on your radar.\n2. ViacomCBS\nAnother stock that's trading at a low valuation is ViacomCBS. At a forward P/E multiple of just 10, it's nowhere near the premium that investors are paying for other companies in the entertainment and streaming business, such as Netflix (NASDAQ:NFLX) and Walt Disney (NYSE:DIS) -- trading at 56 and 70 times their forward profits, respectively.\nAdmittedly, ViacomCBS' Paramount+ streaming service isn't as popular, and that could be a reason investors aren't giving the stock as much of a chance. Overall, the company has a total of 42 million global streaming subscribers (including Paramount+ and other smaller services such as Pluto TV). By comparison, Netflix has more than 200 million subscribers while Disney+ now has 116 million.\nBut Paramount+ doesn't have to be the top streaming service for ViacomCBS to be an attractive buy. In its latest quarter ended June 30, the company reported that streaming revenue grew 92% to $983 million from the year-ago period and advertising revenue rose 24% to $2.1 billion.\nThe lone blemish for the company was its \"licensing and other\" segment, which fell 36% to $1.2 billion -- hurt by the absence of theatrical releases during the pandemic. That kept the company's sales growth relatively modest last quarter, rising 8% to $6.6 billion. However, as the economy continues to recover from the pandemic, those numbers should get stronger.\nMeanwhile, ViacomCBS also offers investors an above-average dividend yield of 2.4%. And with free cash of $2.6 billion over the past 12 months, it is generating more than enough to cover the $601 million in dividends it paid out during that time.\nSo, while Paramount+ may be an afterthought for some investors looking to go into top streaming stocks, that in fact could be an opportunity. ViacomCBS shares still fly under the radar -- up just 8% this year. As subscribers continue to increase and revenues improve, it may just be a matter of time before the stock takes off.","news_type":1},"isVote":1,"tweetType":1,"viewCount":31,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696511365,"gmtCreate":1640733906682,"gmtModify":1640733907030,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/696511365","repostId":"1186633322","repostType":4,"repost":{"id":"1186633322","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640732718,"share":"https://www.laohu8.com/m/news/1186633322?lang=&edition=full","pubTime":"2021-12-29 07:05","market":"us","language":"en","title":"S&P 500 Ends Lower after Four-Day Rally to Record High","url":"https://stock-news.laohu8.com/highlight/detail?id=1186633322","media":"Reuters","summary":"Dec 28  - The S&P 500closed slightly lower after hitting a record intraday high on Tuesday, as a four-day rally lost steam in thin trading and investors weighed Omicron-driven travel disruptions and store closures.The Centers for Disease Control and Prevention  on Monday shortened the recommended isolation time for Americans with asymptomatic cases of COVID-19 to five days from the previous guidance of 10 days.The update follows approvals for new pills and more vaccines to fight COVID-19. It hel","content":"<p>Dec 28 (Reuters) - The S&amp;P 500(.SPX)closed slightly lower after hitting a record intraday high on Tuesday, as a four-day rally lost steam in thin trading and investors weighed Omicron-driven travel disruptions and store closures.</p>\n<p>The Centers for Disease Control and Prevention (CDC) on Monday shortened the recommended isolation time for Americans with asymptomatic cases of COVID-19 to five days from the previous guidance of 10 days.</p>\n<p>The update follows approvals for new pills and more vaccines to fight COVID-19. It helped investors shrug off concerns over thousands of flight cancellations and <a href=\"https://laohu8.com/S/AAPL\">Apple</a> Inc(AAPL.O)shutting its <a href=\"https://laohu8.com/S/NWY\">New York</a> stores due to surging cases, and put U.S. stocks on pace for monthly gains.</p>\n<p>\"This is a holiday-shortened week. So daily movements will likely be exaggerated because of a low relative volume,\" said Sam Stovall, chief investment strategist at CFRA Research in <a href=\"https://laohu8.com/S/NYRT\">New York</a>.</p>\n<p>Seven&nbsp;of the 11 major S&amp;P 500 sector indexes rose on Tuesday. Technology(.SPLRCT)and <a href=\"https://laohu8.com/S/JCS\">Communications</a> Services(.SPLRCL)led declines.</p>\n<p>The Dow Jones Industrial Average(.DJI)rose 95.83 points, or 0.26%, to 36,398.21; the S&amp;P 500(.SPX)lost 4.84 points, or 0.10%, to 4,786.35 and the <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a> Composite(.IXIC)dropped 89.54 points, or 0.56%, to 15,781.72.</p>\n<p>In company news, <a href=\"https://laohu8.com/S/BA\">Boeing</a> Co(BA.N)rose 1.46% as Indonesia lifted a ban on its 737 MAX, three years after the crash of <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the aircraft and loss of all 189 people on board.</p>\n<p>Markets are in the seasonal Santa Claus rally, with CFRA Research data showing the S&amp;P 500 has on average risen 1.3% in the last five trading days of the year, and first two days of the new year since 1969.</p>\n<p>\"<a href=\"https://laohu8.com/S/ISBC\">Investors</a> are digesting the gains from the last three days, ... but there are concerns such as how will the Omicron variant affect the market? Would that end up undoing the Santa Claus rally? What about the Fed raising interest rates, could that cause challenges for the year ahead?\" Stovall said.</p>\n<p>The Federal Reserve signaled earlier this month three quarter-percentage-point interest rate hikes by the end of 2022 as the economy nears full employment and the U.S. central bank copes with an inflation surge. L1N2SZ1G5</p>\n<p>Volume on U.S. exchanges was 7.55 billion shares, compared with the 11.56 billion average for the full session over the last 20 trading days.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.04-to-1 ratio; on Nasdaq, a 1.88-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 81 new 52-week highs and no new lows; the Nasdaq Composite recorded 105 new highs and 264 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500 Ends Lower after Four-Day Rally to Record High</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500 Ends Lower after Four-Day Rally to Record High\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-29 07:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 28 (Reuters) - The S&amp;P 500(.SPX)closed slightly lower after hitting a record intraday high on Tuesday, as a four-day rally lost steam in thin trading and investors weighed Omicron-driven travel disruptions and store closures.</p>\n<p>The Centers for Disease Control and Prevention (CDC) on Monday shortened the recommended isolation time for Americans with asymptomatic cases of COVID-19 to five days from the previous guidance of 10 days.</p>\n<p>The update follows approvals for new pills and more vaccines to fight COVID-19. It helped investors shrug off concerns over thousands of flight cancellations and <a href=\"https://laohu8.com/S/AAPL\">Apple</a> Inc(AAPL.O)shutting its <a href=\"https://laohu8.com/S/NWY\">New York</a> stores due to surging cases, and put U.S. stocks on pace for monthly gains.</p>\n<p>\"This is a holiday-shortened week. So daily movements will likely be exaggerated because of a low relative volume,\" said Sam Stovall, chief investment strategist at CFRA Research in <a href=\"https://laohu8.com/S/NYRT\">New York</a>.</p>\n<p>Seven&nbsp;of the 11 major S&amp;P 500 sector indexes rose on Tuesday. Technology(.SPLRCT)and <a href=\"https://laohu8.com/S/JCS\">Communications</a> Services(.SPLRCL)led declines.</p>\n<p>The Dow Jones Industrial Average(.DJI)rose 95.83 points, or 0.26%, to 36,398.21; the S&amp;P 500(.SPX)lost 4.84 points, or 0.10%, to 4,786.35 and the <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a> Composite(.IXIC)dropped 89.54 points, or 0.56%, to 15,781.72.</p>\n<p>In company news, <a href=\"https://laohu8.com/S/BA\">Boeing</a> Co(BA.N)rose 1.46% as Indonesia lifted a ban on its 737 MAX, three years after the crash of <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the aircraft and loss of all 189 people on board.</p>\n<p>Markets are in the seasonal Santa Claus rally, with CFRA Research data showing the S&amp;P 500 has on average risen 1.3% in the last five trading days of the year, and first two days of the new year since 1969.</p>\n<p>\"<a href=\"https://laohu8.com/S/ISBC\">Investors</a> are digesting the gains from the last three days, ... but there are concerns such as how will the Omicron variant affect the market? Would that end up undoing the Santa Claus rally? What about the Fed raising interest rates, could that cause challenges for the year ahead?\" Stovall said.</p>\n<p>The Federal Reserve signaled earlier this month three quarter-percentage-point interest rate hikes by the end of 2022 as the economy nears full employment and the U.S. central bank copes with an inflation surge. L1N2SZ1G5</p>\n<p>Volume on U.S. exchanges was 7.55 billion shares, compared with the 11.56 billion average for the full session over the last 20 trading days.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.04-to-1 ratio; on Nasdaq, a 1.88-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 81 new 52-week highs and no new lows; the Nasdaq Composite recorded 105 new highs and 264 new lows.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF",".SPX":"S&P 500 Index","SPY":"标普500ETF","SSO":"两倍做多标普500ETF","BK4559":"巴菲特持仓","UPRO":"三倍做多标普500ETF","SPXU":"三倍做空标普500ETF","BK4534":"瑞士信贷持仓","BK4550":"红杉资本持仓","IVV":"标普500指数ETF","OEF":"标普100指数ETF-iShares","BK4504":"桥水持仓","SH":"标普500反向ETF","SDS":"两倍做空标普500ETF","OEX":"标普100"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1186633322","content_text":"Dec 28 (Reuters) - The S&P 500(.SPX)closed slightly lower after hitting a record intraday high on Tuesday, as a four-day rally lost steam in thin trading and investors weighed Omicron-driven travel disruptions and store closures.\nThe Centers for Disease Control and Prevention (CDC) on Monday shortened the recommended isolation time for Americans with asymptomatic cases of COVID-19 to five days from the previous guidance of 10 days.\nThe update follows approvals for new pills and more vaccines to fight COVID-19. It helped investors shrug off concerns over thousands of flight cancellations and Apple Inc(AAPL.O)shutting its New York stores due to surging cases, and put U.S. stocks on pace for monthly gains.\n\"This is a holiday-shortened week. So daily movements will likely be exaggerated because of a low relative volume,\" said Sam Stovall, chief investment strategist at CFRA Research in New York.\nSeven of the 11 major S&P 500 sector indexes rose on Tuesday. Technology(.SPLRCT)and Communications Services(.SPLRCL)led declines.\nThe Dow Jones Industrial Average(.DJI)rose 95.83 points, or 0.26%, to 36,398.21; the S&P 500(.SPX)lost 4.84 points, or 0.10%, to 4,786.35 and the Nasdaq Composite(.IXIC)dropped 89.54 points, or 0.56%, to 15,781.72.\nIn company news, Boeing Co(BA.N)rose 1.46% as Indonesia lifted a ban on its 737 MAX, three years after the crash of one of the aircraft and loss of all 189 people on board.\nMarkets are in the seasonal Santa Claus rally, with CFRA Research data showing the S&P 500 has on average risen 1.3% in the last five trading days of the year, and first two days of the new year since 1969.\n\"Investors are digesting the gains from the last three days, ... but there are concerns such as how will the Omicron variant affect the market? Would that end up undoing the Santa Claus rally? What about the Fed raising interest rates, could that cause challenges for the year ahead?\" Stovall said.\nThe Federal Reserve signaled earlier this month three quarter-percentage-point interest rate hikes by the end of 2022 as the economy nears full employment and the U.S. central bank copes with an inflation surge. L1N2SZ1G5\nVolume on U.S. exchanges was 7.55 billion shares, compared with the 11.56 billion average for the full session over the last 20 trading days.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.04-to-1 ratio; on Nasdaq, a 1.88-to-1 ratio favored decliners.\nThe S&P 500 posted 81 new 52-week highs and no new lows; the Nasdaq Composite recorded 105 new highs and 264 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":676,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608039336,"gmtCreate":1638579418524,"gmtModify":1638579418655,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Oo","listText":"Oo","text":"Oo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608039336","repostId":"2188291505","repostType":4,"repost":{"id":"2188291505","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1638544217,"share":"https://www.laohu8.com/m/news/2188291505?lang=&edition=full","pubTime":"2021-12-03 23:10","market":"us","language":"en","title":"Ford aims to be world's #2 electric vehicle maker within two years - COO","url":"https://stock-news.laohu8.com/highlight/detail?id=2188291505","media":"Reuters","summary":"Dec 3  - Ford Motor Co expects to be the world's second largest electric vehicle manufacturer within two years, with annual production capacity of nearly 600,000, a top company executive said Friday.Driving the automaker's optimism is increasing demand for its next new EV, the Ford F-150 Lightning pickup, with retail reservations now approaching 200,000, according to Lisa Drake, chief operating officer of Ford North America.Speaking at an investor conference, Drake said Ford is working with five","content":"<p>Dec 3 (Reuters) - Ford Motor Co expects to be the world's second largest electric vehicle manufacturer within two years, with annual production capacity of nearly 600,000, a top company executive said Friday.</p>\n<p>Driving the automaker's optimism is increasing demand for its next new EV, the Ford F-150 Lightning pickup, with retail reservations now approaching 200,000, according to Lisa Drake, chief operating officer of Ford North America.</p>\n<p>Speaking at an investor conference, Drake said Ford is working with five global battery suppliers to manufacture and help develop battery cells for its future EVs. Those suppliers include SK On, LG Energy Solution, CATL, BYD&nbsp;and Panasonic .</p>\n<p>Ford expects to reduce EV battery cell cost to $80 per kilowatt-hour at the pack level \"well before the end of the decade,\" Drake said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ford aims to be world's #2 electric vehicle maker within two years - COO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFord aims to be world's #2 electric vehicle maker within two years - COO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-03 23:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 3 (Reuters) - Ford Motor Co expects to be the world's second largest electric vehicle manufacturer within two years, with annual production capacity of nearly 600,000, a top company executive said Friday.</p>\n<p>Driving the automaker's optimism is increasing demand for its next new EV, the Ford F-150 Lightning pickup, with retail reservations now approaching 200,000, according to Lisa Drake, chief operating officer of Ford North America.</p>\n<p>Speaking at an investor conference, Drake said Ford is working with five global battery suppliers to manufacture and help develop battery cells for its future EVs. Those suppliers include SK On, LG Energy Solution, CATL, BYD&nbsp;and Panasonic .</p>\n<p>Ford expects to reduce EV battery cell cost to $80 per kilowatt-hour at the pack level \"well before the end of the decade,\" Drake said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4099":"汽车制造商","BK4555":"新能源车","F":"福特汽车"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2188291505","content_text":"Dec 3 (Reuters) - Ford Motor Co expects to be the world's second largest electric vehicle manufacturer within two years, with annual production capacity of nearly 600,000, a top company executive said Friday.\nDriving the automaker's optimism is increasing demand for its next new EV, the Ford F-150 Lightning pickup, with retail reservations now approaching 200,000, according to Lisa Drake, chief operating officer of Ford North America.\nSpeaking at an investor conference, Drake said Ford is working with five global battery suppliers to manufacture and help develop battery cells for its future EVs. Those suppliers include SK On, LG Energy Solution, CATL, BYD and Panasonic .\nFord expects to reduce EV battery cell cost to $80 per kilowatt-hour at the pack level \"well before the end of the decade,\" Drake said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":40,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879764626,"gmtCreate":1636774997740,"gmtModify":1636774997899,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/879764626","repostId":"2182071013","repostType":4,"repost":{"id":"2182071013","pubTimestamp":1636759045,"share":"https://www.laohu8.com/m/news/2182071013?lang=&edition=full","pubTime":"2021-11-13 07:17","market":"us","language":"en","title":"Doubting that we could be in a stock-market bubble? Here's the chart you need to see.","url":"https://stock-news.laohu8.com/highlight/detail?id=2182071013","media":"MarketWatch","summary":"A shocking week on the inflation front has left a dent in stocks, with major indexes set to deliver ","content":"<p>A shocking week on the inflation front has left a dent in stocks, with major indexes set to deliver 1%-plus losses across the board. That’s even as some Wall Street strategists see little blocking further stock gains or that frequent year-end melt-up.</p>\n<p>Yet the worry festers, such as for Nicolai Tangen, the manager of Norways’ $1.4 trillion sovereign-wealth fund, the biggest money pot in the world.</p>\n<p>“We’re looking at the degree of euphoria. With markets really panicky last year, we have entered a very euphoric phase, and we just need to consistently gauge the levels of euphoria,” Tangen said in a recent interview with Devin Banerjee, editor at large, business and finance for LinkedIn.</p>\n<p>“And then, of course, the real threat is inflation. If inflation really takes off, that’s going to be bad news both for our bond portfolio and for the equity portfolio. So, that’s where we have the laser focus,” added Tangen.</p>\n<p>It’s a reminder that what some see as heady times for stocks aren’t going unnoticed.</p>\n<p>That brings us to our <b>call of the day</b> from Michael O’Rourke, chief market strategist at JonesTrading, who falls into that camp with his latest note entitled “In case there are bubble doubts.”</p>\n<p>He writes: “Since the U.S. financial markets have achieved new levels of insanity, we want to make sure we document this moment in time for posterity’s sake. Apparently, we have not learned anything from the Equity, Housing and Credit bubbles that occurred between 1999 and 2008.</p>\n<p>“It can’t be any clearer than the fact that the S&amp;P 500’s market capitalization is 177% of U.S. GDP,” adds O’Rourke, who provides this chart:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a5dfce87383926286f5e338e535810e6\" tg-width=\"700\" tg-height=\"395\" referrerpolicy=\"no-referrer\"><span>JonesTrading/Bloomberg</span></p>\n<p>During the 2000 tech bubble, the S&amp;P 500’s market capitalization peaked at 121% of nominal gross domestic product, he says.</p>\n<p>“That should paint a stark picture as to how expensive today’s market is relative to the last generational equity bubble,” says O’Rourke, who adds that the current level is also double the average reading of the past three decades and triple the valuation where the S&amp;P 500 bottomed during the 2008-09 financial crisis.</p>\n<p>“Even with the greater inflationary bump to Nominal GDP, it would need to grow at 8% for a decade to return to the historic market cap to GDP average,” he says.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8fb8a4b1f1bfec5d4e8585b0e47fd9d8\" tg-width=\"700\" tg-height=\"386\" referrerpolicy=\"no-referrer\"><span>JonesTrading/Bloomberg</span></p>\n<p>“The $3 trillion in crypto (whose only purpose appears to be speculation) is a&nbsp;clear illustration of an environment that knows no fear. Nonetheless, we are&nbsp;among the few who fear a 50% S&amp;P 500 valuation drop that would bring the&nbsp;index’s market capitalization back in line with its average historic relationship&nbsp;to GDP,” he says.</p>\n<p>O’Rourke reminds of us a “painful” 80% decline for the Nasdaq Composite between March 2000 and October 2002. “Just think, the broad tape is 50% more expensive today than March 2000,” he says.</p>\n<p>Back then, Amazon&nbsp;was a top internet company and highly regarded stock, but shares still slumped 95% between December 1999 and September 2001, he says.</p>\n<p>The strategist goes on to point the finger at the Federal Reserve and other central banks for propping up markets. “Today, the world is no better than the one two decades ago, and it is arguably worse. It is simply that these extra trillions of dollars having entered the economy in a short period of time provide the pretense of a special time meriting unsustainable valuations,” he says.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Doubting that we could be in a stock-market bubble? Here's the chart you need to see.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDoubting that we could be in a stock-market bubble? Here's the chart you need to see.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-13 07:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/doubting-that-we-could-be-in-a-stock-market-bubble-heres-the-chart-you-need-to-see-11636719571?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>A shocking week on the inflation front has left a dent in stocks, with major indexes set to deliver 1%-plus losses across the board. That’s even as some Wall Street strategists see little blocking ...</p>\n\n<a href=\"https://www.marketwatch.com/story/doubting-that-we-could-be-in-a-stock-market-bubble-heres-the-chart-you-need-to-see-11636719571?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"https://www.marketwatch.com/story/doubting-that-we-could-be-in-a-stock-market-bubble-heres-the-chart-you-need-to-see-11636719571?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2182071013","content_text":"A shocking week on the inflation front has left a dent in stocks, with major indexes set to deliver 1%-plus losses across the board. That’s even as some Wall Street strategists see little blocking further stock gains or that frequent year-end melt-up.\nYet the worry festers, such as for Nicolai Tangen, the manager of Norways’ $1.4 trillion sovereign-wealth fund, the biggest money pot in the world.\n“We’re looking at the degree of euphoria. With markets really panicky last year, we have entered a very euphoric phase, and we just need to consistently gauge the levels of euphoria,” Tangen said in a recent interview with Devin Banerjee, editor at large, business and finance for LinkedIn.\n“And then, of course, the real threat is inflation. If inflation really takes off, that’s going to be bad news both for our bond portfolio and for the equity portfolio. So, that’s where we have the laser focus,” added Tangen.\nIt’s a reminder that what some see as heady times for stocks aren’t going unnoticed.\nThat brings us to our call of the day from Michael O’Rourke, chief market strategist at JonesTrading, who falls into that camp with his latest note entitled “In case there are bubble doubts.”\nHe writes: “Since the U.S. financial markets have achieved new levels of insanity, we want to make sure we document this moment in time for posterity’s sake. Apparently, we have not learned anything from the Equity, Housing and Credit bubbles that occurred between 1999 and 2008.\n“It can’t be any clearer than the fact that the S&P 500’s market capitalization is 177% of U.S. GDP,” adds O’Rourke, who provides this chart:\nJonesTrading/Bloomberg\nDuring the 2000 tech bubble, the S&P 500’s market capitalization peaked at 121% of nominal gross domestic product, he says.\n“That should paint a stark picture as to how expensive today’s market is relative to the last generational equity bubble,” says O’Rourke, who adds that the current level is also double the average reading of the past three decades and triple the valuation where the S&P 500 bottomed during the 2008-09 financial crisis.\n“Even with the greater inflationary bump to Nominal GDP, it would need to grow at 8% for a decade to return to the historic market cap to GDP average,” he says.\nJonesTrading/Bloomberg\n“The $3 trillion in crypto (whose only purpose appears to be speculation) is a clear illustration of an environment that knows no fear. Nonetheless, we are among the few who fear a 50% S&P 500 valuation drop that would bring the index’s market capitalization back in line with its average historic relationship to GDP,” he says.\nO’Rourke reminds of us a “painful” 80% decline for the Nasdaq Composite between March 2000 and October 2002. “Just think, the broad tape is 50% more expensive today than March 2000,” he says.\nBack then, Amazon was a top internet company and highly regarded stock, but shares still slumped 95% between December 1999 and September 2001, he says.\nThe strategist goes on to point the finger at the Federal Reserve and other central banks for propping up markets. “Today, the world is no better than the one two decades ago, and it is arguably worse. It is simply that these extra trillions of dollars having entered the economy in a short period of time provide the pretense of a special time meriting unsustainable valuations,” he says.","news_type":1},"isVote":1,"tweetType":1,"viewCount":22,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842638346,"gmtCreate":1636168179409,"gmtModify":1636168179850,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Loik","listText":"Loik","text":"Loik","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/842638346","repostId":"1152406340","repostType":4,"repost":{"id":"1152406340","pubTimestamp":1636157546,"share":"https://www.laohu8.com/m/news/1152406340?lang=&edition=full","pubTime":"2021-11-06 08:12","market":"us","language":"en","title":"Will Pfizer Outgun Merck With Oral COVID-19 Pill?","url":"https://stock-news.laohu8.com/highlight/detail?id=1152406340","media":"Benzinga","summary":"Merck, Inc. is locking horns with peer Pfizer, Inc. in what could be termed as the battle supremacy ","content":"<p><b>Merck, Inc.</b>&nbsp;is locking horns with peer&nbsp;<b>Pfizer, Inc.</b>&nbsp;in what could be termed as the battle supremacy in the COVID-19 treatment market.</p>\n<p>The stakes are high, with&nbsp;an effective treatment for the disease potentially entering the arena in addition to the vaccines that are already on the market.</p>\n<p><b>Pfizer Dips Into COVID-19 Treatment Arena:</b>After acing the&nbsp;COVID-19 vaccine race&nbsp;along with its German partner&nbsp;<b>BioNTech SE</b>, Pfizer is wanting to leave no stone unturned in capitalizing on the COVID opportunity.</p>\n<p>The company announced Friday an interim analysis of data from the Phase 2/3 study of its oral COVID-19 antiviral candidate Paxlovid, showing an 89% reduction in the risk of COVID-19-related hospitalization or death from any cause compared to placebo in patients treated within three days of symptom onset.</p>\n<p>The positive data triggered strong buying in Pfizer shares and a sell-off in Merck shares.</p>\n<p>Merck had its share of upside in early October when it reported positive Phase 3 data for an&nbsp;oral COVID-19 pill,&nbsp;molnupiravir, that it's co-developing the treatment with Ridgeback Biotherapeutics. The Merck news triggered an across-the-board sell-off in vaccine stocks at that time.</p>\n<p>These two companies with deep pockets and marketing expertise are vying for a piece of the COVID-19 treatment market, making the competitive landscape all the more interesting.</p>\n<p><b>Pfizer Vs. Merck Data Comparison:</b>As opposed the 89% reduction in risk of hospitalization or death reported by Pfizer for Paxlovid, an interim analysis of Merck's Phase 3 data released on Oct. 1 showed molnupiravir reducing the risk of hospitalization or death by approximately 50%.</p>\n<p>Only about 0.8% of patients who received Paxlovid were hospitalized through day 28 compared to 7% of patients who received placebo and were hospitalized or died.</p>\n<p>Similar reductions in COVID-19-related hospitalization or death were observed in patients treated within five days of symptom onset.</p>\n<p>Merck reported that 7.3% of patients who received molnupiravir were either hospitalized or died through day 29 compared with 14.1% of placebo-treated patients.</p>\n<p>Through day 28, no deaths were reported in patients who received Paxlovid as compared to 10 deaths in patients who received placebo. With Merck, through day 29, no deaths were reported in patients who received molnupiravir, as compared to eight&nbsp;deaths in patients who received placebo.</p>\n<p>Not only is Pfizer's drug safe, but the level of efficacy is so high that it will very meaningfully shake up the COVID landscape looking to next year— including the outlook for boosters, BofA Securities analyst Geoff Meacham said in a note.</p>\n<p>\"Between&nbsp;<b>Roche Holding AG's</b>&nbsp;recent failure and Merck's decent efficacy, Pfizer's drug will be the clear best-in-class oral, and well positioned to capitalize on the longer term C-19 treatment market that could be in the mid-to-high billions next year,\" Meacham said.</p>\n<p><b>Authorization Before Year-End?</b>At the recommendation of an independent Data Monitoring Committee and in consultation with the U.S. Food and Drug Administration, Pfizer will cease further enrollment into the study due to the overwhelming efficacy demonstrated in these results, the company said.</p>\n<p>It plans to submit the data as part of its ongoing rolling submission to the authorization as soon as possible.</p>\n<p>BofA expects the application to be soon submitted to the FDA, with&nbsp;an authorization likely&nbsp;by the end of the year.</p>\n<p>Meanwhile, Merck announced Thursday it has received the first authorization for molnupiravir in the U.K., with the drug to be marketed under the brand name Lagevrio.</p>\n<p>Its application with the FDA is under review. The European Medicines Agency has recently initiated a rolling review of its Marketing Authorization Application. Merck also said it is actively working to submit applications to other regulatory agencies around the world.</p>\n<p>The commercial outlook could dramatically shift in favor of Pfizer's pill given how much more impressive the data is, BofA said. Merck's revenue guidance of $5 billion to $7 billion through 2022 provided on its third-quarter call last week could be reduced meaningfully, the firm added.</p>\n<p>Meanwhile,&nbsp;<b>Gilead, Inc.'s</b>&nbsp;antiviral remdesivir could remain an option for hospitalized patients, but overall its use is likely to further diminish, in BofA's view.</p>\n<p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Will Pfizer Outgun Merck With Oral COVID-19 Pill?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWill Pfizer Outgun Merck With Oral COVID-19 Pill?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-06 08:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/general/biotech/21/11/23925379/will-pfizer-outgun-merck-with-oral-covid-19-pill><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck, Inc. is locking horns with peer Pfizer, Inc. in what could be termed as the battle supremacy in the COVID-19 treatment market.\nThe stakes are high, with an effective treatment for the disease ...</p>\n\n<a href=\"https://www.benzinga.com/general/biotech/21/11/23925379/will-pfizer-outgun-merck-with-oral-covid-19-pill\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东","PFE":"辉瑞"},"source_url":"https://www.benzinga.com/general/biotech/21/11/23925379/will-pfizer-outgun-merck-with-oral-covid-19-pill","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1152406340","content_text":"Merck, Inc. is locking horns with peer Pfizer, Inc. in what could be termed as the battle supremacy in the COVID-19 treatment market.\nThe stakes are high, with an effective treatment for the disease potentially entering the arena in addition to the vaccines that are already on the market.\nPfizer Dips Into COVID-19 Treatment Arena:After acing the COVID-19 vaccine race along with its German partner BioNTech SE, Pfizer is wanting to leave no stone unturned in capitalizing on the COVID opportunity.\nThe company announced Friday an interim analysis of data from the Phase 2/3 study of its oral COVID-19 antiviral candidate Paxlovid, showing an 89% reduction in the risk of COVID-19-related hospitalization or death from any cause compared to placebo in patients treated within three days of symptom onset.\nThe positive data triggered strong buying in Pfizer shares and a sell-off in Merck shares.\nMerck had its share of upside in early October when it reported positive Phase 3 data for an oral COVID-19 pill, molnupiravir, that it's co-developing the treatment with Ridgeback Biotherapeutics. The Merck news triggered an across-the-board sell-off in vaccine stocks at that time.\nThese two companies with deep pockets and marketing expertise are vying for a piece of the COVID-19 treatment market, making the competitive landscape all the more interesting.\nPfizer Vs. Merck Data Comparison:As opposed the 89% reduction in risk of hospitalization or death reported by Pfizer for Paxlovid, an interim analysis of Merck's Phase 3 data released on Oct. 1 showed molnupiravir reducing the risk of hospitalization or death by approximately 50%.\nOnly about 0.8% of patients who received Paxlovid were hospitalized through day 28 compared to 7% of patients who received placebo and were hospitalized or died.\nSimilar reductions in COVID-19-related hospitalization or death were observed in patients treated within five days of symptom onset.\nMerck reported that 7.3% of patients who received molnupiravir were either hospitalized or died through day 29 compared with 14.1% of placebo-treated patients.\nThrough day 28, no deaths were reported in patients who received Paxlovid as compared to 10 deaths in patients who received placebo. With Merck, through day 29, no deaths were reported in patients who received molnupiravir, as compared to eight deaths in patients who received placebo.\nNot only is Pfizer's drug safe, but the level of efficacy is so high that it will very meaningfully shake up the COVID landscape looking to next year— including the outlook for boosters, BofA Securities analyst Geoff Meacham said in a note.\n\"Between Roche Holding AG's recent failure and Merck's decent efficacy, Pfizer's drug will be the clear best-in-class oral, and well positioned to capitalize on the longer term C-19 treatment market that could be in the mid-to-high billions next year,\" Meacham said.\nAuthorization Before Year-End?At the recommendation of an independent Data Monitoring Committee and in consultation with the U.S. Food and Drug Administration, Pfizer will cease further enrollment into the study due to the overwhelming efficacy demonstrated in these results, the company said.\nIt plans to submit the data as part of its ongoing rolling submission to the authorization as soon as possible.\nBofA expects the application to be soon submitted to the FDA, with an authorization likely by the end of the year.\nMeanwhile, Merck announced Thursday it has received the first authorization for molnupiravir in the U.K., with the drug to be marketed under the brand name Lagevrio.\nIts application with the FDA is under review. The European Medicines Agency has recently initiated a rolling review of its Marketing Authorization Application. Merck also said it is actively working to submit applications to other regulatory agencies around the world.\nThe commercial outlook could dramatically shift in favor of Pfizer's pill given how much more impressive the data is, BofA said. Merck's revenue guidance of $5 billion to $7 billion through 2022 provided on its third-quarter call last week could be reduced meaningfully, the firm added.\nMeanwhile, Gilead, Inc.'s antiviral remdesivir could remain an option for hospitalized patients, but overall its use is likely to further diminish, in BofA's view.","news_type":1},"isVote":1,"tweetType":1,"viewCount":50,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":855210462,"gmtCreate":1635377413498,"gmtModify":1635377538359,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/855210462","repostId":"2178234765","repostType":4,"repost":{"id":"2178234765","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1635376235,"share":"https://www.laohu8.com/m/news/2178234765?lang=&edition=full","pubTime":"2021-10-28 07:10","market":"us","language":"en","title":"Cyclicals drag S&P 500 lower; Microsoft, Alphabet keep Nasdaq flat","url":"https://stock-news.laohu8.com/highlight/detail?id=2178234765","media":"Reuters","summary":"* Microsoft top boost to all three major indexes\n* Energy stocks fall as oil prices drop\n* Dow down ","content":"<p>* Microsoft top boost to all three major indexes</p>\n<p>* Energy stocks fall as oil prices drop</p>\n<p>* Dow down 0.74%, S&amp;P 500 down 0.51%, Nasdaq unchanged</p>\n<p>NEW YORK, Oct 27 (Reuters) - The Nasdaq ended little changed on Wednesday, boosted by gains in Microsoft and Google parent Alphabet on the heels of their quarterly results, but a drop in oil prices and a pullback in Treasury yields weighed on cyclical sectors and pulled the S&amp;P 500 lower.</p>\n<p>Microsoft Corp gained 4.21% to close at a record high after forecasting a strong end to the calendar year, fueled in part by its booming cloud business. Alphabet Inc jumped 4.96% after reporting a record quarterly profit on a surge in ad sales.</p>\n<p>The gains in the two stocks accounted for nearly 90 points to the upside in the tech-heavy Nasdaq while Microsoft was the biggest boost to the Dow Industrials, S&amp;P 500 and Nasdaq.</p>\n<p>A pullback in longer-term U.S. Treasury bond yields and a flattening of the yield curve also helped support growth names such as those in consumer discretionary and communications services, which were the only advancing S&amp;P sectors on the day.</p>\n<p>The benchmark 10-year U.S. Treasury yield declined for a fourth straight day, dropping more than 6 basis points to put it on track for its biggest one-day decline since Aug. 13.</p>\n<p>\"The growthy names will get a boost not just from some of the earnings stuff but because interest rates are lower,\" said Megan Horneman, director of portfolio strategy at Verdence Capital Advisors in Hunt Valley, Maryland.</p>\n<p>\"Interest rates are temporarily lower because of the fact that there is some uncertainty from the tax perspective and what that might do. We do know the Fed is going to taper, that has pretty much been priced in but now you have a lot of talk about what the future of the Federal Reserve may look like.\"</p>\n<p>The Dow Jones Industrial Average fell 266.19 points, or 0.74%, to 35,490.69, the S&amp;P 500 lost 23.11 points, or 0.51%, to 4,551.68 and the Nasdaq Composite added 0.12 point, or unchanged, to 15,235.84.</p>\n<p>In contrast, the flattening curve served to weaken financials, while a drop in crude prices after data on U.S. stockpiles pulled energy names lower, with both sectors suffering their biggest one-day percentage decline in five weeks. JP Morgan shares fell 2.08% and Exxon Mobil declined 2.60%.</p>\n<p>A solid start to earnings season has helped push the S&amp;P 500 and the Dow to all-time highs this week, as investor concerns over the ability of companies to navigate supply-chain bottlenecks, labor shortages and rising price pressures have been allayed for now. The Nasdaq sits less than 1% away from Sept. 7 closing record.</p>\n<p>\"While we are not out of the woods by any means, companies are adjusting quicker than we had anticipated,\" said Horneman.</p>\n<p>Profits for S&amp;P 500 companies are expected to grow 37.6% year-on-year in the third quarter. Out of the 192 companies that have reported earnings, 82.8% have topped analyst expectations, according to Refinitiv IBES data.</p>\n<p>The move into the growth names like technology stocks was also triggered after some U.S. Senate Democrats proposed taxing billionaires' unrealized gains from their assets, while concerns around the timing of rate hikes resurfaced ahead of the Federal Reserve's policy meeting next week.</p>\n<p>The S&amp;P 500 growth index climbed about 0.28% while its value counterpart fell 1.44%.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 2.43-to-1 ratio; on Nasdaq, a 2.29-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 36 new 52-week highs and 5 new lows; the Nasdaq Composite recorded 72 new highs and 133 new lows.</p>\n<p>Volume on U.S. exchanges was 11.74 billion shares, compared with the 10.43 billion average for the full session over the last 20 trading days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cyclicals drag S&P 500 lower; Microsoft, Alphabet keep Nasdaq flat</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCyclicals drag S&P 500 lower; Microsoft, Alphabet keep Nasdaq flat\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-10-28 07:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Microsoft top boost to all three major indexes</p>\n<p>* Energy stocks fall as oil prices drop</p>\n<p>* Dow down 0.74%, S&amp;P 500 down 0.51%, Nasdaq unchanged</p>\n<p>NEW YORK, Oct 27 (Reuters) - The Nasdaq ended little changed on Wednesday, boosted by gains in Microsoft and Google parent Alphabet on the heels of their quarterly results, but a drop in oil prices and a pullback in Treasury yields weighed on cyclical sectors and pulled the S&amp;P 500 lower.</p>\n<p>Microsoft Corp gained 4.21% to close at a record high after forecasting a strong end to the calendar year, fueled in part by its booming cloud business. Alphabet Inc jumped 4.96% after reporting a record quarterly profit on a surge in ad sales.</p>\n<p>The gains in the two stocks accounted for nearly 90 points to the upside in the tech-heavy Nasdaq while Microsoft was the biggest boost to the Dow Industrials, S&amp;P 500 and Nasdaq.</p>\n<p>A pullback in longer-term U.S. Treasury bond yields and a flattening of the yield curve also helped support growth names such as those in consumer discretionary and communications services, which were the only advancing S&amp;P sectors on the day.</p>\n<p>The benchmark 10-year U.S. Treasury yield declined for a fourth straight day, dropping more than 6 basis points to put it on track for its biggest one-day decline since Aug. 13.</p>\n<p>\"The growthy names will get a boost not just from some of the earnings stuff but because interest rates are lower,\" said Megan Horneman, director of portfolio strategy at Verdence Capital Advisors in Hunt Valley, Maryland.</p>\n<p>\"Interest rates are temporarily lower because of the fact that there is some uncertainty from the tax perspective and what that might do. We do know the Fed is going to taper, that has pretty much been priced in but now you have a lot of talk about what the future of the Federal Reserve may look like.\"</p>\n<p>The Dow Jones Industrial Average fell 266.19 points, or 0.74%, to 35,490.69, the S&amp;P 500 lost 23.11 points, or 0.51%, to 4,551.68 and the Nasdaq Composite added 0.12 point, or unchanged, to 15,235.84.</p>\n<p>In contrast, the flattening curve served to weaken financials, while a drop in crude prices after data on U.S. stockpiles pulled energy names lower, with both sectors suffering their biggest one-day percentage decline in five weeks. JP Morgan shares fell 2.08% and Exxon Mobil declined 2.60%.</p>\n<p>A solid start to earnings season has helped push the S&amp;P 500 and the Dow to all-time highs this week, as investor concerns over the ability of companies to navigate supply-chain bottlenecks, labor shortages and rising price pressures have been allayed for now. The Nasdaq sits less than 1% away from Sept. 7 closing record.</p>\n<p>\"While we are not out of the woods by any means, companies are adjusting quicker than we had anticipated,\" said Horneman.</p>\n<p>Profits for S&amp;P 500 companies are expected to grow 37.6% year-on-year in the third quarter. Out of the 192 companies that have reported earnings, 82.8% have topped analyst expectations, according to Refinitiv IBES data.</p>\n<p>The move into the growth names like technology stocks was also triggered after some U.S. Senate Democrats proposed taxing billionaires' unrealized gains from their assets, while concerns around the timing of rate hikes resurfaced ahead of the Federal Reserve's policy meeting next week.</p>\n<p>The S&amp;P 500 growth index climbed about 0.28% while its value counterpart fell 1.44%.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 2.43-to-1 ratio; on Nasdaq, a 2.29-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 36 new 52-week highs and 5 new lows; the Nasdaq Composite recorded 72 new highs and 133 new lows.</p>\n<p>Volume on U.S. exchanges was 11.74 billion shares, compared with the 10.43 billion average for the full session over the last 20 trading days.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF",".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index","SSO":"两倍做多标普500ETF","OEX":"标普100","MSFT":"微软","SDS":"两倍做空标普500ETF","GOOG":"谷歌","SPY":"标普500ETF","SH":"标普500反向ETF","SPXU":"三倍做空标普500ETF","COMP":"Compass, Inc.","IVV":"标普500指数ETF","OEF":"标普100指数ETF-iShares","GOOGL":"谷歌A","UPRO":"三倍做多标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2178234765","content_text":"* Microsoft top boost to all three major indexes\n* Energy stocks fall as oil prices drop\n* Dow down 0.74%, S&P 500 down 0.51%, Nasdaq unchanged\nNEW YORK, Oct 27 (Reuters) - The Nasdaq ended little changed on Wednesday, boosted by gains in Microsoft and Google parent Alphabet on the heels of their quarterly results, but a drop in oil prices and a pullback in Treasury yields weighed on cyclical sectors and pulled the S&P 500 lower.\nMicrosoft Corp gained 4.21% to close at a record high after forecasting a strong end to the calendar year, fueled in part by its booming cloud business. Alphabet Inc jumped 4.96% after reporting a record quarterly profit on a surge in ad sales.\nThe gains in the two stocks accounted for nearly 90 points to the upside in the tech-heavy Nasdaq while Microsoft was the biggest boost to the Dow Industrials, S&P 500 and Nasdaq.\nA pullback in longer-term U.S. Treasury bond yields and a flattening of the yield curve also helped support growth names such as those in consumer discretionary and communications services, which were the only advancing S&P sectors on the day.\nThe benchmark 10-year U.S. Treasury yield declined for a fourth straight day, dropping more than 6 basis points to put it on track for its biggest one-day decline since Aug. 13.\n\"The growthy names will get a boost not just from some of the earnings stuff but because interest rates are lower,\" said Megan Horneman, director of portfolio strategy at Verdence Capital Advisors in Hunt Valley, Maryland.\n\"Interest rates are temporarily lower because of the fact that there is some uncertainty from the tax perspective and what that might do. We do know the Fed is going to taper, that has pretty much been priced in but now you have a lot of talk about what the future of the Federal Reserve may look like.\"\nThe Dow Jones Industrial Average fell 266.19 points, or 0.74%, to 35,490.69, the S&P 500 lost 23.11 points, or 0.51%, to 4,551.68 and the Nasdaq Composite added 0.12 point, or unchanged, to 15,235.84.\nIn contrast, the flattening curve served to weaken financials, while a drop in crude prices after data on U.S. stockpiles pulled energy names lower, with both sectors suffering their biggest one-day percentage decline in five weeks. JP Morgan shares fell 2.08% and Exxon Mobil declined 2.60%.\nA solid start to earnings season has helped push the S&P 500 and the Dow to all-time highs this week, as investor concerns over the ability of companies to navigate supply-chain bottlenecks, labor shortages and rising price pressures have been allayed for now. The Nasdaq sits less than 1% away from Sept. 7 closing record.\n\"While we are not out of the woods by any means, companies are adjusting quicker than we had anticipated,\" said Horneman.\nProfits for S&P 500 companies are expected to grow 37.6% year-on-year in the third quarter. Out of the 192 companies that have reported earnings, 82.8% have topped analyst expectations, according to Refinitiv IBES data.\nThe move into the growth names like technology stocks was also triggered after some U.S. Senate Democrats proposed taxing billionaires' unrealized gains from their assets, while concerns around the timing of rate hikes resurfaced ahead of the Federal Reserve's policy meeting next week.\nThe S&P 500 growth index climbed about 0.28% while its value counterpart fell 1.44%.\nDeclining issues outnumbered advancing ones on the NYSE by a 2.43-to-1 ratio; on Nasdaq, a 2.29-to-1 ratio favored decliners.\nThe S&P 500 posted 36 new 52-week highs and 5 new lows; the Nasdaq Composite recorded 72 new highs and 133 new lows.\nVolume on U.S. exchanges was 11.74 billion shares, compared with the 10.43 billion average for the full session over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":14,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":823566959,"gmtCreate":1633649919403,"gmtModify":1633649919759,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/823566959","repostId":"1163018074","repostType":4,"repost":{"id":"1163018074","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1633646971,"share":"https://www.laohu8.com/m/news/1163018074?lang=&edition=full","pubTime":"2021-10-08 06:49","market":"us","language":"en","title":"Wall Street ends day with solid gains; investors hail U.S. debt-ceiling truce","url":"https://stock-news.laohu8.com/highlight/detail?id=1163018074","media":"Reuters","summary":"U.S. Senate rushes to advance $480 bln debt-limit increase\nU.S. weekly jobless claims fall sharply\nC","content":"<ul>\n <li>U.S. Senate rushes to advance $480 bln debt-limit increase</li>\n <li>U.S. weekly jobless claims fall sharply</li>\n <li>Consumer discretionary and materials lead sectors</li>\n <li>Levi Strauss shares soar after profit beat</li>\n <li>Indexes jump: Dow 0.98%, S&amp;P 0.83%, Nasdaq 1.05%</li>\n</ul>\n<p>Oct 7 (Reuters) - Wall Street ended sharply higher on Thursday in a broad-based rally led by Big Tech, as a truce in the debt-ceiling standoff in the U.S. Congress relieved concerns of a possible government debt default this month.</p>\n<p>Mega-cap stocks jumped with Apple Inc&nbsp;up 0.9% and Amazon.com Inc&nbsp;rising 1.2%, the biggest boosts to the S&amp;P 500 and Nasdaq. Tesla&nbsp;and Google-parent Alphabet&nbsp;both rose more than 1%.</p>\n<p>The U.S. Senate took a step toward passing a $480 billion increase in Treasury Department borrowing authority, which would put off another partisan showdown until December.</p>\n<p>Uncertainty over the debt-ceiling negotiations was one concern investors cited in September as the S&amp;P 500 logged its biggest monthly percentage drop since the onset of the coronavirus pandemic in March 2020.</p>\n<p>\"Today's (market) is driven by a slight move in Washington towards rationality about being able to pay their bills, write some checks,\" said Kim Forrest, chief investment officer at Bokeh Capital Partners in Pittsburgh.</p>\n<p>Meanwhile, data showed the number of Americans filing new claims for jobless benefits dropped last week by the most in three months, suggesting the labor market recovery was regaining momentum as the latest wave of COVID-19 infections began to subside.</p>\n<p>The closely watched monthly U.S. jobs report is due on Friday.</p>\n<p>“Today’s numbers reinforce the expectation that employment will take a significant step up in the coming months, and I think that’s positive for the economy,” said Brad Neuman, director of market strategy at Alger.</p>\n<p>\"The market climbed its wall of worry today as fears of a debt-ceiling impasse receded and hopes for an acceleration in employment gains were reinforced.”</p>\n<p>The Dow Jones Industrial Average&nbsp;rose 0.98% to end at 34,754.94 points, while the S&amp;P 500&nbsp;gained 0.83% to 4,399.76.</p>\n<p>The Nasdaq Composite&nbsp;climbed 1.05% to 14,654.02.</p>\n<p>The S&amp;P 500 materials index&nbsp;jumped 1.35% and the consumer discretionary index&nbsp;rallied 1.50%, both leading among 11 sectors.</p>\n<p>U.S.-traded Chinese stocks Alibaba Group Holding&nbsp;and Tencent Holdings&nbsp;each surged about 8% as concerns around U.S.-Sino trade relations and Evergrande's&nbsp;debt crisis appeared to ease.</p>\n<p>Investors will watch third-quarter earnings reports that start to arrive in earnest next week. Analysts on average estimate S&amp;P 500 companies' earnings per share rose 29% in the third quarter, according to Refinitiv.</p>\n<p>Levi Strauss &amp; Co&nbsp;shares jumped 8.5% after the jeans maker beat third-quarter revenue and profit estimates.</p>\n<p>Volume on U.S. exchanges was 10.1 billion shares, compared with the 11 billion average over the last 20 trading days.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.50-to-1 ratio; on Nasdaq, a 2.49-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 31 new 52-week highs and four new lows; the Nasdaq Composite recorded 93 new highs and 80 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends day with solid gains; investors hail U.S. debt-ceiling truce</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends day with solid gains; investors hail U.S. debt-ceiling truce\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-10-08 06:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>U.S. Senate rushes to advance $480 bln debt-limit increase</li>\n <li>U.S. weekly jobless claims fall sharply</li>\n <li>Consumer discretionary and materials lead sectors</li>\n <li>Levi Strauss shares soar after profit beat</li>\n <li>Indexes jump: Dow 0.98%, S&amp;P 0.83%, Nasdaq 1.05%</li>\n</ul>\n<p>Oct 7 (Reuters) - Wall Street ended sharply higher on Thursday in a broad-based rally led by Big Tech, as a truce in the debt-ceiling standoff in the U.S. Congress relieved concerns of a possible government debt default this month.</p>\n<p>Mega-cap stocks jumped with Apple Inc&nbsp;up 0.9% and Amazon.com Inc&nbsp;rising 1.2%, the biggest boosts to the S&amp;P 500 and Nasdaq. Tesla&nbsp;and Google-parent Alphabet&nbsp;both rose more than 1%.</p>\n<p>The U.S. Senate took a step toward passing a $480 billion increase in Treasury Department borrowing authority, which would put off another partisan showdown until December.</p>\n<p>Uncertainty over the debt-ceiling negotiations was one concern investors cited in September as the S&amp;P 500 logged its biggest monthly percentage drop since the onset of the coronavirus pandemic in March 2020.</p>\n<p>\"Today's (market) is driven by a slight move in Washington towards rationality about being able to pay their bills, write some checks,\" said Kim Forrest, chief investment officer at Bokeh Capital Partners in Pittsburgh.</p>\n<p>Meanwhile, data showed the number of Americans filing new claims for jobless benefits dropped last week by the most in three months, suggesting the labor market recovery was regaining momentum as the latest wave of COVID-19 infections began to subside.</p>\n<p>The closely watched monthly U.S. jobs report is due on Friday.</p>\n<p>“Today’s numbers reinforce the expectation that employment will take a significant step up in the coming months, and I think that’s positive for the economy,” said Brad Neuman, director of market strategy at Alger.</p>\n<p>\"The market climbed its wall of worry today as fears of a debt-ceiling impasse receded and hopes for an acceleration in employment gains were reinforced.”</p>\n<p>The Dow Jones Industrial Average&nbsp;rose 0.98% to end at 34,754.94 points, while the S&amp;P 500&nbsp;gained 0.83% to 4,399.76.</p>\n<p>The Nasdaq Composite&nbsp;climbed 1.05% to 14,654.02.</p>\n<p>The S&amp;P 500 materials index&nbsp;jumped 1.35% and the consumer discretionary index&nbsp;rallied 1.50%, both leading among 11 sectors.</p>\n<p>U.S.-traded Chinese stocks Alibaba Group Holding&nbsp;and Tencent Holdings&nbsp;each surged about 8% as concerns around U.S.-Sino trade relations and Evergrande's&nbsp;debt crisis appeared to ease.</p>\n<p>Investors will watch third-quarter earnings reports that start to arrive in earnest next week. Analysts on average estimate S&amp;P 500 companies' earnings per share rose 29% in the third quarter, according to Refinitiv.</p>\n<p>Levi Strauss &amp; Co&nbsp;shares jumped 8.5% after the jeans maker beat third-quarter revenue and profit estimates.</p>\n<p>Volume on U.S. exchanges was 10.1 billion shares, compared with the 11 billion average over the last 20 trading days.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.50-to-1 ratio; on Nasdaq, a 2.49-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 31 new 52-week highs and four new lows; the Nasdaq Composite recorded 93 new highs and 80 new lows.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite","TCEHY":"腾讯控股ADR","BABA":"阿里巴巴",".SPX":"S&P 500 Index","AMZN":"亚马逊","AAPL":"苹果","LEVI":"李维斯",".DJI":"道琼斯","TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1163018074","content_text":"U.S. Senate rushes to advance $480 bln debt-limit increase\nU.S. weekly jobless claims fall sharply\nConsumer discretionary and materials lead sectors\nLevi Strauss shares soar after profit beat\nIndexes jump: Dow 0.98%, S&P 0.83%, Nasdaq 1.05%\n\nOct 7 (Reuters) - Wall Street ended sharply higher on Thursday in a broad-based rally led by Big Tech, as a truce in the debt-ceiling standoff in the U.S. Congress relieved concerns of a possible government debt default this month.\nMega-cap stocks jumped with Apple Inc up 0.9% and Amazon.com Inc rising 1.2%, the biggest boosts to the S&P 500 and Nasdaq. Tesla and Google-parent Alphabet both rose more than 1%.\nThe U.S. Senate took a step toward passing a $480 billion increase in Treasury Department borrowing authority, which would put off another partisan showdown until December.\nUncertainty over the debt-ceiling negotiations was one concern investors cited in September as the S&P 500 logged its biggest monthly percentage drop since the onset of the coronavirus pandemic in March 2020.\n\"Today's (market) is driven by a slight move in Washington towards rationality about being able to pay their bills, write some checks,\" said Kim Forrest, chief investment officer at Bokeh Capital Partners in Pittsburgh.\nMeanwhile, data showed the number of Americans filing new claims for jobless benefits dropped last week by the most in three months, suggesting the labor market recovery was regaining momentum as the latest wave of COVID-19 infections began to subside.\nThe closely watched monthly U.S. jobs report is due on Friday.\n“Today’s numbers reinforce the expectation that employment will take a significant step up in the coming months, and I think that’s positive for the economy,” said Brad Neuman, director of market strategy at Alger.\n\"The market climbed its wall of worry today as fears of a debt-ceiling impasse receded and hopes for an acceleration in employment gains were reinforced.”\nThe Dow Jones Industrial Average rose 0.98% to end at 34,754.94 points, while the S&P 500 gained 0.83% to 4,399.76.\nThe Nasdaq Composite climbed 1.05% to 14,654.02.\nThe S&P 500 materials index jumped 1.35% and the consumer discretionary index rallied 1.50%, both leading among 11 sectors.\nU.S.-traded Chinese stocks Alibaba Group Holding and Tencent Holdings each surged about 8% as concerns around U.S.-Sino trade relations and Evergrande's debt crisis appeared to ease.\nInvestors will watch third-quarter earnings reports that start to arrive in earnest next week. Analysts on average estimate S&P 500 companies' earnings per share rose 29% in the third quarter, according to Refinitiv.\nLevi Strauss & Co shares jumped 8.5% after the jeans maker beat third-quarter revenue and profit estimates.\nVolume on U.S. exchanges was 10.1 billion shares, compared with the 11 billion average over the last 20 trading days.\nAdvancing issues outnumbered declining ones on the NYSE by a 2.50-to-1 ratio; on Nasdaq, a 2.49-to-1 ratio favored advancers.\nThe S&P 500 posted 31 new 52-week highs and four new lows; the Nasdaq Composite recorded 93 new highs and 80 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":140,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":829351496,"gmtCreate":1633476520232,"gmtModify":1633476522481,"author":{"id":"3586734124712023","authorId":"3586734124712023","name":"Zlatan","avatar":"https://static.tigerbbs.com/851e5397e61566365d8aa47e422075b4","crmLevel":5,"crmLevelSwitch":0},"themes":[],"htmlText":"Whay","listText":"Whay","text":"Whay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/829351496","repostId":"2173197859","repostType":4,"repost":{"id":"2173197859","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1633475486,"share":"https://www.laohu8.com/m/news/2173197859?lang=&edition=full","pubTime":"2021-10-06 07:11","market":"us","language":"en","title":"Emirates slams Boeing over 777X jet delays","url":"https://stock-news.laohu8.com/highlight/detail?id=2173197859","media":"Reuters","summary":"Boston (Reuters) -The head of Dubai airline Emirates piled pressure on planemaker Boeing on Tuesday ","content":"<p>Boston (Reuters) -The head of Dubai airline Emirates piled pressure on planemaker Boeing on Tuesday over delays to its 777X jetliner, warning that the uncertainty would cause significant disruption for one of the world's biggest carriers.</p>\n<p>Emirates President Tim Clark said he wanted \"another grown-up conversation\" with the U.S. planemaker over the timing of the twin-engined jumbo, which is running at least two-and-a-half years behind its originally planned arrival of June 2020.</p>\n<p>\"We work to precision. I struggle with others who can't get that,\" Clark told reporters shortly before he was due to meet Boeing leaders on the sidelines of an airline industry summit.</p>\n<p>Clark, an airline industry veteran who was closely involved in the development of the current 777-300ER model, has lambasted Boeing this year over repeated delays to its 777X.</p>\n<p>Boeing did not immediately respond to a request for comment.</p>\n<p>The company has previously said it plans to start delivering the new, larger version of the 777 wide-body jet by late 2023, three years later than originally planned, partly owing to a longer certification process after fatal 737 MAX jet crashes.</p>\n<p>Clark, who was taking part in an International Air Transport Association meeting in Boston, emphasised that the uncertainty over Boeing's progress with the programme would hamper his airline's complex fleet plans which include Airbus jets.</p>\n<p>Emirates, which has 126 777X jets on order, is a launch customer for the new aircraft that will replace the current 777 jets that are the backbone of its wide-body fleet.</p>\n<p>Clark said that Emirates still did not know when the first 777-9 version of the twin-engine jumbo would arrive, nor whether the smaller 777-8 version would be built at all.</p>\n<p>In May, Clark said Emirates would refuse delivery of 777X jets that did not meet contractual agreements. On Tuesday he said he would like industry contracts to be altered to make manufacturers more liable for the knock-on effects of delays.</p>\n<p>Currently manufacturers are liable for product defects, not indirect \"consequential damages\" such as passenger compensation. Analysts say industrial suppliers are reluctant to take on commitments that create open exposure to airline operations.</p>\n<p>In April the Gulf airline's chairman said that some of the 126 777X jets ordered could be swapped for smaller Boeing 787 Dreamliners.</p>\n<p>Emirates already revised its order for the 777X in 2019, cancelling orders for 24 of the jets as part of a deal that saw it agree to buy 30 Dreamliners.</p>\n<p>Asked on Tuesday whether Emirates could swap more 777X planes for the smaller 787, Clark said much would depend on Boeing.</p>\n<p>Turning to recovery, Clark said bookings had increased significantly to markets that are reopening after COVID-19.</p>\n<p>\"We've reduced the loss over this time last year by a significant percentage,\" he said.</p>\n<p>\"With opening of borders, we've seen a major kick-in of income, of demand, so in the second half of the financial year, we're looking to see a much greater improvement as to the first half,\" he added.</p>\n<p>\"We still won't be out of the woods ... but going forward into the 2022-23 (April/March) financial year, I'm sure the business will really start to generate the cash that it needs and go profitable during the course of 2022-23, moderately so.\"</p>\n<p>Emirates is due to report first-half earnings next month.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Emirates slams Boeing over 777X jet delays</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEmirates slams Boeing over 777X jet delays\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-10-06 07:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Boston (Reuters) -The head of Dubai airline Emirates piled pressure on planemaker Boeing on Tuesday over delays to its 777X jetliner, warning that the uncertainty would cause significant disruption for one of the world's biggest carriers.</p>\n<p>Emirates President Tim Clark said he wanted \"another grown-up conversation\" with the U.S. planemaker over the timing of the twin-engined jumbo, which is running at least two-and-a-half years behind its originally planned arrival of June 2020.</p>\n<p>\"We work to precision. I struggle with others who can't get that,\" Clark told reporters shortly before he was due to meet Boeing leaders on the sidelines of an airline industry summit.</p>\n<p>Clark, an airline industry veteran who was closely involved in the development of the current 777-300ER model, has lambasted Boeing this year over repeated delays to its 777X.</p>\n<p>Boeing did not immediately respond to a request for comment.</p>\n<p>The company has previously said it plans to start delivering the new, larger version of the 777 wide-body jet by late 2023, three years later than originally planned, partly owing to a longer certification process after fatal 737 MAX jet crashes.</p>\n<p>Clark, who was taking part in an International Air Transport Association meeting in Boston, emphasised that the uncertainty over Boeing's progress with the programme would hamper his airline's complex fleet plans which include Airbus jets.</p>\n<p>Emirates, which has 126 777X jets on order, is a launch customer for the new aircraft that will replace the current 777 jets that are the backbone of its wide-body fleet.</p>\n<p>Clark said that Emirates still did not know when the first 777-9 version of the twin-engine jumbo would arrive, nor whether the smaller 777-8 version would be built at all.</p>\n<p>In May, Clark said Emirates would refuse delivery of 777X jets that did not meet contractual agreements. On Tuesday he said he would like industry contracts to be altered to make manufacturers more liable for the knock-on effects of delays.</p>\n<p>Currently manufacturers are liable for product defects, not indirect \"consequential damages\" such as passenger compensation. Analysts say industrial suppliers are reluctant to take on commitments that create open exposure to airline operations.</p>\n<p>In April the Gulf airline's chairman said that some of the 126 777X jets ordered could be swapped for smaller Boeing 787 Dreamliners.</p>\n<p>Emirates already revised its order for the 777X in 2019, cancelling orders for 24 of the jets as part of a deal that saw it agree to buy 30 Dreamliners.</p>\n<p>Asked on Tuesday whether Emirates could swap more 777X planes for the smaller 787, Clark said much would depend on Boeing.</p>\n<p>Turning to recovery, Clark said bookings had increased significantly to markets that are reopening after COVID-19.</p>\n<p>\"We've reduced the loss over this time last year by a significant percentage,\" he said.</p>\n<p>\"With opening of borders, we've seen a major kick-in of income, of demand, so in the second half of the financial year, we're looking to see a much greater improvement as to the first half,\" he added.</p>\n<p>\"We still won't be out of the woods ... but going forward into the 2022-23 (April/March) financial year, I'm sure the business will really start to generate the cash that it needs and go profitable during the course of 2022-23, moderately so.\"</p>\n<p>Emirates is due to report first-half earnings next month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BA":"波音"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2173197859","content_text":"Boston (Reuters) -The head of Dubai airline Emirates piled pressure on planemaker Boeing on Tuesday over delays to its 777X jetliner, warning that the uncertainty would cause significant disruption for one of the world's biggest carriers.\nEmirates President Tim Clark said he wanted \"another grown-up conversation\" with the U.S. planemaker over the timing of the twin-engined jumbo, which is running at least two-and-a-half years behind its originally planned arrival of June 2020.\n\"We work to precision. I struggle with others who can't get that,\" Clark told reporters shortly before he was due to meet Boeing leaders on the sidelines of an airline industry summit.\nClark, an airline industry veteran who was closely involved in the development of the current 777-300ER model, has lambasted Boeing this year over repeated delays to its 777X.\nBoeing did not immediately respond to a request for comment.\nThe company has previously said it plans to start delivering the new, larger version of the 777 wide-body jet by late 2023, three years later than originally planned, partly owing to a longer certification process after fatal 737 MAX jet crashes.\nClark, who was taking part in an International Air Transport Association meeting in Boston, emphasised that the uncertainty over Boeing's progress with the programme would hamper his airline's complex fleet plans which include Airbus jets.\nEmirates, which has 126 777X jets on order, is a launch customer for the new aircraft that will replace the current 777 jets that are the backbone of its wide-body fleet.\nClark said that Emirates still did not know when the first 777-9 version of the twin-engine jumbo would arrive, nor whether the smaller 777-8 version would be built at all.\nIn May, Clark said Emirates would refuse delivery of 777X jets that did not meet contractual agreements. On Tuesday he said he would like industry contracts to be altered to make manufacturers more liable for the knock-on effects of delays.\nCurrently manufacturers are liable for product defects, not indirect \"consequential damages\" such as passenger compensation. Analysts say industrial suppliers are reluctant to take on commitments that create open exposure to airline operations.\nIn April the Gulf airline's chairman said that some of the 126 777X jets ordered could be swapped for smaller Boeing 787 Dreamliners.\nEmirates already revised its order for the 777X in 2019, cancelling orders for 24 of the jets as part of a deal that saw it agree to buy 30 Dreamliners.\nAsked on Tuesday whether Emirates could swap more 777X planes for the smaller 787, Clark said much would depend on Boeing.\nTurning to recovery, Clark said bookings had increased significantly to markets that are reopening after COVID-19.\n\"We've reduced the loss over this time last year by a significant percentage,\" he said.\n\"With opening of borders, we've seen a major kick-in of income, of demand, so in the second half of the financial year, we're looking to see a much greater improvement as to the first half,\" he added.\n\"We still won't be out of the woods ... but going forward into the 2022-23 (April/March) financial year, I'm sure the business will really start to generate the cash that it needs and go profitable during the course of 2022-23, moderately so.\"\nEmirates is due to report first-half earnings next month.","news_type":1},"isVote":1,"tweetType":1,"viewCount":3,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}